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Abstract 
Metabolic Strategies to Cope with Overcrowding in a Pseudomonas aeruginosa Biofilm 
Jeanyoung Jo 
 Bacteria, while traditionally studied in liquid suspensions, are often found in nature as 
biofilms, aggregates of cells enclosed in self-produced matrices. Cells in biofilms have a fitness 
advantage over those that are free-living, as the biofilm lifestyle is correlated with increased 
resistance to various assaults, including antimicrobials, UV exposure, and dehydration. These 
biofilm-associated characteristics have important clinical implications, as biofilm-based bacterial 
infections are a major cause of morbidity in immunocompromised individuals. With this 
increased resiliency, however, comes a major challenge that arises during biofilm growth: the 
formation of resource gradients. My thesis work focused on one particular gradient, that of 
oxygen, which is established in biofilms formed by Pseudomonas aeruginosa. This bacterium 
has multiple mechanisms for coping with limited access to oxygen, including a highly-branched 
respiratory system for optimal oxygen scavenging and production and utilization of redox-active 
molecules called phenazines. The purpose of this thesis has been to investigate the different 
strategies used by P. aeruginosa to deal with the oxygen limitation precipitated by the biofilm 
lifestyle.  
 In Chapter 1, I will provide the necessary background for understanding the principles of 
redox balancing, metabolism, respiration, biofilm physiology, and phenazine utilization in P. 
aeruginosa. The work described in Chapter 2 provides evidence for the formation of a novel 
terminal oxidase complex that plays a biofilm-specific role in P. aeruginosa growth. The results 
in this chapter also suggest that specific terminal oxidase complexes differ in the timing of their 
contributions to biofilm growth and implicate the novel complex in mediating reduction of 
phenazines in biofilms. 
 Chapter 3 expands upon the principle of metabolic versatility exemplified by the results 
discussed in Chapter 2. The research presented in this chapter looks at how varying the source 
of electrons that feed into the respiratory chain influences downstream electron transfer steps, 
including terminal oxidase activities and phenazine production and utilization. The data 
presented in Chapters 2 and 3 add to the growing body of evidence that bacterial growth in 
liquid culture is distinct from that in biofilms and underscores the need for more biofilm-based 
research that can inform treatment strategies for P. aeruginosa infections.  
 The results described in Chapter 4 take an even broader look at the strategies used by 
P. aeruginosa to sustain efficient metabolism under conditions of potential stress. An important 
node of central metabolism is pyruvate, which can be transformed in a number of ways. In this 
chapter, I will consider two pathways of pyruvate metabolism: fermentation to lactate and 
carboxylation to oxaloacetate. I will present data indicating that a previously-uncharacterized 
lactate dehydrogenase contributes to P. aeruginosa growth under specific growth conditions and 
that pyruvate carboxylation contributes to optimal progress through central metabolic pathways. 
I will also describe experiments that characterize the contributions of another carboxylase, 
previously thought to function as the pyruvate carboxylase, to P. aeruginosa’s ability to grow on 
selected nutrient sources. Finally, I will discuss how redox state informs biofilm formation in a 
phylogenetically distinct bacterium, Bacillus subtilis, highlighting the universality of redox 
reactions in driving metabolic processes. 
 In sum, the research presented in this thesis broadens our understanding of the 
immense respiratory and metabolic flexibility of P. aeruginosa and serves as an important 
reminder of the discrete factors that govern liquid culture and biofilm growth. 
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Chapter 1: Introduction 
1.1: Balancing life’s reactions: The importance of redox homeostasis 
 Though life, as a concept, is difficult to define, a unique feature that can help us to 
understand it is homeostasis: a balanced internal condition that persists in spite of changes in 
the environment. Metabolism is a network of reactions that enables growth while keeping cells 
in this state of balance. This thesis focuses on pathways of organotrophy and aerobic 
respiration, in which carbon sources are metabolized to produce energy using oxygen. At one 
end of this scheme are the carbon sources that feed electrons into the metabolic pathways. At 
the other end is oxygen, which is reduced upon the final electron transfer step carried out by the 
terminal oxidase(s). In between the two, the respiratory chain performs a series of coordinated 
reactions that couple electron transfer to cellular energy generation.  
 When a carbon source is catabolized, it is oxidized through a series of reactions that 
generate reduced intracellular intermediates. Electrons released from the oxidation of carbon 
sources are passed through a series of carriers, each one more electronegative than the last, 
until they arrive at the terminal electron acceptor. In aerobically respiring organisms, this is 
molecular oxygen (O2). The transfer of electrons between the membrane-associated proteins 
that constitute the respiratory chain is coupled to the pumping of protons across the membrane 
to generate an electrochemical gradient (also called the proton motive force or ∆p), which 
ultimately drives cellular energy production in the form of adenosine triphosphate (ATP) 
synthesis. For these reactions to continually proceed, substrates must be regenerated and the 
cellular redox state must be maintained at a potential that favors catabolism.  
 Imbalances that disturb cellular redox homeostasis can have harmful consequences for 
the cell. Our lab studies the various mechanisms through which the clinically-relevant bacterium 
Pseudomonas aeruginosa maintains redox homeostasis and how redox state affects bacterial 
physiology. We are especially interested in learning more about the mechanisms that underlie 
redox homeostasis in biofilms, multicellular assemblages of bacteria encased within a self-
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produced matrix (Høiby et al. 2011). P. aeruginosa exists as biofilms both in nature as well as in 
clinical environments (Hall-Stoodley, Costerton, and Stoodley 2004; Williams, Zlosnik, and Ryall 
2007; Ciofu et al. 2012; Penesyan, Gillings, and Paulsen 2015). The presence of P. aeruginosa 
biofilms in the latter context is a major problem for the treatment of infections caused by this 
bacterium, as biofilms are more resistant to external stressors, such as antibiotic treatment, than 
free-living, planktonic cells (Ciofu et al. 2012). However, as cells switch from the planktonic to 
the biofilm mode of growth, they encounter new challenges they must overcome, perhaps the 
most notable being the formation of steep nutrient gradients across biofilm depth (Werner et al. 
2004). Therefore, a more thorough understanding of the metabolic processes that drive biofilm 
formation will serve not only to broaden our understanding of the physiology of multicellularity 
but will also lead to more efficient ways to combat this opportunistic pathogen. 
1.2: Fueling the electron transport chain: Carbon sources 
 P. aeruginosa is a heterotrophic, motile, Gram-negative bacterium known for its 
metabolic versatility, which allows it to grow under many conditions. One facet of this versatility 
is seen in its ability to grow on a variety of carbon sources (Stanier, Palleroni, and Doudoroff 
1966; Ornston 1971; Wargo 2013). The P. aeruginosa genome, already considered quite large 
for that of a bacterium, encodes a noticeably significant amount of membrane transport 
systems, about two-thirds of which are involved in nutrient uptake (Stover et al. 2000). Once 
these substrates are transported into the cell, a multitude of potential pathways exists for their 
catabolism (Figure 1.1). A few key pathways of carbon catabolism are summarized below. 
 Glucose and other hexoses are broken down via the Entner-Doudoroff pathway, an 
alternative pathway akin to glycolysis. The Entner-Doudoroff pathway is almost completely 
restricted to prokaryotes (i.e., bacteria and archaea), and is commonly found among aerobic, 
Gram-negative bacteria (White, Drummond, and Fuqua 2012). While many bacteria can employ 
both the Entner-Doudoroff and glycolytic pathways depending on environmental factors, 
pseudomonads are restricted to the Entner-Doudoroff pathway because they lack two key 
2
Figure 1.1. An overview of Pseudomonas aeruginosa central metabolism. An abridged 
overview of the central metabolic pathways in P. aeruginosa. Dark blue, Entner-Doudoroff 
pathway; green, gluconeogenesis; orange, tricarboxylic acid (TCA) cycle; purple, generation of 
phosphoenolpyruvate (PEP); red, pyruvate carboxylation; yellow, pyruvate fermentation; light 
blue, pathways of amino acid synthesis; gray, anabolic building blocks. Within amino acid 
synthesis pathways, yellow highlights indicate amino acids that lead to the synthesis of other 
amino acids while bold and italicized indicate essential amino acids. (Madigan et al., 2015, 
White et al., 2012, KEGG Pathway Database (https://www.genome.jp/kegg/pathway.html)).
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enzymes necessary to carry out glycolysis. In contrast to glycolysis, which has a net ATP 
production of two molecules per glucose, the Entner-Doudoroff pathway generates just one net 
ATP per glucose (White, Drummond, and Fuqua 2012). The enzymes involved in this pathway 
are produced upon exposure to hexoses, but not in response to three- or four-carbon sugar 
acids (Ornston 1971) and oxidize glucose to pyruvate. Once pyruvate is generated, it can be 
oxidized to acetyl-CoA, reduced to lactate, or carboxylated to oxaloacetate (Figure 1.1). The 
fate of pyruvate is determined by the environmental conditions to which the bacterium is 
exposed. 
 Under aerobic conditions, pyruvate is usually oxidized to acetyl-CoA, which is further 
oxidized via the tricarboxylic acid (TCA) cycle (also called the citric acid or Krebs cycle). The 
TCA cycle begins when acetyl-CoA, together with oxaloacetate, forms the 6-carbon compound 
citric acid. Through a series of reactions, citric acid is oxidized in a stepwise fashion to ultimately 
regenerate oxaloacetate, thus fulfilling the “cyclic” nature of the TCA cycle (Madigan et al. 2015; 
Figure 1.1), and producing reduced cofactors and electron carriers such as FADH and 
NAD(P)H. TCA cycle intermediates serve as precursors for the biosynthesis of amino acids, 
cytochromes, and fatty acids (Madigan et al. 2015; Figure 1.1). It is important that TCA cycle 
intermediates are constantly replenished so that the cycle can continue to run. This 
replenishment occurs through a series of anaplerotic reactions, i.e., reactions that generate the 
intermediates of a metabolic pathway. One of the anaplerotic reactions that replenishes the TCA 
cycle is mediated by the enzyme pyruvate carboxylase, which is essential for oxaloacetate 
replenishment when P. aeruginosa is growing on a sugar (White, Drummond, and Fuqua 2012; 
Figure 1.1).  
 As citric acid is oxidized, the electrons released from these reactions are transferred to 
NAD(P)+ and FAD to generate NAD(P)H and FADH2, respectively. In P. aeruginosa, the TCA 
cycle is the predominant source of reducing power that fuels electron transport (Lee et al. 2015). 
While various metabolites can influence the cellular redox potential and directly or indirectly 
donate electrons to the electron transport chain (ETC), NADH participates in numerous 
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reactions of central metabolism and is the canonical donor to the ETC in textbook models 
(White, Drummond, and Fuqua 2012; Madigan et al. 2015). It is imperative that NADH is re-
oxidized to NAD+ to enable continual metabolic function. The oxidation of NADH is coupled to 
ATP synthesis through the ETC, which serves as the major pathway through which NAD+ is 
regenerated. 
1.3: Dissipating intracellular redox stress: The electron transport chain 
1.3.1: Electron carriers 
 The overall machinery and steps of electron transfer and proton pumping are similar 
between bacteria and eukaryotes. The respiratory machinery is embedded in the inner 
membrane of mitochondria in eukaryotes (van der Bliek, Sedensky, and Morgan 2017) and in 
the cytoplasmic membranes of bacteria (Madigan et al. 2015). Respiratory electron carriers 
include flavoproteins, quinones, iron-sulfur proteins, and cytochromes, all of which are proteins 
except for quinones, which are lipids. The protein-based electron carriers contain prosthetic 
groups, which are the actual sites of electron transfer (White, Drummond, and Fuqua 2012). 
The prosthetic groups in flavoproteins are flavins, which include flavin adenine dinucleotide 
(FAD) and flavin mononucleotide (FMN). The prosthetic group in iron-sulfur proteins is the iron-
sulfur cluster. The prosthetic group in cytochromes is heme. These electron carriers possess 
different redox potentials and are arranged such that the electron passes sequentially to carriers 
with higher potentials until it reaches the molecule with the highest potential, the final electron 
acceptor. 
 My main thesis work centered on the physiological role of a cytochrome complex. The 
heme prosthetic group of cytochromes is made up of four pyrrole rings (hence giving them the 
classification of tetrapyrroles) joined together through methene bridges (Figure 1.2). Each heme 
contains a centrally-located iron atom that is bound to the nitrogen of each of the four pyrrole 
rings, and it is this iron that serves as the electron carrier (Figure 1.2). Each pyrrole ring can be 
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modified by a side chain, and the side chains that adorn the pyrrole rings of a heme dictate the 
heme classification (White, Drummond, and Fuqua 2012). 
  
 There are five classes of hemes, and the heme nomenclature is carried over when 
describing the cytochromes to which they belong: a, b, c, d, and o. Hemes d and o have 
currently only been found in bacterial cytochromes (White, Drummond, and Fuqua 2012). 
Because hemes are classified by their decorating side chains, they typically show distinguishing 
spectrophotometric curves. A cytochrome’s characteristic peak wavelength is often incorporated 
into its name, particularly for cytochromes from eukaryotes (i.e., cytochrome b556, which is a 
cytochrome containing a b-type heme that shows a peak at 556 nm). Occasionally, the name of 
a cytochrome will bear a subscript 3, which indicates the O2-binding heme (White, Drummond, 
and Fuqua 2012; Cramer and Kallas 2016). For example, the mitochondrial terminal oxidase (to 
be discussed further below) is called cytochrome aa3; the name of this cytochrome tells us that 


















Figure 1.2. General structure of a heme. Heme 
consists of four pyrrole rings interconnected through 
methene bridges and a central iron, which is bound to 
the heme via the nitrogen of each pyrrole ring. The 
iron atom is the electron carrier; its oxidized form is 
ferric (Fe(III)) iron while its reduced form is ferrous 
(Fe(II))  iron.
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cytochrome names contain a prime (‘) annotation, which also denotes the heme that is likely to 
bind O2 (Cramer and Kallas 2016).  
1.3.2: Electron transfer through the ETC 
 Here, I will provide a general overview of the steps of the aerobic respiratory chains that 
function in mitochondria (Figure 1.3) and pseudomonads (Figure 1.4). Electrons primarily enter 
the ETC at the NADH dehydrogenase (called Complex I in eukaryotes). The electron released 
by the oxidation of NADH is transferred to ubiquinone, a molecule in the membrane. This redox 
reaction is coupled to the translocation of protons across the membrane and contributes to the 
formation of a proton gradient. Succinate dehydrogenase (Complex II in eukaryotes) also 
reduces ubiquinone by oxidizing succinate, a TCA cycle intermediate. This electron transfer step 
serves as a direct link between the TCA cycle and the respiratory chain. The hydrophobic nature 
of ubiquinone allows it to shuttle electrons from the dehydrogenases to the next electron carrier, 
the cytochrome bc1 complex (Complex III) (Madigan et al. 2015; van der Bliek, Sedensky, and 
Morgan 2017). This complex then passes electrons to another mobile electron carrier, 
cytochrome c, which delivers electrons to O2 via the activity of the terminal oxidase (Complex 
IV). The redox reactions catalyzed by the bc1 complex and the terminal oxidase are both 
coupled to proton translocation across the membrane. The resulting proton gradient is used to 
power ATP production by the ATP synthase (ATPase; or Complex V) (Madigan et al. 2015).  
1.3.3: The implications of a branched ETC 
 Eukaryotes have a relatively straightforward electron transport chain (Figure 1.3), and 
the mitochondrial electron transfer pathways are generally invariable across the domain. 
Bacterial respiratory pathways are often more branched than those of eukaryotes (Poole and 
Cook 2000; White, Drummond, and Fuqua 2012). Across the bacterial domain, there is more 
flexibility in terms of the substrates that can be used as electron donors and acceptors in the 
respiratory chain (White, Drummond, and Fuqua 2012). Furthermore, bacterial respiratory 
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chains exhibit more redundancy along various steps of the electron transfer pathways, with 
multiple iterations of a protein complex existing to catalyze a particular step in the pathway 
(Poole and Cook 2000; Williams, Zlosnik, and Ryall 2007; Hirai et al. 2016; Jo et al. 2017). 
These branch points are often influenced by external factors, such that bacterial respiratory 
chains can be modulated in response to environmental conditions. This provides bacteria with 
more metabolic versatility, as they are able to adapt their respiratory chains to be the most 
optimal for specific conditions. For example, the respiratory system of Escherichia coli can 
terminate at one of two terminal oxidases: an energetically favorable but low-O2-affinity terminal 
oxidase, “Bo3“, is used when O2 is abundant while a less energetically favorable but high-O2-
affinity terminal oxidase, “Bd”, is used when O2 is scarce (Williams, Zlosnik, and Ryall 2007). 
 Our lab’s model organism, P. aeruginosa, is well-known for its ability to thrive under 
conditions of low O2 (Comolli and Donohue 2004; Alvarez-Ortega and Harwood 2007; Williams, 
Zlosnik, and Ryall 2007; Arai 2011). Not coincidentally, it has even more versatility at the 
terminal end of the respiratory chain than E. coli (Williams, Zlosnik, and Ryall 2007). P. 
Figure 1.3. Mitochondrial electron transport chain. Electrons enter the electron transport 
chain (ETC) at Complexes I (orange) or II (pink), the primary dehydrogenases, which then 
reduce ubiquinone (Q). Q is oxidized by Complex III (the bc1 complex; purple) which is in turn 
oxidized by the mobile electron carrier cytochrome c (green). Cytochrome c donates electrons 
to Complex IV (the terminal oxidase; blue), which delivers electrons to their final destination, O2. 
Complexes I, III, and IV contribute to the generation of a proton gradient (∆p), which is used by 
Complex V (ATP synthase; yellow) to generate energy in the form of ATP.
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aeruginosa’s ability to dominate in microaerobic environments is largely due to its arsenal of five 
terminal oxidases (Figure 1.4), all of which differ in expression patterns, environmental 
sensitivities, and O2 affinity (Alvarez-Ortega and Harwood 2007; Kawakami et al. 2010; Hirai et 
al. 2016)). A more in-depth description of these terminal oxidases will follow in the next section.  
1.3.4: P. aeruginosa colony biofilms as a model system 
 We use P. aeruginosa colony biofilms as a model to study how resource limitation affects 
the redox homeostasis of cells in densely-packed aggregates. By placing a 10-µl spot of cells 
onto an agar plate and monitoring community development, we are able to investigate how P. 
aeruginosa cells coordinate to form elaborate architectures over time. Our lab has shown that 
O2 availability plays a crucial role in driving biofilm morphogenesis. While the details of redox 
balancing in biofilms will be discussed further later in this chapter, it is important to note that as 
biofilms develop (and grow thicker), O2 is consumed rather rapidly within the biofilm, with no O2 
Figure 1.4. P. aeruginosa electron transport chain. Electrons enter the electron transport chain 
(ETC) at the NADH (orange) or succinate (pink) dehydrogenases, which then reduce ubiquinone 
(Q). Q can be oxidized by quinol oxidases (brown) or the bc1 complex, the latter of which is 
oxidized by the mobile electron carrier cytochrome c (green). P. aeruginosa encodes two quinol 
oxidases, Bo3 and Cio. Cytochrome c  reduces one of three cytochrome c oxidases (blue), Aa3, 
Cco1, or Cco2. The quinol and cytochrome c oxidases are terminal oxidases that deliver electrons 
to their final destination, O2. Electron transfer steps mediated by the NADH dehydrogenase, the bc1 
complex, and the terminal oxidases contribute to the generation of a proton gradient (∆p), which is 
used by ATP synthase (yellow) to generate energy in the form of ATP.
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detected below a depth of ~75-80 µm from the surface (Dietrich et al. 2013; Jo et al. 2017). 
Biofilms are fully oxic during early stages of development; however, as they grow thicker, they 
develop a considerable anoxic zone such that cells positioned further into the colony have less 
access to O2 than cells at the periphery (Jo et al. 2017; Chapter 2).  
 Limited access to O2, the terminal electron acceptor, poses a problem to the biofilm 
because this compromises the ETC’s ability to dissipate the accumulated reducing power that is 
created during metabolism. This is quantifiable and manifests as an increased intracellular 
NADH/NAD+ ratio as biofilms develop (Dietrich et al. 2013). Once the biofilm’s NADH/NAD+ ratio 
reaches a tipping point, cells within the biofilm will coordinate and begin to wrinkle their surface, 
thereby increasing their access to O2. This wrinkling coincides with a drop in NADH/NAD+ ratios 
back down to levels during early development (Dietrich et al. 2013). Therefore, access to O2 is 
directly related to intracellular redox state and P. aeruginosa has a variety of mechanisms 
through which they maximize their access to O2, one of which is a large complement of terminal 
oxidases. 
1.3.5: The terminal oxidases of P. aeruginosa 
This section is adapted from:  
Jo, J, Price-Whelan, A, Dietrich, LEP (2014). An aerobic exercise: Defining the roles of 
Pseudomonas aeruginosa terminal oxidases. J Bacteriol 196, 4203-4205. 
In 2014, I co-authored a commentary article in the Journal of Bacteriology about the terminal 
oxidases of P. aeruginosa. This commentary was written as a companion piece to a study 
published in the same issue that elucidated the efficiencies of the respiratory chain terminated 
by each of these oxidases and determined their affinities for O2. This section is a modified 
version of that commentary piece, the published version of which is included as an appendix to 
my thesis.   
 P. aeruginosa is an exceptionally metabolically versatile organism, and the presence of 
an ETC terminating at five different oxidases is but one aspect of this adaptability (Figure 1.5). 
The mitochondrial respiratory chain terminates at the Aa3 (or Cox) complex, which accepts 
electrons from cytochrome c and is therefore referred to as a cytochrome c oxidase. P. 
aeruginosa encodes an Aa3 oxidase as well as two more cytochrome c oxidases, Cco1 and 
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Cco2. Furthermore, it contains two terminal oxidases, Bo3 and Cio, that receive their electrons 
directly from the ubiquinone pool and, as such, are called (ubi)quinol oxidases (Williams, 
Zlosnik, and Ryall 2007).  
 A diverse collection of terminal oxidases may be especially important for an organism 
that has a proficiency for persisting in biofilms, which are characterized by the formation of 
steep O2 gradients (Xu et al. 1998; Werner et al. 2004; Wessel et al. 2014) P. aeruginosa’s five 
terminal oxidases have varying proton-pumping efficiencies, affinities for O2 (Arai et al. 2014), 
and are expressed in response to different environmental factors (Comolli and Donohue 2004; 
Alvarez-Ortega and Harwood 2007; Kawakami et al. 2010; Arai et al. 2014). These divergent 
characteristics allow P. aeruginosa to thrive under many different conditions and contribute to its 
overall success as a ubiquitously-found bacterium. 
The P. aeruginosa membrane-bound electron transport chain can employ five 
different oxygen reductases. Ubiquinone (Ub) is reduced by a dehydrogenase (not 
shown) and acts as the electron donor for the cytochrome bc1 complex, Cyo, or CIO. 
The cytochrome bc1 complex reduces a c-type cytochrome, which then acts as the 
electron donor for Aa3, Cbb3-1 (or Cco1), or Cbb3-2 (or Cco2). Heme-copper oxidases 
are represented by pink shapes. Oxidases that support growth better under 
microaerobic conditions are shaded yellow, while those that support growth better 
under typical conditions are shaded blue. These roles are influenced by intrinsic 
chemical properties and expression levels of the individual complexes. Approximate 
affinities for oxygen (Km Values obtained amperometrically) are shown. 
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 The Bo3 terminal oxidase (which is sometimes referred to as Cyo) has mostly been 
characterized in E. coli, which uses this low-O2-affinity enzyme to grow under highly aerobic 
conditions (D’Mello, Hill, and Poole 1995). Arai and colleagues confirmed that this enzyme is 
also a low affinity enzyme in P. aeruginosa (Km = 3.2 µM; Arai et al. 2014) whose expression is 
upregulated specifically in response to iron starvation (Kawakami et al. 2010). Because its 
overall expression is very low, Bo3 is not expected to contribute significantly to P. aeruginosa 
growth under laboratory conditions (Kawakami et al. 2010; Arai 2011).  
 Cio, or the cyanide insensitive oxidase, is the only copper-free terminal oxidase in P. 
aeruginosa. It is encoded by a two-gene operon bearing high sequence homology (at both the 
DNA and amino acid levels) to the E. coli bd quinol oxidases (Cunningham, Pitt, and Williams 
1997) and for this reason the P. aeruginosa Cio is often referred to as a bd-type quinol oxidase. 
However, spectral studies have not detected cytochrome d in P. aeruginosa, so Cio is believed 
to belong to an atypical subfamily of bd-type quinol oxidases with an altered heme composition 
(Cunningham, Pitt, and Williams 1997). E. coli’s bd oxidases are known for their high O2 affinity 
and expression under microaerobic growth conditions (Cunningham, Pitt, and Williams 1997; 
Williams, Zlosnik, and Ryall 2007). P. aeruginosa’s Cio has also been demonstrated to be 
important for microaerobic growth in both liquid cultures and biofilms (Alvarez-Ortega and 
Harwood 2007) and therefore had also been assumed to have a high affinity for O2. However, 
more recent work measuring the affinities of P. aeruginosa’s terminal oxidases surprisingly 
showed that Cio is a low-affinity enzyme (Km = 4 µM; Arai et al. 2014). 
 As its name implies, Cio is also resistant to cyanide, a virulence factor that P. aeruginosa 
produces during early stationary phase (Blumer and Haas 2000). Micromolar concentrations of 
cyanide inhibit complexes belonging to the heme copper oxidase (HCO) superfamily (Blumer 
and Haas 2000), which includes the Aa3, Bo3, and Cco oxidases produced by P. aeruginosa, 
and cyanide has been detected in stationary-phase P. aeruginosa cultures at 300-500 µM 
(Lenney and Gilchrist 2011). P. aeruginosa mutants lacking the genes encoding Cio are less 
resistant to cyanide (Comolli and Donohue 2002). Furthermore, transcriptional reporters have 
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shown cio to be upregulated by cyanide (Comolli and Donohue 2002) and low O2 
concentrations (Alvarez-Ortega and Harwood 2007).  
 The P. aeruginosa Aa3 terminal oxidase, while phylogenetically related to the 
mitochondrial terminal oxidase, does not seem to play a significant role in supporting P. 
aeruginosa growth under normal laboratory conditions, as it is not expressed at high levels in 
cultures grown aerobically in a nutrient-rich medium (Kawakami et al. 2010). This is in contrast 
to many bacteria that do utilize Aa3 for growth, including Bacillus subtilis and P. denitrificans 
(Arai 2011). P. aeruginosa Aa3, on the other hand, is upregulated in response to nutrient 
limitation, specifically carbon, nitrogen, or iron starvation (Kawakami et al. 2010) and has been 
shown to be regulated by the sigma factor RpoS (Schuster et al. 2004). Bacterial sigma factors 
are positive regulators of transcription that can have regulons containing dozens to hundreds of 
genes (Schulz et al. 2015). RpoS is one such regulator that is active at the onset of stationary 
phase (Potvin, Sanschagrin, and Levesque 2008). That the genes encoding the Aa3 oxidase are 
upregulated by RpoS, then, is in line with observations that their expression is increased when 
nutrients are limited, as is often the case in stationary phase (Madigan et al. 2015). 
 The final two terminal oxidases, Cco1 and Cco2, are both members of the family of cbb3 
cytochrome c oxidases. cbb3-type oxidases are exclusively found in bacteria and are known for 
their very high affinities for O2 (Pitcher and Watmough 2004). Because of their O2 affinity, these 
enzymes tend to be induced under hypoxic conditions. The P. aeruginosa Cco’s indeed are high 
affinity enzymes, with Km values that are an order of magnitude lower than those of Bo3, Cio, 
and Aa3 (nanomolar vs. micromolar, respectively; Arai et al. 2014). Consistent with this, Cco2 is 
regulated by Anr, a transcription factor that regulates gene expression at the shift from aerobic 
to microaerobic conditions (Ray and Williams 1997; Comolli and Donohue 2004). However, 
Cco1 is constitutively expressed by P. aeruginosa, even under high aeration conditions (Comolli 
and Donohue 2004). The Cco’s have been demonstrated to be the predominant enzymes that 
support P. aeruginosa growth under normal laboratory conditions, with Cco1 being sufficient to 
support wild-type (WT) levels of growth under aerobic conditions and either Cco1 or Cco2 able 
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to support WT levels of growth under microaerobic conditions (Arai et al. 2014; Jo et al. 2017). A 
more detailed look at the functional redundancy of Cco1 and Cco2, as well as their roles in 
biofilm development, will follow in Chapter 2. 
1.4: Other strategies for redox balancing 
 In addition to its branched aerobic respiratory chain, P. aeruginosa possesses alternative 
metabolic pathways that can function to balance the intracellular redox state and generate ATP. 
These include anaerobic respiration (through denitrification) and fermentation.  
1.4.1: Denitrification 
 Denitrification is the process by which nitrate (NO3) is reduced to molecular nitrogen (N2) 
via the intermediates nitrite, nitric oxide, and nitrous oxide (Figure 1.6; Zumft 1997; Williams, 
Figure 1.6. P. aeruginosa denitrification and pyruvate fermentation pathways. (A) The 
denitrification (blue) and pyruvate fermentation (yellow) pathways as they fit into overall P. 
aeruginosa metabolism. Red shaded boxes indicate steps in which the reduced intermediate 
NADH is formed; green shaded boxes indicate steps in which NADH can be re-oxidized to 
NAD+. Asterisk (*) refers to the anaplerotic step of pyruvate carboxylation, further discussed in 
Chapter 4 (section 4.2). (B) The stepwise reduction of nitrate (NO3) to molecular nitrogen (N2) 
via denitrification.
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Zlosnik, and Ryall 2007). Most components of the anaerobic respiratory pathway are the same 
between aerobic respiration and denitrification (Williams, Zlosnik, and Ryall 2007); as such, 
denitrification is also coupled to the generation of a proton gradient for ATP production. As in 
aerobic respiration, electrons from NADH pass to the quinone pool, which can then pass 
electrons directly to terminal reductases or to the bc1 complex, the latter of which can also 
donate electrons to terminal reductases. The denitrification pathways of P. aeruginosa are 
physiologically relevant for hypoxic and anoxic environments, which will be touched upon briefly 
in sections 1.5 and 1.6; however, because denitrification is outside the scope of my thesis, I will 
not discuss it further here.   
1.4.2: Fermentation 
 Under anoxic conditions, P. aeruginosa is able to grow or survive using fermentation of 
arginine or pyruvate, respectively (Williams, Zlosnik, and Ryall 2007; Figure 1.6). Arginine 
fermentation requires a complex growth medium and yields modest levels of growth. Pyruvate 
fermentation produces lactate and generates enough energy to support anaerobic survival 
(Williams, Zlosnik, and Ryall 2007; Glasser, Kern, and Newman 2014; Lin et al. 2018). The 
contribution of pyruvate fermentation to P. aeruginosa physiology will be further discussed in 
Chapter 4 (section 4.1).  
1.4.3: Phenazine reduction: Extracellular electron transfer 
 The previous sections have described the immense versatility found within central 
metabolic pathways of P. aeruginosa. By modulating flux through these pathways in response to 
environmental conditions, P. aeruginosa can maintain a balanced intracellular redox state. 
Another strategy that can be employed by this bacterium to deal with redox stress is the 
production and utilization of phenazines. Phenazines are endogenous secondary metabolites 
that were traditionally considered to be antibiotics, toxic to competing bacteria in the 
environment (Chin-A-Woeng and Bloemberg 2003). More recently, the redox-active quality of 
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phenazines has been credited for helping P. aeruginosa thrive in environments in which iron 
(Wang and Newman 2008) or O2 (Price-Whelan, Dietrich, and Newman 2007; Wang, Kern, and 
Newman 2010; Dietrich et al. 2013) are limiting.  
 The phenazine biosynthetic pathway in P. aeruginosa begins with the conversion of 
chorismate to phenazine-1-carboxylic acid (PCA), the precursor phenazine, by the redundant 
operons phzA1-G1 (phz1) and phzA2-G2 (phz2) (Recinos et al. 2012). PCA can then be 
Figure 1.7. Electron shuttling by phenazines. (A) The phenazine biosynthetic pathway starts 
with the precursor phenazine, phenazine-1-carboxylic acid (PCA). PhzH converts PCA to 
phenazine-1-carboxamide (PCN), PhzM converts PCA to 5-methyl-PCA (5-Me-PCA), PhzS 
converts 5-Me-PCA to pyocyanin (PYO). (B) Phenazines are reduced (red) intracellularly and are 
transported out of the cell, where they are oxidized (ox) by extracellular oxidants such as O2. These 
oxidized phenazines can then be transported back into cell where they can oxidize NADH to NAD+. 
(C) A model for phenazine-mediated redox balancing in P. aeruginosa colony biofilms. Cells closer 
to the biofilm-air interface can use O2 as a terminal electron acceptor while cells near the biofilm-
agar interface cannot. Oxidized phenazines originating from the oxic zones of the biofilm are able 
to accept electrons from cells in the anoxic zones, thereby allowing these cells to dissipate 
intracellular redox state in the absence of oxygen.
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modified by several phenazine biosynthetic enzymes to yield the derivatives phenazine-1-
carboxamide (PCN), 5-methyl-PCA (5-Me-PCA), and pyocanin (PYO) (Figure 1.7A). These 
phenazine derivatives possess differing redox potentials that contribute to their varying 
specificities toward different oxidants (Wang and Newman 2008; Wang, Kern, and Newman 
2010). 
 Phenazines, through their redox-activity, play a role in iron acquisition. Iron is often found 
in the insolube Fe(III) form in aerobic environments (Wang and Newman 2008), posing a 
problem for organisms needing this substrate for growth. P. aeruginosa is able to overcome this 
obstacle by using phenazines to reduce Fe(III) to the soluble and bioavailable form, Fe(II) 
(Hernandez, Kappler, and Newman 2004).  
 Phenazines also support P. aeruginosa growth under conditions of O2 limitation. 
Previous work from our group has shown that the methylated phenazines, specifically 5-Me-
PCA, are the primary contributors to redox balancing in P. aeruginosa colony biofilms (Sakhtah 
et al. 2016), where O2 availability decreases with depth. A mutant unable to synthesize 
phenazines, ∆phz (in which both phz1 and phz2 operons are deleted), displays a significant 
biofilm phenotype relative to the WT, such that it is unable to maintain an anoxic zone. 
Intracellular NADH/NAD+ measurements have shown that the ∆phz mutant experiences redox 
stress, in the form of accumulated reducing equivalents, earlier than the WT. This redox stress 
correlates with decreased O2 concentration and is ameliorated by an earlier onset of wrinkling 
(Price-Whelan, Dietrich, and Newman 2007; Dietrich et al. 2013). In addition to wrinkling earlier, 
∆phz biofilms are much thinner and form higher ridges (wrinkles) than those formed by the WT, 
and these features serve to keep ∆phz biofilms fully aerobic throughout development. 
Additionally, phenazines have been shown to support anaerobic survival of P. aeruginosa 
(Wang, Kern, and Newman 2010) and to enhance energy generation during pyruvate 
fermentation (Glasser, Kern, and Newman 2014). Phenazines are reduced intracellularly and in 
turn react with oxidants (such as O2 and Fe(III)) outside the cell (Wang and Newman 2008; 
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Figure 1.7B). This “electron shuttling” by phenazines helps to alleviate redox stress in cells with 
limited access to O2 (Figure 1.7C). 
 Additionally, the production of pyocyanin (PYO), another methylated phenazine, by P. 
aeruginosa has been linked to virulence in mice (Lau et al. 2004). Phenazines have been 
detected in sputum samples of patients with respiratory illnesses (Wilson et al. 1988), and their 
presence is negatively correlated with lung function (Hunter et al. 2012). Furthermore, as with 
most cellular pathways in P. aeruginosa, phenazine production has been shown to be sensitive 
to environmental conditions, including carbon source (van Rij et al. 2004; Huang et al. 2012; 
Bosire, Blank, and Rosenbaum 2016). 
1.5: The implications of metabolic versatility on P. aeruginosa’s impact as a clinically-
relevant pathogen 
 P. aeruginosa’s metabolic versatility undoubtedly contributes to the bacterium’s ability to 
thrive in diverse environments, one being the human host. P. aeruginosa is the leading cause of 
morbidity and mortality in patients with the genetic disease cystic fibrosis (CF), with about 80% 
of afflicted individuals suffering from chronic infections in their lungs (Williams and Davies 2012). 
The underlying cause of CF is a mutation in the gene encoding a chloride channel, the CF 
transmembrane conductance regulator (CFTR), which results in abnormal ion transport across 
epithelial membranes (Williams, Zlosnik, and Ryall 2007; Conway and Cohen 2015). This leads 
to the formation of a dehydrated layer on epithelial cells, including those of the gastrointestinal 
and pulmonary systems, and increased mucus viscosity (Murray, Egan, and Kazmierczak 2007; 
Williams, Zlosnik, and Ryall 2007). This viscous mucus, or sputum, is resistant to normal bodily 
clearing and provides a breeding ground for bacteria. 
 The mucus of the CF lung is a heterogeneous environment, with different metabolites, 
O2 availabilities, and antibiotic concentrations present along the airway (Ciofu et al. 2012; 
Cowley et al. 2015). Normal pulmonary mucus consists of water, salts, mucins, and surfactants; 
mucins are glycoprotein components of mucus that contribute to its gel-like consistency and 
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surfactants function in facilitating gas exchange across the mucosal layer (Conway and Cohen 
2015). In CF sputum, these components are present at altered levels and additional molecules 
normally absent in healthy sputum are detected. These points will be elaborated upon in 
Chapter 4 (section 4.1).  
 Although the environmental conditions of the CF lung are quite varied, P. aeruginosa is 
consistently one of the most commonly-found pathogenic bacteria colonizing CF sputum. This is 
perhaps unsurprising given the metabolic versatility described above; its abilities to utilize 
diverse substrates as energy sources and scavenge small amounts of available O2 may allow P. 
aeruginosa to flourish in these conditions. Virtually all CF patients are prone to P. aeruginosa 
infections and disease prognosis significantly worsens when these infections become chronic 
and establish as biofilms (Høiby et al. 2011; Williams and Davies 2012; Ciofu et al. 2012). 
 In the CF lung environment, P. aeruginosa also produces various virulence factors, some 
of which can at once kill competing cells (including those of the host as well as other invading 
bacteria) while benefiting their producer. These include phenazines, which have been detected 
in the sputum of CF patients (Wilson et al. 1988). Another virulence factor released by P. 
aeruginosa is cyanide, which, as previously mentioned, inhibits the activity of heme-copper 
terminal oxidases and has been detected in CF sputum (Ryall et al. 2008; Sanderson et al. 
2008). P. aeruginosa’s Cio terminal oxidase allows it to grow even when cyanide is present in its 
surrounding environment, but any competing cells that do not encode a cyanide-insensitive 
oxidase will be sensitive to killing by this respiratory toxin. Detection of both phenazines and 
cyanide in sputum samples has been correlated with the presence of chronic P. aeruginosa 
infection in patients as well as compromised lung function (Hunter et al. 2012; Ryall et al. 2008; 
Sanderson et al. 2008). 
1.6: Biofilms in chronic lung infections 
 Another major factor contributing to pathogenesis is P. aeruginosa’s ability to form robust 
biofilms. Biofilms are multicellular assemblages of bacteria encased within a self-produced 
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matrix composed of extracellular DNA, proteins, and polysaccharides (Høiby et al. 2011). As 
previously mentioned, the formation of an O2 gradient presents an obstacle for cells growing in 
biofilms. As a consequence of both O2 diffusion into the biofilm and O2 consumption by resident 
cells, cells found deeper within the biofilm have less access to O2 than those at the periphery 
(Werner et al. 2004). This leads to metabolic heterogeneity along the O2 gradient (Ciofu et al. 
2012), with cells in each microenvironment tuned to maximize energy generation/conservation 
in their specific set of conditions (Williams, Zlosnik, and Ryall 2007; Poole and Cook 2000). 
 Despite the inherent challenges of the biofilm lifestyle, this is the primary mode of 
bacterial growth in nature and in a host (Høiby et al. 2011; Penesyan, Gillings, and Paulsen 
2015), likely because cells within biofilms are afforded more protection against outside stresses 
such as antibiotics. Indeed, the biofilm lifestyle is primarily to blame for the failure of antibiotic 
treatments in CF patients (Ciofu et al. 2012) and the establishment of chronic infections (Høiby 
et al. 2011). P. aeruginosa biofilms in diseased lungs are often characterized by higher mutation 
rates and exhibit genetic modifications with conferred phenotypes that include increased matrix 
production and antibiotic resistance (Williams and Davies 2012). Because sublethal 
concentrations of antibiotics have been shown to increase mutation rates in P. aeruginosa (Nair 
et al. 2013), the fact that biofilm cells are even more resistant to antibiotics poses a major 
obstacle in the quest to find new drugs that can effectively kill P. aeruginosa. Furthermore, the 
heterogeneous nature of CF lung environments likely contributes to the presence of “persister” 
cells, which are able to survive in microenvironments of lower antibiotic concentrations while 
contributing to the establishment of chronic infection (Williams and Davies 2012). 
 Metabolic versatility and diverse strategies for redox balancing also contribute to P. 
aeruginosa’s ability to form robust biofilms. Its arsenal of terminal oxidases allows it to flourish 
under a spectrum of O2 concentrations ranging from atmospheric to microaerobic. Its abilities to 
denitrify and ferment allow it to survive and grow under anoxic conditions. The production and 
utilization of redox-active phenazines further support redox balancing and growth under micro- 
and anaerobic conditions. In the following chapters, I will expand upon these strategies and 
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demonstrate that P. aeruginosa is even more metabolically versatile than previously 
appreciated. In Chapter 2, I will describe a novel Cco terminal oxidase complex that contributes 
to biofilm physiology, phenazine utilization, and virulence. In Chapter 3, I will discuss how 
carbon sources affect the expression and utilization of P. aeruginosa aerobic respiratory chain 
components and phenazine-dependent metabolism, underscoring how this bacterium’s 
physiology is highly dependent on the environmental conditions under which is it grown. Finally, 
in Chapter 4, I will discuss other metabolic pathways that contribute to P. aeruginosa redox 
balancing and biofilm development as well as a redox-based mechanism of biofilm development 
in the phylogenetically distinct bacterium Bacillus subtilis. Together, these results will allow for a 
deeper appreciation for the various adaptations used by P. aeruginosa to maintain redox 
homeostasis and flourish in the biofilm lifestyle. 
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Chapter Two 
An orphan cbb3-type cytochrome oxidase subunit supports Pseudomonas aeruginosa 
biofilm growth and virulence 
This chapter is adapted from: 
Jo, J, Cortez, KL, Cornell, WC, Price-Whelan, A, Dietrich, LE (2017). An orphan cbb3-type 
cytochrome oxidase subunit supports Pseudomonas aeruginosa biofilm growth and virulence. 
eLife 6, e30205. 
For this work, I formulated hypotheses, engineered all deletion and reporter constructs, and 
designed and performed all experiments, except competition assays (Figures 2.3A and 2.3B; 
performed by Krista L. Cortez) and thin sectioning of biofilms (Figure 2.3C, Figure 2.4, Figure 
2.5B (bottom), and Figure 2.5C; performed by William Cole Cornell). I contributed to the 
analysis and interpretation of all generated data and in the writing of this paper. 
I thank Rachel Hainline for technical assistance with competition assays, Christopher 
Beierschmitt for technical assistance with worm pathogenicity assays, and Konstanze Schiessl 
for help with image analysis and feedback on the manuscript. 
2.1: Abstract 
 Hypoxia is a common challenge faced by bacteria during associations with hosts due in 
part to the formation of densely packed communities (biofilms). cbb3-type cytochrome c 
oxidases, which catalyze the terminal step in respiration and have a high affinity for oxygen, 
have been linked to bacterial pathogenesis. The pseudomonads are unusual in that they often 
contain multiple full and partial (i.e., “orphan”) operons for cbb3-type oxidases and oxidase 
subunits. Here, we describe a unique role for the orphan catalytic subunit CcoN4 in colony 
biofilm development and respiration in the opportunistic pathogen Pseudomonas aeruginosa 
PA14. We also show that CcoN4 contributes to the reduction of phenazines, antibiotics that 
support redox balancing for cells in biofilms, and to virulence in a Caenorhabditis elegans model 
of infection. These results highlight the relevance of the colony biofilm model to pathogenicity 
and underscore the potential of cbb3-type oxidases as therapeutic targets. 
2.2: Introduction 
 Among the oxidants available for biological reduction, molecular oxygen (O2) provides 
the highest free energy yield. Since the accumulation of O2 in the atmosphere between 
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~2.4-0.54 billion years ago (Kirschvink and Kopp 2008; Dietrich, Tice, and Newman 2006), 
organisms that can use it for growth and survival, and tolerate its harmful byproducts, have 
evolved to exploit this energy and increased in complexity (Knoll and Sperling 2014; Falkowski 
2006). At small scales and in crowded environments, rapid consumption of O2 leads to 
competition for this resource and has promoted diversification of bacterial and archaeal 
mechanisms for O2 reduction that has not occurred in eukaryotes (Brochier-Armanet, Talla, and 
Gribaldo 2009). The various enzymes that allow bacteria to respire O2 exhibit a range of 
affinities and proton-pumping efficiencies and likely contribute to competitive success in hypoxic 
niches (Morris and Schmidt 2013). Such environments include the tissues of animal and plant 
hosts that are colonized by bacteria of high agricultural (Preisig et al. 1996) and clinical (Way et 
al. 1999; Weingarten, Grimes, and Olson 2008) significance. 
 The opportunistic pathogen Pseudomonas aeruginosa, a colonizer of both plant and 
animal hosts (Rahme et al. 1995), has a branched respiratory chain with the potential to reduce 
O2 to water using at least five different terminal oxidase complexes: two quinol oxidases (bo3 
(Cyo) and a bd-type cyanide insensitive oxidase (CIO)) and three cytochrome c oxidases (aa3, 
cbb3-1, and cbb3-2) (Figure 2.1A). Several key publications have described P. aeruginosa’s 
complement of terminal oxidases and oxidase subunits, revealing features specific to this 
organism (Williams, Zlosnik, and Ryall 2007; Comolli and Donohue 2004; Alvarez-Ortega and 
Harwood 2007; Arai et al. 2014; Kawakami et al. 2010; Jo, Price-Whelan, and Dietrich 2014). P. 
aeruginosa is somewhat unusual in that it encodes two oxidases belonging to the cbb3-type 
family. These enzymes are notable for their relatively high catalytic activity at low O2 
concentrations and restriction to the bacterial domain (Brochier-Armanet, Talla, and Gribaldo 
2009; Pitcher and Watmough 2004). (The P. aeruginosa cbb3-type oxidases are often referred to 
as cbb3-1 and cbb3-2; however, we will use “Cco1” and “Cco2” for these enzymes, consistent 
with the annotations of their encoding genes.) Most bacterial genomes that encode cbb3-type 
oxidases contain only one operon for such a complex, which is induced specifically under 
conditions of O2 limitation (Cosseau and Batut 2004). In P. aeruginosa, the cco2 operon is 
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Figure 2.1. The respiratory chain and arrangement of cco genes and protein 
products in P. aeruginosa, and the phylogenetic distribution of orphan ccoN 
genes. (A) Branched electron transport chain in P. aeruginosa, containing five terminal 
oxidases. (B) Organization of cco genes in the P. aeruginosa genome. The cartoon of 
the Cco complex is based on the Cco structure from P. stutzeri (PDB: 3mk7) 
(Buschmann et al. 2010a). (C) Left: graphical representation of the portion of genomes 
in each bacterial phylum that contain ccoO and N homologs. The clades 
Chrysiogenetes, Gemmatimonadetes, and Zetaproteobacteria were omitted because 
they each contain only one species with ccoO and N homologs. The height of each 
rectangle indicates the total number of genomes included in the analysis. The width of 
each shaded rectangle represents the portion of genomes that contain ccoN homologs. 
Middle: genomes that contain more ccoN than ccoO homologs (indicating the presence 
of orphan ccoN genes) are listed. Right: numbers of ccoO and ccoN homologs in each 
genome. Blue highlights genomes containing more than one orphan ccoN homolog. 
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induced during growth at low O2 concentrations, but the cco1 operon is expressed constitutively 
at high levels (Comolli and Donohue 2004; Kawakami et al. 2010). 
 An additional quirk of the P. aeruginosa terminal oxidase complement lies in the 
presence of genes for “orphan” cbb3-type subunits at chromosomal locations distinct from the 
cco1 and cco2 operons. While the cco1 and cco2 operons, which are chromosomally adjacent, 
each contain four genes encoding a functional Cco complex (consisting of subunits N, O, P, and 
Q), the two additional partial operons ccoN3Q3 and ccoN4Q4 each contain homologs coding for 
only the Q and catalytic N subunits (Figure 2.1B). Expression of the ccoN3Q3 operon is 
induced under anaerobic denitrification conditions (Alvarez-Ortega and Harwood 2007), and by 
nitrite exposure during growth under 2% O2 (Hirai et al. 2016). During aerobic growth in liquid 
cultures, ccoN4Q4 is induced by cyanide, which is produced in stationary phase (Hirai et al. 
2016). However, additional expression studies indicate that ccoN4Q4 transcription is influenced 
by redox conditions, as this operon is induced by O2 limitation (Alvarez-Ortega and Harwood 
2007) and slightly downregulated in response to pyocyanin, a redox-active antibiotic produced 
by P. aeruginosa (Dietrich et al. 2006).  
 In a recent study, Hirai et al. characterized the biochemical properties and physiological 
roles of P. aeruginosa cbb3 isoforms containing combinations of canonical and orphan subunits 
(Hirai et al. 2016). In a strain lacking all of the aerobic terminal oxidases, expression of any 
isoform conferred the ability to grow using O2, confirming that isoforms containing the orphan N 
subunits are functional. When preparations from wild-type, stationary-phase P. aeruginosa cells 
were separated on 2D gels and probed with anti-CcoN4 antibody, this subunit was detected at 
the same position as the assembled CcoNOP complex, showing that CcoN4-containing 
heterocomplexes form in vivo. Furthermore, the authors found that the products of ccoN3Q3 
and ccoN4Q4 contributed resistance to nitrite and cyanide, respectively, during growth in liquid 
cultures under low-O2 conditions. While these results provide insight into contributions of the 
cbb3 heterocomplexes to growth in liquid cultures, potential roles for N3- and N4-containing 
isoforms in biofilm growth and pathogenicity have yet to be explored.  
32
 The biofilm lifestyle—in which cells grow in a dense community encased in a self-
produced matrix—has been linked to the establishment and persistence of infections in diverse 
systems (Edwards and Kjellerup 2012; Rybtke et al. 2015). Biofilm development promotes the 
formation of O2 gradients such that cells at a distance from the biofilm surface are subjected to 
hypoxic or anoxic conditions (Werner et al. 2004). Using a colony morphology assay to study 
redox metabolism and its relationship to community behavior, we have shown that O2 limitation 
for cells in biofilms leads to an imbalance in the intracellular redox state. This can be relieved by 
a change in community morphology, which increases the surface area-to-volume ratio of the 
biofilm and therefore access to O2 for resident cells (Kempes et al. 2014). For P. aeruginosa 
cells in biofilms, the intracellular accumulation of reducing power can also be prevented by 
production and reduction of endogenous antibiotics called phenazines, which mediate 
extracellular electron transfer to oxidants available at a distance (Dietrich et al. 2013). We have 
found that biofilm-specific phenazine production contributes to pathogenicity in a murine model 
of acute pulmonary infection (Recinos et al. 2012), further underscoring the importance of 
phenazine-mediated redox balancing for P. aeruginosa cells in communities. 
 Because of the formation of an O2 gradient inherent to the biofilm lifestyle, we 
hypothesized that the differential regulation of the P. aeruginosa cco operons affects their 
contributions to metabolic electron flow in biofilm subzones. We evaluated the roles of various 
cbb3-type oxidase isoforms in multicellular behavior and virulence. Our results indicate that 
isoforms containing the orphan subunit CcoN4 can support survival in biofilms via O2 and 
phenazine reduction and contribute to P. aeruginosa pathogenicity in a Caenorhabditis elegans 
“slow killing” model of infection.   
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2.3: Results 
2.3.1: A small minority of bacterial genomes encode cbb3-type oxidase subunits in partial 
(“orphan”) operons 
 Biochemical, genetic, and genomic analyses suggest that the CcoN and CcoO subunits, 
typically encoded by an operon, form the minimal functional unit of cbb3-type oxidases 
(Ducluzeau, Ouchane, and Nitschke 2008; de Gier et al. 1996; Zufferey et al. 1996). CcoN is the 
membrane-integrated catalytic subunit and contains two b-type hemes and a copper ion. CcoO 
is membrane-anchored and contains one c-type heme. Additional redox subunits and/or 
subunits implicated in complex assembly, such as CcoQ and CcoP, can be encoded by adjacent 
genes (Figure 2.1B). ccoNO-containing clusters are widely distributed across phyla of the 
bacterial domain (Ducluzeau, Ouchane, and Nitschke 2008). We used the EggNOG database, 
which contains representative genomes for more than 3000 bacterial species (Huerta-Cepas et 
al. 2016) to obtain an overview of the presence and frequency of cco genes. Out of 3318 
queried bacterial genomes we found 467 with full cco operons (encoding potentially functional 
cbb3-type oxidases with O and N subunits). Among these, 78 contain more than one full operon. 
We also used EggNOG to look for orphan ccoN genes by examining the relative numbers of 
ccoO and ccoN homologs in individual genomes. We found 14 genomes, among which 
Pseudomonas species are overrepresented, that contain orphan ccoN genes (Figure 2.1C), 
and our analysis yielded 3 species that contain more than one orphan ccoN gene: 
Pseudomonas mendocina, Pseudomonas aeruginosa, and Achromobacter xylosoxidans. P. 
mendocina is a soil bacterium and occasional nosocomial pathogen that is closely related to P. 
aeruginosa, based on 16S rRNA gene sequence comparison (Anzai et al. 2000). A. 
xylosoxidans, in contrast, is a member of a different proteobacterial class but nevertheless is 
often mistaken for P. aeruginosa (Saiman et al. 2001). Like P. aeruginosa, it is an opportunistic 
pathogen that can cause pulmonary infections in immunocompromised individuals and patients 
with cystic fibrosis (De Baets et al. 2007; Firmida et al. 2016). Hirai et al. previously reported a 
ClustalW-based analysis of CcoN homologs specifically from pseudomonads, which indicated 
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the presence of orphan genes in additional species not represented in the EggNOG database. 
These include P. denitrificans, which contains two orphan genes (Hirai et al. 2016).  
2.3.2: CcoN4-containing isoforms function specifically in biofilms to support community 
morphogenesis and respiration 
 During growth in a biofilm, subpopulations of cells are subjected to regimes of electron 
donor and O2 availability that may create unique metabolic demands and require modulation of 
the respiratory chain for survival (Alvarez-Ortega and Harwood 2007; Borriello et al. 2004; 
Werner et al. 2004). We therefore investigated the contributions of individual cco genes and 
gene clusters to P. aeruginosa PA14 biofilm development using a colony morphology assay, 
which has demonstrated sensitivity to electron acceptor availability and utilization (Dietrich et al. 
2013). Because the Cco1 and Cco2 complexes are the most important cytochrome oxidases for 
growth of P. aeruginosa in fully aerated and O2-limited liquid cultures (Alvarez-Ortega and 
Harwood 2007; Arai et al. 2014), we predicted that mutations disabling the functions of Cco1 
and Cco2 would affect colony growth. Indeed, a mutant lacking both the cco1 and cco2 operons 
(“∆cco1cco2”) produced thin biofilms with a smaller diameter than the wild type. After five days 
of development, this mutant displayed a dramatic phenotype consisting of a tall central ring 
feature surrounded by short ridges that emanate radially (Figure 2.2A, Figure 2.2— figure 
supplement 1A). ∆cco1cco2 colonies were also darker in color, indicating increased uptake of 
the dye Congo red, which binds to the extracellular matrix produced by biofilms (Friedman and 
Kolter 2004). Surprisingly, a strain specifically lacking the catalytic subunits of Cco1 and Cco2 
(“∆N1∆N2”), while showing a growth defect similar to that of ∆cco1cco2 when grown in liquid 
culture (Figure 2.2C), showed biofilm development that was similar to that of the wild type 
(Figure 2.2A, Figure 2.2--figure supplement 1A).  
 As it is known that CcoN3 and CcoN4 can form functional complexes with subunits of 
the Cco1 and Cco2 oxidases in P. aeruginosa PAO1 (Hirai et al. 2016), this led us to 
hypothesize that Cco isoforms containing the orphan subunits CcoN3 and/or CcoN4 could 
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substitute for Cco1 and Cco2 in the biofilm context. Deleting ccoN3 (“∆N3” or “∆N1∆N2∆N3”) did 
not have an observable effect on biofilm development when mutants were compared to 
respective parent strains (Figure 2.2— figure supplement 1A). However, the phenotype of a 
Figure 2.2. CcoN4-containing heterocomplexes make biofilm-specific 
contributions to morphogenesis and respiration. (A) Top: Five-day-old colony 
biofilms of PA14 WT and cco mutant strains. Biofilm morphologies are representative of 
more than ten biological replicates. Images were generated using a Keyence digital 
microscope. Scale bar is 1 cm. Bottom: 3D surface images of the biofilms shown in the 
top panel. Images were generated using a Keyence wide-area 3D measurement 
system. Height scale bar: bottom (blue) to top (red) is 0 - 0.7 mm for WT, ∆N1∆N2, and 
∆N4; 0 - 1.5 mm for ∆N1∆N2∆N4 and ∆cco1cco2. (B) TTC reduction by cco mutant 
colonies after one day of growth. Upon reduction, TTC undergoes an irreversible color 
change from colorless to red. Bars represent the average, and error bars represent the 
standard deviation, of individually-plotted biological replicates (n = 5). P-values were 
calculated using unpaired, two-tailed t tests comparing each mutant to WT (****, P ≤ 
0.0001). For full statistical reporting, refer to Table 4. (C) Mean growth of PA14 WT and 
cco mutant strains in MOPS defined medium with 20 mM succinate. Error bars 
represent the standard deviation of biological triplicates.
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“∆N1∆N2∆N4” mutant was consistent with our model, as it mimicked that of the ∆cco1cco2 
mutant in both liquid-culture and biofilm growth (Figures 2.2A and 2.2C, Figure 2.2— figure 
supplement 1A). Furthermore, we found that a mutant lacking only ccoN4 (“∆N4”) displayed an 
altered phenotype in that it began to form wrinkle structures earlier than the wild type (Figure 
2.2— figure supplement 1A), which developed into a disordered region of wrinkles inside a 
central ring, surrounded by long, radially emanating ridges (Figure 2.2A). Reintroduction of the 
ccoN4 gene into either of these strains restored the phenotypes of the respective parent strains 
(Figure 2.2— figure supplement 1A). Deletion of either ccoN2 or ccoN3 in the ∆N4 
background did not exacerbate the colony phenotype seen in ∆N4 alone. However, the 
“∆N1∆N4” double mutant showed an intermediate phenotype relative to ∆N4 and ∆N1∆N2∆N4 
(Figure 2.2— figure supplement 1B), suggesting some functional redundancy for CcoN1 and 
CcoN4. The developmental pattern of the ∆N4 colony is reminiscent of those displayed by 
mutants defective in phenazine production and sensing (Figure 2.2— figure supplement 1A) 
(Dietrich et al. 2008, 2013; Sakhtah et al. 2016; Okegbe et al. 2017). Although ∆N4 itself 
showed a unique phenotype in the colony morphology assay, its growth in shaken liquid cultures 
was indistinguishable from that of the wild type (Figure 2.2C). Deleting the three non-cbb3-type 
terminal oxidases (“∆cox∆cyo∆cio”), did not affect biofilm morphology (Figure 2.2— figure 
supplement 2C). These results suggest that CcoN4-containing Cco isoform(s) play 
physiological roles that are specific to the growth conditions encountered in biofilms. 
 Next, we asked whether CcoN4 contributes to respiration in biofilms. We tested a suite 
of cco mutants for reduction of triphenyl tetrazolium chloride (TTC), an activity that is often 
associated with cytochrome c oxidase-dependent respiration (Rich et al. 2001). The ∆cco1cco2 
mutant showed a severe defect in TTC reduction, which was recapitulated by the ∆N1∆N2∆N4 
mutant. As in the colony morphology assay, this extreme phenotype was not recapitulated in a 
mutant lacking only CcoN1 and CcoN2, indicating that CcoN4 contributes to respiratory activity 
in PA14 biofilms. Although we did not detect a defect in TTC reduction for the ∆N4 mutant, we 
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saw an intermediate level of TTC reduction for ∆N1∆N4 compared to ∆N1∆N2 and 
∆N1∆N2∆N4, further implicating the CcoN4 subunit in this activity (Figure 2.2B).  
 A recent study implicated CcoN4 in resistance to cyanide, a respiratory toxin that is 
produced by P. aeruginosa (Hirai et al. 2016). The altered biofilm phenotypes of ∆N4 mutants 
could therefore be attributed to an increased sensitivity to cyanide produced during biofilm 
growth. We deleted the hcn operon, coding for cyanide biosynthetic enzymes, in the wild-type, 
phenazine-null, and various cco mutant backgrounds. The biofilm morphologies and liquid-
culture growth of these strains were unaffected by the ∆hcnABC mutation, indicating that the 
biofilm-specific role of CcoN4 explored in this work is independent of its role in mediating 
cyanide resistance (Figure 2.2— figure supplement 2). Additionally, we examined genomes 
available in the Pseudomonas Genome Database for the presence of homologs encoding CcoN 
subunits (ccoN genes) and enzymes for cyanide synthesis (hcnABC) (Winsor et al. 2016) and 
did not find a clear correlation between the presence of hcnABC and ccoN4 homologs (Figure 
2.2— figure supplement 3).  
 Together, the effects of cco gene mutations that we observed in assays for colony 
morphogenesis and TTC reduction suggest that one or more CcoN4-containing Cco isoform(s) 
support respiration and redox balancing, and is/are utilized preferentially in comparison to 
CcoN1- and CcoN2-containing Cco complexes, in biofilms. We performed a sequence 
alignment of the CcoN subunits encoded by the PA14 genome and identified residues that are 
unique to CcoN4 or shared uniquely between CcoN4 and CcoN1, which showed the strongest 
functional redundancy with CcoN4 in our assays (Figure 2.2— figure supplement 4A). We 
also threaded the CcoN4 sequence using the available structure of the CcoN subunit from P. 
stutzeri (Buschmann et al. 2010) and highlighted these residues (Figure 2.2— figure 
supplement 4B). It is noteworthy that most of the highlighted residues are surface-exposed, 
specifically on one half of the predicted CcoN4 structure, where they may engage in binding an 
unknown protein partner or specific lipids. In contrast, sites that have been described as points 
of interaction with CcoO and CcoP are mostly conserved, further supporting the notion that 
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Figure 2.3. CcoN4 confers a competitive advantage in biofilms, particularly when 
O2 becomes limiting. (A) Relative fitness of various YFP-labeled cco mutants when 
co-cultured with WT in mixed-strain biofilms for three days. Error bars represent the 
standard deviation of biological triplicates. P-values were calculated using unpaired, 
two-tailed t tests (**, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001). For full statistical 
reporting, refer to Table 4. (B) Time course showing relative fitness, over a period of 
three days, of various cco mutants when co-cultured with WT in mixed-strain biofilms. 
Results are shown for experiments in which the WT was co-cultured with various 
“labeled” strains, i.e. those that were engineered to constitutively express YFP. (See 
Figure 3—figure supplement 1 for results from experiments in which the labeled WT 
was co-cultured with unlabeled mutants.) Error bars represent the standard deviation 
of biological triplicates. (C) Change in thickness over three days of development for 
colony biofilms of WT and ∆phz as assessed by thin sectioning and DIC microscopy. 
After the onset of wrinkling, thickness was determined for the base (i.e., the “valley” 
between wrinkles). Error bars represent the standard deviation of biological triplicates. 
(D) O2 profiles of colonies at selected timepoints within the first three days of biofilm 
development. Green, WT; yellow, ∆phz; gray, outside the colony (measurements made 
in the agar directly below the colony). Error bars denote standard deviation of 
biological triplicates. 
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CcoN4 can interact with these subunits in Cco complexes.  
2.3.3: Different CcoN subunits are required for competitive fitness in early or late colony 
development 
 To further test CcoN4’s contribution to growth in biofilms, we performed competition 
assays in which ∆N4 and other mutants were grown as mixed-strain biofilms with the wild type. 
In each of these assays, one strain was labeled with constitutively-expressed YFP so that the 
strains could be distinguished during enumeration of colony forming units (CFUs). Experiments 
were performed with the label on each strain to confirm that YFP expression did not affect 
fitness (Figure 2.3— figure supplement 1A, B). When competitive fitness was assessed after 
three days of colony growth (Figure 2.3A), ∆N4 cells showed a disadvantage, with the wild type 
outcompeting ∆N4 by a factor of two. This was similar to the disadvantage observed for the 
∆N1∆N2 mutant, further suggesting that the orphan subunit CcoN4 plays a significant role in 
biofilm metabolism. Remarkably, deletion of ccoN4 in mutants already lacking ccoN1 and ccoN2 
led to a drastic decrease in fitness, with the wild type outcompeting ∆N1∆N2∆N4 by a factor of 
16. This disadvantage was comparable to that observed for the mutant lacking the full cco 
operons (∆cco1cco2), underscoring the importance of CcoN4-containing isoforms during biofilm 
growth. 
 To further explore the temporal dynamics of N subunit utilization, we repeated the 
competition assay, but sampled each day over the course of three days (Figure 2.3B). The 
fitness disadvantage that we had found for strains lacking CcoN1 and CcoN2 was evident after 
only one day of growth and did not significantly change after that. In contrast, the ∆N4-specific 
decline in fitness did not occur before the second day. These data suggest that the contributions 
of the various N subunits to biofilm metabolism differ depending on developmental stage.  
 DIC imaging of thin sections from wild-type colonies reveals morphological variation over 
depth that may result from decreasing O2 availability (Figure 2.3— figure supplement 1C). We 
have previously reported that three-day-old PA14 colony biofilms are hypoxic at depth (Dietrich 
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et al. 2013) and that O2 availability is generally higher in thinner biofilms, such as those formed 
by a phenazine-null mutant (∆phz). We have proposed that the utilization of phenazines as 
electron acceptors in wild-type biofilms enables cellular survival in the hypoxic zone and 
promotes colony growth (Okegbe, Price-Whelan, and Dietrich 2014). The relatively late-onset 
phenotype of the ∆N4 mutant in the competition assay suggested to us that CcoN4 may play a 
role in survival during formation of the hypoxic colony subzone and that this zone could arise at 
a point between one and two days of colony growth. We measured O2 concentrations in wild-
type and ∆phz biofilms at specific time points over development, and found that O2 declined 
similarly with depth in both strains (Figure 2.3D). The rate of increase in height of ∆phz tapered 
off when a hypoxic zone began to form, consistent with our model that the base does not 
increase in thickness when electron acceptors (O2 or phenazines) are not available. Although 
we cannot pinpoint the exact depth at which the O2 microsensor leaves the colony base and 
enters the underlying agar, we can estimate these values based on colony thickness 
measurements (Figure 2.3C). When we measured the thickness of wild-type and ∆phz biofilms 
over three days of incubation, we found that the values began to diverge between 30 and 48 
hours of growth, after the colonies reached ~70 µm in height, which coincides with the depth at 
which O2 becomes undetectable. ∆phz colonies reached a maximum thickness of ~80 µm, while 
wild-type colonies continued to grow to ~150 µm (Figure 2.3C). In this context, it is interesting 
to note that the point of divergence for the increase in wild-type and ∆phz colony thickness 
corresponds to the point at which CcoN4 becomes important for cell viability in our mixed-strain 
colony growth experiments (Figure 2.3B). We hypothesize that this threshold thickness leads to 
a level of O2 limitation that is physiologically relevant for the roles of phenazines and CcoN4 in 
biofilm metabolism. 
2.3.4: cco genes show differential expression across biofilm subzones 
 P. aeruginosa’s five canonical terminal oxidases are optimized to function under and in 
response to distinct environmental conditions, including various levels of O2 availability (Arai et 
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al. 2014; Kawakami et al. 2010; Alvarez-Ortega and Harwood 2007; Comolli and Donohue 
2004). Furthermore, recent studies, along with our results, suggest that even within the Cco 
terminal oxidase complexes, the various N subunits may perform different functions (Hirai et al. 
2016). We sought to determine whether differential regulation of cco genes could lead to 
uneven expression across biofilm subzones. To test this, we engineered reporter strains in 
which GFP expression is regulated by the cco1, cco2, or ccoN4Q4 promoters. Biofilms of these 
strains were grown for three days, thin-sectioned, and imaged by fluorescence microscopy. 
Representative results are shown in the left panel of Figure 2.4. The right panel of Figure 2.4 
contains plotted GFP signal intensity and O2 concentration measurements over depth for PA14 
wild-type colonies. cco1 and ccoN4 expression patterns indicate that the Cco1 oxidase and the 
CcoN4 subunit are produced throughout the biofilm (Figure 2.4). cco2 expression, on the other 
hand, is relatively low in the top portion of the biofilm and shows a sharp induction starting at a 
depth of ~45 µm. This observation is consistent with previous studies showing that cco2 
expression is regulated by Anr, a global transcription factor that controls gene expression in 
response to a shift from oxic to anoxic conditions (Comolli and Donohue 2004; Kawakami et al. 
2010; Ray and Williams 1997).  
 Though previous studies have evaluated expression as a function of growth phase in 
shaken liquid cultures for cco1 and cco2, this property has not been examined for ccoN4Q4. We 
monitored the fluorescence of our engineered cco gene reporter strains during growth under this 
condition in a nutrient-rich medium. As expected based on the known constitutive expression of 
cco1 and Anr-dependence of cco2 induction, we saw cco1-associated fluorescence increase 
before that associated with cco2. Induction of ccoN4Q4 occurred after that of cco1 and cco2 
(Figure 2.4— figure supplement 1), consistent with microarray data showing that this locus is 
strongly induced by O2 limitation (Alvarez-Ortega and Harwood 2007). However, our 
observation that ccoN4Q4 is expressed in the aerobic zone, where cco2 is not expressed, in 
biofilms (Figure 2.4) suggests that an Anr-independent mechanism functions to induce this 
operon during multicellular growth. 
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 Our results indicate that different Cco isoforms may function in specific biofilm subzones, 
but that CcoN4-containing isoforms could potentially form throughout the biofilm. These data, 
together with our observation that ∆N4 biofilms exhibit a fitness disadvantage from day two 
(Figure 2.3B), led us to more closely examine the development and chemical characteristics of 
the biofilm over depth. 
2.3.5: Microelectrode-based redox profiling reveals differential phenazine reduction 
activity in wild-type and cco mutant biofilms 
 The results shown in Figure 2.2B implicate CcoN4-containing isoforms in the reduction 
of TTC, a small molecule that interacts with the respiratory chain (Rich et al. 2001). Similar 
activities have been demonstrated for phenazines, including the synthetic compound phenazine 
methosulfate (PMS) (Nachlas, Margulies, and Seligman 1960) and those produced naturally by 
P. aeruginosa (Armstrong and Stewart-Tull 1971). Given that CcoN4 and phenazines function to 
Figure 2.4. cco genes are differentially expressed over biofilm depth. Left: Representative 
images of thin sections prepared from WT biofilms grown for three days. Each biofilm is 
expressing a translational GFP reporter under the control of the cco1, cco2, or ccoQ4N4 
promoter. Reporter fluorescence is shown in green and overlain on respective DIC images. 
Right: Fluorescence values corresponding to images on the left. Fluorescence values for a 
strain containing the gfp gene without a promoter (the empty MCS control) have been 
subtracted from each respective plot. O2 concentration over depth (open circles) from three-
day-old WT biofilms is also shown. Error bars represent the standard deviation of biological 
triplicates and are not shown in cases where they would be obscured by the point markers. y-
axis in the right panel provides a scale bar for the left panel. Reporter fluorescence images and 
values are representative of four biological replicates. 
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Figure 2.5. Characterization of chemical gradients and matrix distribution in PA14 WT 
and mutant colony biofilms. (A) Left: Change in O2 concentration (blue) and redox potential 
(orange) with depth for WT and ∆phz biofilms grown for two days. For O2 profiles, error bars 
represent the standard deviation of biological triplicates. For redox profiles, data are 
representative of at least five biological replicates. Right: model depicting the distribution of O2 
and reduced vs. oxidized phenazines in biofilms. (B) Top: Change in redox potential with depth 
for WT and various mutant biofilms grown for two days. Data are representative of at least five 
biological replicates. Bottom: Thickness of three-day-old colony biofilms of the indicated strains. 
Bars represent the average of the plotted data points (each point representing one biological 
replicate, n ≥ 4), and error bars represent the standard deviation. P-values were calculated 
using unpaired, two-tailed t tests comparing each mutant to WT (n.s., not significant; **, P ≤ 
0.01; ****, P ≤ 0.0001). For full statistical reporting, refer to Table 4. (C) Left: Representative thin 
sections of WT and cco mutant biofilms, stained with lectin and imaged by fluorescence 
microscopy. Biofilms were grown for two days before sampling. Right: Relative quantification of 
lectin stain signal intensity. Coloration of strain names in the left panel provides a key for the 
plotted data, and the y-axis in the right panel provides a scale bar for the left panel. Lectin-
staining images and values are representative of four biological replicates.
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influence morphogenesis at similar stages of biofilm growth (Figures 2.2A, 3, Figure 2.2— 
figure supplement 1, Figure 2.3— figure supplement 1A, B), we wondered whether the role 
of CcoN4 in biofilm development was linked to phenazine metabolism. We used a Unisense 
platinum microelectrode with a 20-30 µm tip to measure the extracellular redox potential in 
biofilms as a function of depth. This electrode measures the inclination of the sample to donate 
or accept electrons relative to a Ag/AgCl reference electrode. We found that wild-type colonies 
showed a decrease in redox potential over depth, indicating an increased ratio of reduced to 
oxidized phenazines, while the redox potential of ∆phz colonies remained unchanged (Figure 
2.5A). To confirm that phenazines are the primary determinant of the measured redox potential 
in the wild type, we grew ∆phz colonies on medium containing PMS (which resembles the 
natural phenazines that regulate P. aeruginosa colony morphogenesis (Sakhtah et al. 2016)), 
and found that these colonies yielded redox profiles similar to those of the wild type (Figure 2.5
— figure supplement 1A). Therefore, though the microelectrode we employed is capable of 
interacting with many redox-active substrates, we found that its signal was primarily determined 
by phenazines in our system. In addition, while wild-type colonies showed rapid decreases in O2 
availability starting at the surface, the strongest decrease in redox potential was detected after 
~50 µm (Figure 2.5A). These results suggest that the bacteria residing in the biofilm 
differentially utilize O2 and phenazines depending on their position and that O2 is the preferred 
electron acceptor.  
 We hypothesized that one or more of the CcoN subunits encoded by the PA14 genome 
is required for phenazine reduction and tested this by measuring the redox potential over depth 
for a series of cco mutants (Figure 2.5B, top). We saw very little reduction of phenazines in the 
∆cco1cco2 colony, suggesting that cbb3-type oxidases are required for this activity. In contrast, 
the mutant lacking the catalytic subunits of Cco1 and Cco2, ∆N1∆N2, showed a redox profile 
similar to the wild type, indicating that isoforms containing one or both of the orphan CcoN 
subunits could support phenazine reduction activity. Indeed, although redox profiles obtained for 
the ∆N1∆N2 and ∆N4 mutants were similar to those obtained for the wild type, the redox profile 
45
of the ∆N1∆N2∆N4 mutant recapitulated that of ∆cco1cco2. These results indicate redundancy 
in the roles of some of the CcoN subunits. Consistent with this, ∆N1∆N4 showed an 
intermediate defect in phenazine reduction. We note that the triple mutant ∆cox∆cyo∆cio 
showed a wild-type-like redox profile, indicating that the cbb3-type terminal oxidases are 
sufficient for normal phenazine reduction (Figure 2.5— figure supplement 1B). Extraction and 
measurement of phenazines released from wild-type and cco mutant biofilms showed that 
variations in redox profiles could not be attributed to differences in phenazine production 
(Figure 2.5— figure supplement 1C). 
 Our group has previously shown that a ∆phz mutant compensates for its lack of 
phenazines by forming thinner colonies, thus limiting the development of the hypoxic subzone 
seen in the wild type (Dietrich et al. 2013). We therefore hypothesized that mutants unable to 
reduce phenazines would likewise result in thinner colonies. Indeed, we observed that the cco 
mutants that lacked phenazine reduction profiles in the top panel of Figure 2.5B produced 
biofilms that were significantly thinner than wild-type and comparable to that of the ∆phz mutant 
(Figure 2.5B, bottom). 
 Our group has also reported that reduction of nitrate, an alternate electron acceptor for 
P. aeruginosa (Williams, Zlosnik, and Ryall 2007), can serve as an additional redox-balancing 
strategy for cells in biofilms (Dietrich et al. 2013). Colony wrinkling is stimulated by a reduced 
cellular redox state; thus, provision of nitrate in the growth medium inhibits colony feature 
formation. We hypothesized that nitrate reduction could compensate for defects in O2 and 
phenazine reduction and inhibit colony wrinkling in the cco mutants that are the focus of this 
study. To test this, we grew strains on medium containing 10 or 40 mM potassium nitrate. We 
found that 10 mM nitrate was sufficient to inhibit wrinkling for up to 4 days of incubation in the 
wild type, ∆N4, and ∆N1∆N4, but that ∆phz and ∆N1∆N2∆N4 had initiated wrinkling at this point 
(Figure 2.5— figure supplement 1D). When we grew these strains on medium containing 40 
mM nitrate, we saw increased inhibition of wrinkling such that the wild type, ∆phz, ∆N4, and 
∆N1∆N4 remained completely smooth at 4 days of incubation. Though ∆N1∆N2∆N4 had shown 
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some feature formation after 4 days on this medium, it was diminished relative to the same point 
on 10 mM nitrate. These results suggest that O2 reduction, phenazine reduction, and nitrate 
reduction can operate in synchrony to oxidize the redox states of cells in biofilms and that 
provision of nitrate can compensate for defects in O2 and phenazine reduction to enable 
maintenance of redox homeostasis. 
2.3.6: Wild-type and cco mutant colony biofilms show increased matrix production at a 
consistent depth 
 We have recently demonstrated that extracellular matrix production, a hallmark of biofilm 
formation, is regulated by redox state in PA14 colony biofilms. Increased matrix production 
correlates with the accumulation of reducing power (as indicated by higher cellular NADH/NAD+ 
ratios) due to electron acceptor limitation and is visible in the hypoxic region of ∆phz colonies 
(Dietrich et al. 2013; Okegbe et al. 2017). The morphologies of our cco mutants (Figure 2.2A) 
suggest that matrix production can also be induced by respiratory chain dysfunction, which may 
be linked to defects in phenazine utilization (Figure 2.5B). To further examine the relationships 
between Cco isoforms and redox imbalance in biofilms, we prepared thin sections from two day-
old colonies and stained with fluorescein-labeled lectin, which binds preferentially to the Pel 
polysaccharide component of the matrix (Jennings et al. 2015). Consistent with their similar 
gross morphologies, the wild-type and ∆N1∆N2 biofilms showed similar patterns of staining, with 
a faint band of higher intensity at a depth of ~40 µm (Figure 2.5C). ∆N4 also showed a similar 
pattern, with a slightly higher intensity of staining in this band. ∆N1∆N2∆N4 and ∆cco1cco2 
showed more staining throughout each sample, with wider bands of greater intensity at the ~40 
µm point. These data suggest that deletion of the Cco complexes leads to a more reduced 
biofilm, which induces production of more matrix, and that CcoN4 contributes significantly to 
maintaining redox homeostasis when O2 is limiting. 
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2.3.7: ccoN4 contributes to P. aeruginosa virulence in a C. elegans slow killing model 
 We have previously shown that a mutant defective in biofilm-specific phenazine 
production, which also shows altered colony morphology (Dietrich et al. 2008, 2013), exhibits 
decreased virulence (Recinos et al. 2012). We and others have suggested that one way in 
which phenazines could contribute to virulence is by acting as electron acceptors to balance the 
intracellular redox state in the hypoxic conditions that are encountered during infection (Price-
Whelan, Dietrich, and Newman 2006; Newman 2008; Dietrich et al. 2013). Because CcoN4 is 
required for wild-type biofilm architecture and respiration (Figures 2.2A, 2.2C, and 2.5C), we 
hypothesized that it could also contribute to virulence. To test this, we conducted virulence 
assays using the nematode Caenorhabditis elegans as a host. It has been shown that P. 
aeruginosa is pathogenic to C. elegans and that the slow killing assay mimics an infection-like 
killing of C. elegans by the bacterium (Tan, Mahajan-Miklos, and Ausubel 1999). While ∆N1∆N2 
killed with wild type-like kinetics, ∆N1∆N2∆N4 and ∆cco1cco2 both showed comparably-
impaired killing relative to wild-type PA14 (Figure 2.6). 
Figure 2.6. CcoN4-containing isoform(s) 
make unique contributions to PA14 
virulence. Slow-killing kinetics of WT, gacA, 
and various cco mutant strains in the nematode 
Caenorhabditis elegans. Nearly 100% of the C. 
elegans population exposed to WT PA14 is 
killed after four days of exposure to the 
bacterium, while a mutant lacking GacA, a 
regulator that controls expression of virulence 
genes in P. aeruginosa, shows decreased 
killing, with ~50% of worms alive four days 
pos t -exposu re . (A ) ∆N1∆N2∆N4 and 
∆cco1cco2 show comparably attenuated 
pathogenicity relative to WT. Error bars 
represent the standard deviation of at least six 
biological replicates. At 2.25 days post-
exposure, significantly less C. elegans were 
killed by ∆N1∆N2∆N4 than by WT (unpaired 
two-tailed t test; p = 0.0022). (B) ∆N1∆N2 
displays only slightly reduced pathogenicity 
when compared to WT. At 2.25 days post-
exposure, significantly more C. elegans were 
killed by ∆N1∆N2 than by ∆N1∆N2∆N4 
(unpaired two-tailed t test; p = 0.003). For full 
statistical reporting, refer to Table 4. Error bars 
represent the standard deviation of at least four 
biological replicates, each with a starting 
sample size of 30-35 worms per replicate.
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2.4: Discussion 
 Biofilm formation contributes to P. aeruginosa pathogenicity and persistence during 
different types of infections, including the chronic lung colonizations seen in individuals with 
cystic fibrosis (Tolker-Nielsen 2014; Rybtke et al. 2015). The conditions found within biofilm 
microenvironments are distinct from those in well-mixed liquid cultures with respect to 
availability of electron donors and acceptors. We have previously described the roles of 
phenazines, electron-shuttling antibiotics produced by P. aeruginosa, in biofilm-specific 
metabolism. In this study, we focused on P. aeruginosa’s large complement of genes encoding 
cbb3-type cytochrome oxidase subunits and set out to test their contributions to metabolic 
electron flow in biofilms.  
 The P. aeruginosa genome contains four different homologs of ccoN, encoding the 
catalytic subunit of cbb3-type oxidase. Only two of these (ccoN1 and ccoN2) are co-transcribed 
with a ccoO homolog, encoding the other critical component of an active cbb3-type oxidase 
(Figure 2.1B). However, genetic studies have demonstrated that all four versions of CcoN can 
form functional complexes when expressed with either of the two CcoO homologs (Hirai et al. 
2016). In well-mixed liquid cultures, mutants lacking the “orphan” subunits did not show growth 
defects (Figure 2.2C) (Hirai et al. 2016). We were therefore surprised to find that the ∆N4 
mutant showed a unique morphotype in a colony biofilm assay (Figure 2.2A, Figure 2.2— 
figure supplement 1A). We have applied this assay extensively in our studies of the 
mechanisms underlying cellular redox balancing and sensing and noted that the phenotype of 
∆N4 was similar to that of mutants with defects in electron shuttling and redox signaling (Dietrich 
et al. 2013; Okegbe et al. 2017).  
 We characterized the effects of a ∆N4 mutation on biofilm physiology through a series of 
assays. In well-mixed liquid cultures, ∆cco1cco2 showed a growth phenotype similar to that of 
∆N1∆N2. While Hirai et al. have shown that wild-type P. aeruginosa cultures grown 
planktonically do form Cco heterocomplexes containing CcoN4, our observations suggest that 
such complexes do not contribute significantly to growth under these conditions. Consistent with 
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this, deleting ccoN4 in the ∆N1∆N2 background had no effect on planktonic growth (Figure 
2.2C). However, in biofilm-based experiments, we found that deleting N4 alone was sufficient to 
cause an altered morphology phenotype (Figure 2.2A and Figure 2.2— figure supplement 
1A), and that deleting N4 in either a ∆N1 or a ∆N1∆N2 background profoundly affected biofilm 
physiology. These experiments included quantification of respiratory activity in colonies, in which 
deletion of CcoN4 led to a significant decrease (Figure 2.2B); biofilm co-culturing, in which 
CcoN4 was required for competitive fitness (Figure 2.3A and B, Figure 2.3— figure 
supplement 1); redox profiling, which showed that CcoN4 can contribute to phenazine 
reduction (Figure 2.5B, top); colony thickness measurements, which showed that CcoN4 is 
required for the formation of the hypoxic and anoxic zones (Figure 2.5B, bottom); and matrix 
profiling, which showed that CcoN4 contributes to the repression of Pel polysaccharide 
production (Figure 2.5C). The overlap in zones of expression between cco1, cco2, and 
ccoN4Q4 seen in colony thin sections (Figure 2.4) implies that CcoN4 can form 
heterocomplexes with Cco1 and Cco2 subunits that span the depth of the colony and function to 
influence the physiology of P. aeruginosa biofilms in these ways. 
 The mutant phenotypes and gene expression profiles reported in this study suggest 
roles for CcoN4 in O2 and phenazine reduction specifically in the biofilm context, and allow us to 
draw conclusions about the roles of other CcoN subunits. The expression of ccoN4Q4 
throughout the biofilm depth suggests that CcoN4-containing isoforms could contribute to 
cytochrome c oxidation in both oxic and hypoxic zones (Figure 2.4). This constitutes a deviation 
from the previously published observation that these genes are specifically induced in hypoxic 
liquid cultures when compared to well-aerated ones (Alvarez-Ortega and Harwood 2007). 
Therefore, the ccoN4Q4 expression we observed in the relatively oxic, upper portion of the 
colony may be specific to biofilms. 
 ∆N4 displayed a colony morphology indicative of redox stress and had a fitness 
disadvantage compared to the wild type (Figures 2.2A, 2.3A and B, Figure 2.5B, bottom, 
Figure 2.3— figure supplement 1). However, because it did not show a defect in phenazine 
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reduction (Figure 2.5B, top), we attribute its colony morphology and impaired fitness 
phenotypes to its proposed role in O2 reduction (Hirai et al. 2016). Similarly, ∆N1∆N2 showed 
reduced fitness compared to the wild type (Figure 2.3A and B, Figure 2.3— figure 
supplement 1) while showing phenazine reduction comparable to that of the wild type (Figure 
2.5B), implying that one or both of these subunits contribute to oxygen reduction in biofilms. 
When CcoN4 was deleted in conjunction with CcoN1 and CcoN2, however, the resulting strain 
showed a severe phenazine reduction defect, a phenotype recapitulated by deleting both cco 
operons (Figure 2.5B). Thus, our observations suggest a role for the cbb3-type oxidases in 
phenazine reduction in addition to their established roles in O2 reduction, thereby expanding our 
understanding of their overall contributions P. aeruginosa’s physiology and viability. 
 The results described here can inform our model of how cells survive under distinct 
conditions in the microenvironments within biofilms. Previous work has shown that pyruvate 
fermentation can support survival of P. aeruginosa under anoxic conditions (Eschbach et al. 
2004) and that phenazines facilitate this process (Glasser, Kern, and Newman 2014). Additional 
research suggests that phenazine reduction is catalyzed adventitiously by P. aeruginosa 
flavoproteins and dehydrogenases (Glasser et al. 2017). Our observation that cbb3-type 
cytochrome oxidases, particularly those containing the CcoN1 or CcoN4 subunits, were required 
for phenazine reduction in hypoxic biofilm subzones (Figure 2.5B) further implicates the 
electron transport chain in utilization of these compounds. It is also interesting in light of the 
historical roles of phenazines acting as mediators in biochemical studies of the cytochrome bc1 
complex and cytochrome oxidases (King 1963; Armstrong and Stewart-Tull 1971; Davidson et 
al. 1992). Based on this earlier work, we can speculate that different CcoN subunits may 
indirectly influence phenazine reduction, which could occur at the cytochrome c binding site of 
the CcoO subunit or elsewhere in the electron transport chain, through effects these CcoN 
subunits have on the overall function or stability of respiratory complexes. Ultimately, various 
mechanisms of phenazine reduction and phenazine-related metabolisms may be relevant at 
different biofilm depths or depending on electron donor availability. Our results suggest that, in 
51
the colony biofilm system, enzyme complexes traditionally considered to be specific to oxygen 
reduction may contribute to anaerobic survival. 
 Because biofilm formation is often associated with colonization of and persistence in 
hosts, we tested whether CcoN4 contributes to P. aeruginosa pathogenicity in C. elegans. 
Similar to our observations in biofilm assays, we found that the ∆cco1cco2 mutant displayed a 
more severe phenotype than the ∆N1∆N2 mutant, suggesting that an orphan subunit can 
substitute for those encoded by the cco1 and cco2 operons. We also found that deleting ccoN4 
in ∆N1∆N2 led to a ∆cco1cco2-like phenotype, suggesting that CcoN4 is the subunit that can 
play this role (Figure 2.6). In host microenvironments where O2 is available, CcoN4-containing 
isoforms could contribute to its reduction. Additionally, in hypoxic zones, CcoN4-containing 
isoforms could facilitate the reduction of phenazines, enabling cellular redox balancing. Both of 
these functions would contribute to persistence of the bacterium within the host. The 
contributions of the cbb3-type oxidases to P. aeruginosa pathogenicity raise the possibility that 
compounds interfering with Cco enzyme function could be effective therapies for these 
infections. Such drugs would be attractive candidates due to their specificity for bacterial 
respiratory chains and, as such, would not affect the host’s endogenous respiratory enzymes.  
 Our discovery that an orphan cbb3-type oxidase subunit contributes to growth in biofilms 
further expands the picture of P. aeruginosa’s remarkable respiratory flexibility. Beyond 
modularity at the level of the terminal enzyme complex (e.g., utilization of an aa3- vs. a cbb3-
type oxidase), the activity of P. aeruginosa’s respiratory chain is further influenced by 
substitution of orphan cbb3-type catalytic subunits for native ones. Utilization of CcoN4-
containing isoforms promotes phenazine reduction activity and may influence aerobic 
respiration in P. aeruginosa biofilms. For the exceptional species that contain orphan cbb3-type 
catalytic subunits, this fine level of control could be particularly advantageous during growth and 
survival in environments covering a wide range of electron acceptor availability (Cowley et al. 
2015).  
52
2.5: Materials and methods 
2.5.1: Bacterial strains and growth conditions 
 P. aeruginosa strain UCBPP-PA14 (Rahme et al. 1995) was routinely grown in lysogeny 
broth (LB; 1% tryptone, 1% NaCl, 0.5% yeast extract) (Bertani 2004) at 37 ˚C with shaking at 
250 rpm unless otherwise indicated. Overnight cultures were grown for 12-16 hours. For genetic 
manipulation, strains were typically grown on LB solidified with 1.5% agar. Strains used in this 
study are listed in Table 2.3. In general, liquid precultures served as inocula for experiments. 
Overnight precultures for biological replicates were started from separate clonal source colonies 
on streaked agar plates. For technical replicates, a single preculture served as the source 
inoculum for subcultures. 
2.5.2: Construction of mutant P. aeruginosa strains 
 For making markerless deletion mutants in P. aeruginosa PA14 (Table 2.3) 1 kb of 
flanking sequence from each side of the target gene were amplified using the primers listed in 
Table 2.1 and inserted into pMQ30 through gap repair cloning in Saccharomyces cerevisiae 
InvSc1 (Shanks et al. 2006). Each plasmid listed in Table 2.2 was transformed into Escherichia 
coli strain UQ950, verified by restriction digests, and moved into PA14 using biparental 
conjugation. PA14 single recombinants were selected on LB agar plates containing 100 µg/ml 
gentamicin. Double recombinants (markerless deletions) were selected on LB without NaCl and 
modified to contain 10% sucrose. Genotypes of deletion mutants were confirmed by PCR. 
Combinatorial mutants were constructed by using single mutants as hosts for biparental 
conjugation, with the exception of ∆cco1cco2, which was constructed by deleting the cco1 and 
cco2 operons simultaneously as one fragment. ccoN4 complementation strains were made in 
the same manner, using primers LD438 and LD441 listed in Table 2.1 to amplify the coding 
sequence of ccoN4, which was verified by sequencing and complemented back into the site of 
the deletion.  
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2.5.3: Colony biofilm morphology assays  
 Overnight precultures were diluted 1:100 in LB (∆N1∆N2, ∆N1∆N2∆N3, ∆N1∆N2∆N4, 
∆N1∆N2∆N4∆N3, ∆N1∆N2∆N4::N4, ∆cco1cco2, ∆N1∆N2∆hcn, ∆N1∆N2∆N4∆hcn, 
∆cco1cco2∆hcn, and ∆cox∆cyo∆cio were diluted 1:50) and grown to mid-exponential phase (OD 
at 500 nm ≈ 0.5). Ten microliters of subcultures were spotted onto 60 mL of colony morphology 
medium (1% tryptone, 1% agar [Teknova A7777] containing 40 µg/ml Congo red dye [VWR 
AAAB24310-14] and 20 µg/ml Coomassie blue dye [Omnipur; VWR EM-3300]) in a 10 cm x 10 
cm x 1.5 cm square Petri dish (LDP D210-16). For preparation of biofilms grown on on 
phenazine methosulfate (PMS), colony morphology medium was supplemented with 200 µM 
PMS (Amresco 0361) after autoclaving. For nitrate experiments, colony morphology medium 
was supplemented with 0, 10, or 40 mM potassium nitrate. Plates were incubated for up to five 
days at 25 ˚C with > 90% humidity (Percival CU-22L) and imaged daily using a Keyence 
VHX-1000 digital microscope. Images shown are representative of at least ten biological 
replicates. 3D images of biofilms were taken on day 5 of development using a Keyence 
VR-3100 wide-area 3D measurement system. ∆cox∆cyo∆cio, hcn deletion mutants, and strains 
grown for the nitrate experiment were imaged using a flatbed scanner (Epson E11000XL-GA) 
and are representative of at least three biological replicates  
2.5.4: TTC reduction assay  
 One microliter of overnight cultures (five biological replicates), grown as described 
above, was spotted onto a 1% tryptone, 1.5% agar plate containing 0.001% (w/v) TTC (2,3,5-
triphenyl-tetrazolium chloride [Sigma-Aldrich T8877]) and incubated in the dark at 25 ˚C for 24 
hours. Spots were imaged using a scanner (Epson E11000XL-GA) and TTC reduction, 
normalized to colony area, was quantified using Adobe Photoshop CS5. Colorless TTC 
undergoes an irreversible color change to red when reduced. Pixels in the red color range were 
quantified and normalized to colony area using Photoshop CS5. 
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2.5.5: Liquid culture growth assays   
 (i) Overnight precultures were diluted 1:100 (∆N1∆N2, ∆N1∆N2∆N4, and ∆cco1cco2 
were diluted 1:50) in 1% tryptone in a clear- flat-bottom polystyrene 96-well plate (VWR 
82050-716) and grown for two hours (OD500nm ≈ 0.2). These cultures were then diluted 100-fold 
in 1% tryptone in a new 96-well plate and incubated at 37 °C with continuous shaking on the 
medium setting in a Biotek Synergy 4 plate reader.  Growth was assessed by taking OD 
readings at 500 nm every thirty minutes for at least 24 hours.  
 (ii) hcn mutants: Overnight precultures were diluted 1:100 (∆N1∆N2∆hcn, 
∆N1∆N2∆N4∆hcn, and ∆cco1cco2∆hcn were diluted 1:50) in MOPS minimal medium (50 mM 4-
morpholinepropanesulfonic acid (pH 7.2), 43 mM NaCl, 93 mM NH4Cl, 2.2 mM KH2PO4, 1 mM 
MgSO4•7H2O, 1 µg/ml FeSO4•7H2O, 20 mM sodium succinate hexahydrate) and grown for 2.5 
hours until OD at 500 nm ≈ 0.1. These cultures were then diluted 100-fold in MOPS minimal 
medium in a clear, flat-bottom polystyrene 96-well plate and incubated at 37 °C with continuous 
shaking on the medium setting in a Biotek Synergy 4 plate reader. Growth was assessed by 
taking OD readings at 500 nm every thirty minutes for at least 24 hours.  
 (iii) Terminal oxidase reporters: Overnight precultures were grown in biological 
triplicate; each biological triplicate was grown in technical duplicate. Overnight precultures were 
diluted 1:100 in 1% tryptone and grown for 2.5 hours until OD at 500 nm ≈ 0.1. These cultures 
were then diluted 100-fold in 1% tryptone in a clear, flat-bottom, polystyrene black 96-well plate 
(VWR 82050-756) and incubated at 37 °C with continuous shaking on the medium setting in a 
Biotek Synergy 4 plate reader. Expression of GFP was assessed by taking fluorescence 
readings at excitation and emission wavelengths of 480 nm and 510 nm, respectively, every 
hour for 24 hours. Growth was assessed by taking OD readings at 500 nm every 30 minutes for 
24 hours. Growth and RFU values for technical duplicates were averaged to obtain the 
respective values for each biological replicate. RFU values for a strain without a promoter 
inserted upstream of the gfp gene (MCS-gfp) were considered background and subtracted from 
the fluorescence values of each reporter.  
55
2.5.6: Competition assays  
 Overnight precultures of fluorescent (YFP-expressing) and non-fluorescent strains were 
diluted 1:100 in LB (∆N1∆N2, ∆N1∆N2∆N4 and ∆cco1cco2 were diluted 1:50) and grown to mid-
exponential phase (OD at 500 nm ≈ 0.5).  Exact OD at 500 nm values were read in a Spectronic 
20D+ spectrophotometer (Thermo Scientific) and cultures were adjusted to the same OD. 
Adjusted cultures were then mixed in a 1:1 ratio of fluorescent:non-fluorescent cells and ten µl 
of this mixture were spotted onto colony morphology plates and grown for three days as 
described above. At specified time points, biofilms were collected, suspended in one mL of 1% 
tryptone, and homogenized on the “high” setting in a bead mill homogenizer (Omni Bead Ruptor 
12); day one colonies were homogenized for 35 seconds while days two and three colonies 
were homogenized for 99 seconds. Homogenized cells were serially diluted and 10-6, 10-7, and 
10-8 dilutions were plated onto 1% tryptone plates and grown overnight at 37 °C. Fluorescent 
colony counts were determined by imaging plates with a Typhoon FLA7000 fluorescent scanner 
(GE Healthcare) and percentages of fluorescent vs. non-fluorescent colonies were determined.  
2.5.7: Construction of terminal oxidase reporters  
 Translational reporter constructs for the Cco1, Cco2, and CcoN4Q4 operons were 
constructed using primers listed in Table 2.1. Respective primers were used to amplify promoter 
regions (500 bp upstream of the operon of interest), adding an SpeI digest site to the 5’ end of 
the promoter and an XhoI digest site to the 3’ end of the promoter. Purified PCR products were 
digested and ligated into the multiple cloning site (MCS) of the pLD2722 vector, upstream of the 
gfp sequence. Plasmids were transformed into E. coli strain UQ950, verified by sequencing, and 
moved into PA14 using biparental conjugation with E. coli strain S17-1. PA14 single 
recombinants were selected on M9 minimal medium agar plates (47.8 mM Na2HPO4•7H2O, 22 
mM KH2PO4, 8.6 mM NaCl, 18.6 mM NH4Cl, 1 mM MgSO4, 0.1 mM CaCl2, 20 mM sodium 
citrate dihydrate, 1.5% agar) containing 100 µg/ml gentamicin. The plasmid backbone was 
resolved out of PA14 using Flp-FRT recombination by introduction of the pFLP2 plasmid (Hoang 
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et al. 1998) and selected on M9 minimal medium agar plates containing 300 µg/ml carbenicillin 
and further on LB agar plates without NaCl and modified to contain 10% sucrose. The presence 
of gfp in the final clones was confirmed by PCR. 
2.5.8: Thin sectioning analyses  
 Two layers of 1% tryptone with 1% agar were poured to depths of 4.5 mm (bottom) and 
1.5 mm (top). Overnight precultures were diluted 1:100 (∆N1∆N2, ∆N1∆N4, ∆N1∆N2∆N4, 
∆cco1cco2 were diluted 1:50) in LB and grown for two hours, until early-mid exponential phase. 
Five to ten µL of subculture were then spotted onto the top agar layer and colonies were 
incubated in the dark at 25 ˚C with > 90% humidity (Percival CU-22L) and grown for up to three 
days. At specified time points to be prepared for thin sectioning, colonies were covered by a 1.5-
mm-thick 1% agar layer. Colonies sandwiched between two 1.5-mm agar layers were lifted from 
the bottom layer and soaked for four hours in 50 mM L-lysine in phosphate buffered saline 
(PBS) (pH 7.4) at 4 ˚C, then fixed in 4% paraformaldehyde, 50 mM L-lysine, PBS (pH 7.4) for 
four hours at 4˚C, then overnight at 37 °C. Fixed colonies were washed twice in PBS and 
dehydrated through a series of ethanol washes (25%, 50%, 70%, 95%, 3x 100% ethanol) for 60 
minutes each. Colonies were cleared via three 60-minute incubations in Histoclear-II (National 
Diagnostics HS-202) and infiltrated with wax via two separate washes of 100% Paraplast Xtra 
paraffin wax (Electron Microscopy Sciences; Fisher Scientific 50-276-89) for two hours each at 
55 ˚C, then colonies were allowed to polymerize overnight at 4 ˚C. Tissue processing was 
performed using an STP120 Tissue Processor (Thermo Fisher Scientific 813150). Trimmed 
blocks were sectioned in ten µm-thick sections perpendicular to the plane of the colony using an 
automatic microtome (Thermo Fisher Scientific 905200ER), floated onto water at 45 ˚C, and 
collected onto slides. Slides were air-dried overnight, heat-fixed on a hotplate for one hour at 45 
˚C, and rehydrated in the reverse order of processing. Rehydrated colonies were immediately 
mounted in TRIS-Buffered DAPI:Fluorogel (Electron Microscopy Sciences; Fisher Scientific 
50-246-93) and overlaid with a coverslip. Differential interference contrast (DIC) and fluorescent 
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confocal images were captured using an LSM700 confocal microscope (Zeiss). Each strain was 
prepared in this manner in at least biological triplicates. 
2.5.9: Colony thickness measurements  
 Colonies were prepared for thin sectioning as described above, but growth medium was 
supplemented with 40 µg/ml Congo Red dye and 20 µg/ml Coomassie Blue dye. Colony height 
measurements were obtained from confocal DIC images using Fiji image processing software 
(Schindelin et al. 2012).    
2.5.10: Lectin staining  
 Two-day-old colonies were prepared for thin sectioning as described above. Rehydrated 
colonies were post-stained in 100 µg/mL fluorescein-labeled Wisteria floribunda lectin (Vector 
Laboratories FL-1351) in PBS before being washed twice in PBS, mounted in TRIS-buffered 
DAPI and overlaid with a coverslip. Fluorescent confocal images were captured using an 
LSM700 confocal microscope (Zeiss).  
2.5.11: Redox profiling of biofilms  
 A 25 µm-tip redox microelectrode and external reference (Unisense RD-25 and REF-
RM) were used to measure the extracellular redox state of day two (~ 48 h) biofilms (grown as 
for the colony biofilm morphology assays). The redox microelectrode measures the tendency of 
a sample to take up or release electrons relative to the reference electrode, which is immersed 
in the same medium as the one on which the sample is grown. The redox microelectrode was 
calibrated according to manufacturer’s instructions using a two-point calibration to 1% 
quinhydrone in pH 4 buffer and 1% quinhydrone in pH 7 buffer. Redox measurements were 
taken every five µm throughout the depth of the biofilm using a micromanipulator (Unisense 
MM33) with a measurement time of three seconds and a wait time between measurements of 
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five seconds. Profiles were recorded using a multimeter (Unisense) and the SensorTrace 
Profiling software (Unisense).  
2.5.12: Oxygen profiling of biofilms  
 A 25 µm-tip oxygen microsensor (Unisense OX-25) was used to measure oxygen 
concentrations within biofilms during the first two days of development, grown as described 
above. For oxygen profiling on three-day-old colonies (Figure 2.4), biofilms were grown as for 
the thin sectioning analyses. To calibrate the oxygen microsensor, a two-point calibration was 
used. The oxygen microsensor was calibrated first to atmospheric oxygen using a calibration 
chamber (Unisense CAL300) containing water continuously bubbled with air. The microsensor 
was then calibrated to a “zero” point using an anoxic solution of water thoroughly bubbled with 
N2; to ensure complete removal of all oxygen, N2 was bubbled into the calibration chamber for a 
minimum of 30 minutes before calibrating the microsensor to the zero calibration point. Oxygen 
measurements were then taken throughout the depth of the biofilm using a measurement time 
of three seconds and a wait time between measurements of five seconds. For six-hour-old 
colonies, a step size of one µm was used to profile through the entire colony; for 12-hour and 
24-hour colonies, two µm; for 48-hour colonies, five µm. A micromanipulator (Unisense MM33) 
was used to move the microsensor within the biofilm and profiles were recorded using a 
multimeter (Unisense) and the SensorTrace Profiling software (Unisense). 
2.5.13: Phenazine quantification  
 Overnight precultures were diluted 1:10 in LB and spotted onto a 25- mm 0.2 µm filter 
disk (pore size: 0.2 µm; GE Healthcare 110606) placed into the center of one 35 x 10 mm round 
Petri dish (Falcon 351008). Colonies were grown for two days in the dark at 25 ˚C with > 90% 
humidity. After two days of growth, each colony (with filter disk) was lifted off its respective plate 
and weighed. Excreted phenazines were then extracted from the agar medium overnight in five 
mL of 100% methanol (in the dark, nutating at room temperature). Three hundred µl of this 
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overnight phenazine/methanol extraction were then filtered through a 0.22 µm cellulose Spin-X 
column (Thermo Fisher Scientific 07-200-386) and 200 µl of the flow-through were loaded into 
an HPLC vial. Phenazines were quantified using high-performance liquid chromatography 
(Agilent 1100 HPLC System) as described previously (Dietrich et al. 2006; Sakhtah et al. 2016). 
2.5.14: C. elegans pathogenicity (slow killing) assays  
 Slow killing assays were performed as described previously (Tan, Mahajan-Miklos, and 
Ausubel 1999; Powell and Ausubel 2008). Briefly, ten µl of overnight PA14 cultures (grown as 
described above) were spotted onto slow killing agar plates (0.3% NaCl, 0.35% Bacto-Peptone, 
1 mM CaCl2, 1 mM MgSO4, 5 µg/ml cholesterol, 25 mM KPO4, 50 µg/ml FUDR, 1.7% agar) and 
plates were incubated for 24 hours at 37 °C followed by 48 hours at room temperature (~23 °C). 
Larval stage 4 (L4) nematodes were picked onto the PA14-seeded plates and live/dead worms 
were counted for up to four days. Each plate was considered a biological replicate and had a 
starting sample size of 30-35 worms.  
2.5.15: Statistical analysis  
 Data analysis was performed using GraphPad Prism version 7 (GraphPad Software, La 
Jolla California USA). Values are expressed as mean ± SD. Statistical significance of the data 
presented was assessed with the two-tailed unpaired Student’s t-test. Values of P ≤ 0.05 were 
considered significant (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤0.001; ****, P ≤ 0.0001). A summary of 
the statistical analyses performed can be found in Table 2.4.  
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2.7: Tables 
Table 2.1: Primers used in this study.
primer 
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Table 2.1 (continued): Primers used in this study.
primer 
number



































Table 2.2: Plasmids used in this study
plasmid description source
pMQ30 7.5 kb mobilizable vector; oriT, sacB, GmR. Shanks et al. 2006
pAKN69 Contains mini-Tn7(Gm)PA1/04/03::eyfp fusion. Lambertsen et al. 
2004
pLD2722 GmR, TetR flanked by Flp recombinase target (FRT) sites to 
resolve out resistance casettes.
this study
pFLP2 Site-specific excision vector with cI857-controlled FLP 
recombinase encoding sequence, sacB, ApR.
Hoang et al. 1998
pLD1852 ∆ccoN1 PCR fragment introduced into pMQ30 by gap repair 
cloning in yeast strain InvSc1.
this study
pLD1610 ∆ccoN2 PCR fragment introduced into pMQ30 by gap repair 
cloning in yeast strain InvSc1.
this study
pLD1616 ∆ccoN3 PCR fragment introduced into pMQ30 by gap repair 
cloning in yeast strain InvSc1.
this study
pLD1264 ∆ccoN4 PCR fragment introduced into pMQ30 by gap repair 
cloning in yeast strain InvSc1.
this study
pLD1929 ∆cco1 cco2 PCR fragment introduced into pMQ30 by gap repair 
cloning in yeast strain InvSc1.
this study
pLD2791 ∆hcn PCR fragment introduced into pMQ30 by gap repair cloning 
in yeast strain InvSc1.
this study
pLD1853 Full genomic sequence of ccoN4 PCR fragment introduced into 
pMQ30 by gap repair cloning in yeast strain InvSc1. Verified by 
sequencing.
this study
pLD1966 ∆aa3 PCR fragment introduced into pMQ30 by gap repair cloning 
in yeast strain IncSc1.
this study
pLD1967 ∆bo3 PCR fragment introduced into pMQ30 by gap repair cloning 
in yeast strain IncSc1.
this study
pLD2044 ∆cio PCR fragment introduced into pMQ30 by gap repair cloning 
in yeast strain IncSc1.
this study
pLD2777 PCR-amplified cco1 promoter ligated into pSEK103 using SpeI 
and XhoI.
this study
pLD2778 PCR-amplified cco2 promoter ligated into pSEK103 using SpeI 
and XhoI.
this study




Table 2.3: Strains used in this study
strain number description source
Pseudomonas aeruginosa strains
UCBPP-PA14 Clinical isolate UCBPP-PA14. Rahme et al. 1995
PA14 ∆phz LD24 PA14 with deletions in phzA1-G1 and phzA2-G2 
operons.
Dietrich et al. 2006
PA14 ∆ccoN1 LD1784 PA14 with deletion in PA14_44370. this study
PA14 ∆ccoN2 LD1614 PA14 with deletion in PA14_44340. this study
PA14 ∆ccoN3 LD1620 PA14 with deletion in PA14_40510. this study
PA14 ∆ccoN4 LD2833 PA14 with deletion in PA14_10500. this study
PA14 ∆ccoN1 
∆ccoN2
LD1888 PA14 with deletions in PA14_44370 and 





LD1951 PA14 with deletions in PA14_44370 and 





LD1692 PA14 with deletions in PA14_44340 and 





LD1649 PA14 with deletions in PA14_40510 and 





LD1977 PA14 with deletions in PA14_443470, 





LD1976 PA14 with deletions in PA14_443470, 






LD2020 PA14 with deletions in PA14_443470, 
PA14_44340, PA14_10500, and PA14_40510. 
Made by mating pLD1264 into LD1977.
this study
PA14 ∆cco1cco2 LD1933 PA14 with both cco operons (PA14_44340- 
PA14_44400) deleted simultaneously.
this study
PA14 ∆cox ∆cyo 
∆cio
LD2587 PA14 with deletions in PA14_01290-01320 (cox/
aa3 operon), PA14_47150-47210 (cyo/bo3 
operon), and PA14_13030-13040 (cio operon). 
Made by mating pLD1966, pLD1967, and 
pLD2044, in that order, to PA14.
this study
PA14 ∆hcn LD2827 PA14 with deletion in hcnABC operon 
(PA14_36310-36330).
this study
PA14 ∆phz ∆hcn LD2828 PA14 with deletions in phzA1-G1, phzA2-G2, and 




Table 2.3 (continued): Strains used in this study
strain number description source
PA14 ∆ccoN4 
∆hcn
LD2829 PA14 with deletions in PA14_10500 and hcnABC 




LD2830 PA14 with deletions in PA14_44370, PA14_44340, 






LD2831 PA14 with deletions in PA14_44370, PA14_44340, 
PA14_10500 and hcnABC operon. Made by 




LD2832 PA14 with deletions in cco1, cco2, and hcnABC 
operons. Made by mating pLD2791 into LD1933.
this study
PA14 gacA::Tn LD1560 MAR2xT7 transposon insertion into PA14_30650. Liberati et al. 2006
PA14 
∆ccoN4::ccoN4
LD1867 PA14 ∆ccoN4 strain with wild-type ccoN4 
complemented back into the site of deletion. Made 





LD2576 PA14 ∆ccoN1 ∆ccoN2 ∆ccoN4 strain with wild-
type ccoN4 complemented back into the site of 
deletion. Made by mating pLD1853 into LD1976.
this study
PA14 MCS-gfp LD2820 PA14 without a promoter driving gfp expression. this study
PA14 Pcco1-gfp LD2784 PA14 with promoter of cco1 operon driving gfp 
expression.
this study
PA14 Pcco2-gfp LD2786 PA14 with promoter of cco2 operon driving gfp 
expression.
this study




PA14-yfp LD2780 WT PA14 constitutively expressing eyfp. this study
PA14 ∆ccoN1 
∆ccoN2-yfp
LD2013 PA14 ∆ccoN1 ∆ccoN2 constitutively expressing 
eyfp. Made by mating pAKN69 into LD1888.
this study
PA14 ∆ccoN4-yfp LD2834 PA14 ∆ccoN4 constitutively expressing eyfp. 





LD2136 PA14 ∆ccoN1 ∆ccoN2 ∆ccoN4 constitutively 





LD2012 PA14 ∆cco1cco2 constitutively expressing eyfp. 
Made by mating pAKN69 into LD1933.
this study
Escherichia coli strains
UQ950 LD44 E. coli DH5 λpir strain for cloning. F-∆(argF- 
lac)169φ80 dlacZ58(∆M15) glnV44(AS) rfbD1 




Table 2.4: Statistical analyses. 
Table 2.3 (continued): Strains used in this study
strain number description source
BW29427 LD661 Donor strain for conjugation. thrB1004 pro thi rpsL 




β2155 LD69 Helper strain. thrB1004 pro thi strA hsdsS 
lacZ∆M15 (F’lacZ∆M15 lacIq traD36 proA+ proB+) 
∆dapA::erm (Ermr)pir::RP4 [::kan (Kmr) from 
SM10]
Dehio and Meyer, 
1997
S17-1 LD2901 StrR , TpR , F− RP4-2-Tc::Mu aphA::Tn7 recA λpir 
lysogen
Simon et al. 1983
Saccharomyces cerevisiae strains

















WT 5 73.22 72.94 3.387 1.515 69.02 77.43
∆N4 5 68.97 70.6 6.44 2.88 60.97 76.96
∆N1∆N2 5 52.18 50.46 5.142 2.3 45.79 58.56
∆N1∆N4 5 11.57 12.42 2.011 0.8991 9.074 14.07
∆N1∆N2∆N4 5 0.001958 0.001117 0.001696 0.0007586 -0.0001481 0.004064
∆cco1cco2 5 0.001367 0.0008644 0.001237 0.0005532 -0.0001686 0.002903
t-test P value P value  summary
WT vs. ∆N4 0.2273 ns
WT vs. ∆N1∆N2 <0.0001 ****





















WT-YFP 12 54.95 54.92 4.387 1.266 52.16 57.74
∆N4-YFP 3 29.92 30.83 2.234 1.29 24.37 35.46
∆N1∆N2-YFP 3 30.49 31.91 3.527 2.036 21.73 39.25
∆N1∆N2∆N4-YFP 3 4.408 4.296 3.23 1.865 -3.617 12.43
∆cco1cco2-YFP 3 7.097 5.306 4.093 2.363 -3.072 17.27
t-test P value P value  summary
WT-YFP vs. 
























WT 12 45.05 45.08 4.387 1.266 42.26 47.84
∆N4 3 28.22 31.31 7.442 4.297 9.731 46.71
∆N1∆N2 3 27.81 28.57 2.514 1.451 21.56 34.05
∆N1∆N2∆N4 3 7.002 6.973 0.7508 0.4335 5.137 8.867
∆cco1cco2 3 5.38 4.183 2.146 1.239 0.05034 10.71
t-test P value P value  summary
WT vs. ∆N4 0.0002 ***





















WT 8 150.3 151.2 10.31 3.644 141.7 158.9
∆N1∆N2 4 139.3 137.6 12.33 6.166 119.6 158.9
∆N4 7 131.9 127.8 8.915 3.369 123.7 140.2
∆N1∆N4 4 99.96 99.34 2.726 1.363 95.62 104.3
∆cco1cco2 4 95.19 95.56 1.559 0.7793 92.71 97.67
∆N1∆N2∆N4 4 102.8 99.79 8.664 4.332 88.98 116.6
∆phz 7 84.98 84.23 10.93 4.131 74.87 95.09
t-test P value P value  summary
WT vs. 
∆N1∆N2 0.1302 ns






















WT 9 27.44 39 18.48 6.16 13.24 41.65
gacA::Tn 9 92.56 93 8.546 2.849 85.99 99.12
∆N1∆N2 4 19 21.5 14.07 7.036 -3.39 41.39
∆N1∆N2∆N4 6 64.17 68 18 7.35 45.27 83.06
∆cco1cco2 9 70.56 76 22.69 7.565 53.11 88





WT vs. ∆N1∆N2 0.4362 ns
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2.8: Figure supplements 
Figure 2.2—figure supplement 1. Effects of individual and combined cco gene deletions 
on colony biofilm morphogenesis. (A) Morphologies of WT, ∆phz, and cco single, 
combinatorial, and ccoN4 complementation strains after 3 and 5 days of incubation. Images 
shown are representative of at least five biological replicates and were generated using a 
Keyence digital microscope. Scale bar is 1 cm. (B) Development of WT, ∆N4 and N subunit 
double mutants containing ∆N4. Images shown are representative of at least three biological 
replicates and were generated using a Keyence digital microscope. Scale bar is 1 cm. (C) 
Development of WT and the triple mutant ∆cox∆cyo∆cio in which only the cbb3-type terminal 
oxidases are present. Images were generated using a flatbed scanner (Epson Expression 
11000XL) and are representative of at least three biological replicates. Scale bar is 1 cm. 
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Figure 2.2—figure supplement 2. PA14 WT, ∆phz, and cco mutant growth 
phenotypes are unaffected by endogenous cyanide production. (A) Colony 
development over four days for ∆phz, ∆hcnABC, and cco combinatorial mutants. 
Images were generated using a flatbed scanner (Epson Expression 11000XL) and are 
representative of at least three biological replicates. Scale bar is 1 cm. (B) Growth of 
∆phz, ∆hcnABC, and cco combinatorial mutants in MOPS defined medium with 20 
mM succinate. Error bars represent the standard deviation of biological triplicates and 
are not shown in cases where they would be obscured by the point marker.
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Figure 2.2—figure supplement 3. Pseudomonads with CcoN homologs. We examined genomes 
available in the Pseudomonas Genome Database (Winsor et al. 2016) for CcoN homologs by 
performing a protein BLAST search on CcoN1 from P. aeruginosa PA14. All hits from full genomes, 
excluding other P. aeruginosa strains, were aligned using ClustalW and a tree was built using the 
geneious tree builder (Geneious 10 (Kearse et al. 2012)). We also included draft genomes that 
contained genes involved in phenazine biosynthesis (highlighted in purple). The tree revealed four 
clusters, each being more closely related to one of the four N subunits from PA14, which allowed us to 
annotate the N subunits accordingly. We next probed all genomes with N subunits for the presence of 
genes involved in cyanide synthesis (hcnABC) and phenazine biosynthesis (phzABCDEFG). We did not 
find a clear correlation between the presence of CcoN4 and Hcn proteins (Hirai et al. 2016). We note 
that with the exception of two P. fluorescens strains, those containing phzABCDEFG operons also 
contained ccoN4.  
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Figure 2.2—figure supplement 4. Comparison of the PA14 CcoN subunit sequences and 
analysis of the predicted structure of CcoN4. (A) Amino acid alignment (ClustalW) of the 
four CcoN subunits encoded by the PA14 genome. Residues conserved among all four N 
subunits are highlighted in black; residues conserved among any three of the four N subunits in 
gray; residues shared exclusively between CcoN1 and CcoN4 in yellow; and residues unique to 
CcoN4 in purple. (B) Predicted structure of CcoN4 from P. aeruginosa PA14, obtained by 
threading the PA14 sequence through the reported structure for the CcoN subunit of P. stutzeri 
(PDB: 5DJQ; (Buschmann et al. 2010b)) using SWISS-MODELL (Biasini et al. 2014). Surface-
exposed residues that are shared exclusively between CcoN1 and CcoN4 are shown in yellow, 
while residues that are unique to CcoN4 are shown in magenta. Ribbon structures of the CcoO 
and CcoP subunits from P. stutzeri are shown in red and green, respectively. Structures were 





Figure 2.3—figure supplement 1. CcoN4 is necessary for optimal fitness in biofilms, 
particularly when O2 becomes limiting. (A) Relative fitness of YFP-labeled WT when co-
cultured with various cco mutant strains in mixed-strain biofilms for three days. Error bars 
represent the standard deviation of biological triplicates. P-values were calculated using 
unpaired, two-tailed t tests (***, P ≤ 0.001; ****, P ≤ 0.0001). For full statistical reporting, refer to 
Table 4. (B) Time course showing relative fitness, over a period of three days, of YFP-labeled 
WT when co-cultured with various cco mutant strains in mixed-strain biofilms. Error bars 
represent the standard deviation of biological triplicates. (C) DIC image of a three-day-old WT 
biofilm.
79
Figure 2.4—figure supplement 1. Expression of cco reporters in shaken liquid cultures. 
(A) Fluorescence of translational reporter strains, engineered to express GFP under the control 
of the cco1, cco2, or ccoN4Q4 promoter during growth in 1% tryptone. Fluorescence values for 
a strain containing the gfp gene without a promoter (the MCS control) were treated as 
background and subtracted from each growth curve.  (B) Liquid-culture growth of translational 
reporter strains in 1% tryptone. Error bars in (A) and (B) represent the standard deviation of 
biological triplicates and are not drawn in cases where they would be obscured by point 
markers.
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Figure 2.5—figure supplement 1. Use of a redox microelectrode to measure phenazine 
reduction in colony biofilms. (A) Change in redox potential over depth for two-day-old 
biofilms of PA14 WT, ∆phz, and ∆phz grown on 200 µM phenazine methosulfate (PMS). Data 
are representative of at least three biological replicates. To ensure that addition of PMS did not 
alter the baseline redox potential, a measurement was also taken of agar only. (B) Change in 
redox potential with depth for WT, ∆phz, and ∆cox∆cyo∆cio biofilms grown for two days. Data 
are representative of at least two biological replicates. (C) Levels of phenazines extracted from 
the agar medium underneath the colony and separated by HPLC, adjusted for biomass, for 
PA14 WT and various cco mutant biofilms grown for two days. Data represent the area under 
each peak in absorbance units for the phenazines indicated, and error bars represent standard 
deviation of at least three biological replicates. The phenazines pyocyanin (PYO), phenazine-1-
carboxamide (PCN), and phenazine-1-carboxylic acid (PCA) were quantified. (D) Colony biofilm 
morphologies on day four of development for WT and various cco mutant biofilms grown on 
colony morphology plates containing 0, 10, and 40 mM potassium nitrate. Images were 
generated using a flatbed scanner (Epson Expression 11000XL) and are representative of at 
least three biological replicates. Scale bar is 1 cm.  
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Chapter 3 
Carbon source influences electron flow through the aerobic respiratory chain of 
Pseudomonas aeruginosa 
This chapter represents a manuscript that is being prepared for publication. I was responsible 
for all the work, except for the thin-sectioning of biofilms (Figure 3.4B), which was performed by 
William Cole Cornell. Matthew Greenwald and Brett Colbert assisted in the construction of 
transcriptional reporters for terminal oxidases. While most of the experiments have been 
completed, some are still pending; these will be mentioned throughout the text. 
3.1: Introduction 
 A hallmark of the domain Bacteria is metabolic diversity, i.e. the vast variety of pathways 
and substrates that can be used to generate energy for growth or survival (Madigan et al., 
2015). The metabolic diversity of bacteria allows them to persist in conditions that generally do 
not support eukaryotes, which produce energy almost exclusively by redox transformations of 
oxygen and water (Poole and Cook, 2000). An additional advantage for many bacteria is 
metabolic versatility, in which one species is able use multiple substrates and/or pathways for 
energy generation. Metabolic versatility affords the ability to grow in disparate environments and 
provides resilience in changing conditions. 
 A feature of bacteria that contributes to their metabolic versatility is respiratory chain 
branching (Madigan et al., 2015; Poole and Cook, 2000; White et al., 2012). While the 
mitochondrial electron transport chain (ETC) has one route for electrons to be delivered to the 
final electron acceptor, oxygen (O2), bacterial respiratory chains often have multiple routes 
(most commonly two or three) (White et al., 2012). Furthermore, many species of bacteria are 
able to use substrates other than O2, such as nitrate, as the final electron acceptor. This confers 
the ability to grow and respire anaerobically.  
 Work from our group and others has recently uncovered an additional level of branching 
in the respiratory chain of the Gram-negative, opportunistic pathogen Pseudomonas 
aeruginosa. P. aeruginosa’s ETC terminates at one of five canonical terminal oxidases, the 
enzymes that catalyze the final electron transfer step to reduce O2 to water (Arai, 2011; Williams 
et al., 2007). Each of these terminal oxidases possesses unique characteristics, including 
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different expression patterns and affinities for O2 (Alvarez-Ortega and Harwood, 2007; Arai et 
al., 2014; Comolli and Donohue, 2004; Kawakami et al., 2010). Our picture of the diversity at the 
terminal end of the ETC was further expanded by the discovery that the P. aeruginosa “Cco” 
complexes, which belong to the cbb3 family of terminal oxidases, can contain subunits encoded 
by multiple, redundant operons present at distinct sites in the genome (Hirai et al., 2016). These 
heterocomplexes (i.e., isoforms) were shown to have specific roles under different conditions 
(Hirai et al., 2016) and to contribute differentially to biofilm physiology and redox state (Jo et al., 
2017). 
 Another important aspect of P. aeruginosa metabolic versatility lies at the opposite, 
inaugural end of the ETC. This bacterium, being a chemoorganoheterotroph, obtains energy by 
oxidizing organic compounds, which also serve as source of carbon and electrons. The 
metabolism of carbon sources generates reducing equivalents, mainly in the form of NADH, 
which are re-oxidized when they feed electrons to the ETC (Madigan et al., 2015; White et al., 
2012). It has long been appreciated that pseudomonads can metabolize a wide range of carbon 
sources and fine-tune their respiratory chains in response to changing environmental conditions 
(Poole and Cook, 2000; Stanier et al., 1966; Williams et al., 2007). When the genome of this 
bacterium was first sequenced, it was the largest of the bacterial genomes sequenced up to that 
point at ~ 6.3 million base pairs, and its size was attributed to the metabolic versatility of the 
organism (Stover et al., 2000). Of special note was the large number of membrane transport 
systems encoded, two thirds of which were annotated to be involved in nutrient uptake. These 
systems undoubtedly play a role in P. aeruginosa’s ability to thrive under diverse environmental 
conditions.  
 While P. aeruginosa can be found in nutrient-rich environments, such as soil, it is also 
found in more limited environments, such as water reservoirs (Eichner et al., 2014). Another 
environment in which P. aeruginosa is commonly found is in the lungs of patients with cystic 
fibrosis (CF) (Ciofu et al., 2012; Eichner et al., 2014; Høiby et al., 2011; Williams and Davies, 
2012) where a defect in a chloride channel leads to the accumulation of thick mucus. P. 
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aeruginosa persists in this heterogeneous environment despite the scarcity of its preferred 
electron acceptor, O2. Mutations in genes involved in nutrient uptake (Son et al., 2007) and 
primary metabolic pathways like the tricarboxylic acid (TCA) cycle (Hoboth et al., 2009) have 
been shown to be selected for in strains adapted to persist in CF lungs. 
 Metabolism is often conceptualized as a modular process in which the oxidation of 
diverse carbon sources can be coupled to the respiration of diverse electron acceptors via 
common, central pathways. However, this is an oversimplification as different carbon sources 
offer varying degrees of reducing power. As carbon sources are oxidized, electrons released 
from this process are transferred via dehydrogenases to ubiquinone, a redox-active lipid that 
ultimately reduces terminal oxidases. The redox state of the ubiquinone pool in the membrane 
has been shown to affect gene expression in Escherichia coli and Rhodobacter capsulatus, 
indicating that the so-called “charging” of the ubiquinone pool is an important regulatory step in 
bacterial respiration (Aussel et al., 2014). Therefore, it is perhaps unsurprising that different 
carbon sources have been shown to alter electron flow through central metabolic pathways and 
the activity of respiratory chain enzymes (Saint-Amans et al., 2001). 
 Furthermore, nutrient conditions, including carbon source identity and availability, have 
been shown to affect the development of P. aeruginosa biofilms (Shrout et al., 2006; Sriramulu 
et al., 2005). Biofilms are dense organizations of cells enclosed in a self-produced matrix with 
important implications for virulence (Elias and Banin, 2012; Høiby et al., 2011). Additionally, the 
production of phenazines, redox-active secondary metabolites that support redox balancing 
when O2 is limiting (Glasser et al., 2014; Wang et al., 2010), is sensitive to environmental 
conditions (van Rij et al., 2004). Phenazines are necessary for the formation of an anoxic zone 
in a colony biofilm model (Dietrich et al., 2013) and recent work from our group indicates that 
they interact with components of the ETC (Jo et al., 2017). While P. aeruginosa’s metabolic 
versatility is well-known, how and whether specific carbon sources affect electron flow to 
phenazines and through the respiratory chain during biofilm growth has not been studied.  
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 To investigate how electron donor affects downstream metabolic processes, I looked at 
the influence of carbon source on P. aeruginosa PA14 physiology. I began by testing a wide 
range of carbon sources for respiratory activity, and then chose three representative carbon 
sources for follow-up experiments: glucose (a fermentable carbon source metabolized via 
glycolysis [or, in the case of P. aeruginosa, the analogous Entner-Doudoroff pathway]), 
succinate (a TCA cycle intermediate), and tryptone (an undefined medium representative of 
nutrient-rich conditions (Frimmersdorf et al., 2010) and one that is commonly used to grow P. 
aeruginosa in laboratories).  
 I was particularly interested in investigating how the presence of specific terminal 
oxidases and phenazines might influence P. aeruginosa’s utilization of different carbon sources. 
I chose to focus on the Cco and Cio terminal oxidases, as those have been shown to be 
sufficient for P. aeruginosa growth under the microaerobic conditions in which this bacterium 
thrives (Alvarez-Ortega and Harwood, 2007). These terminal oxidases represent two diverging 
pathways of electron flow through the P. aeruginosa ETC: Cio accepts electrons from the 
quinone pool while the Cco’s accept electrons from cytochrome c (Figure 3.1A). As work from 
our group has recently implicated the Cco terminal oxidases in phenazine utilization in biofilms 
(Jo et al., 2017), I also assessed how specific carbon sources influence phenazine production. 
My results indicate that the identity of the carbon source has profound effects on PA14 growth, 
colony biofilm morphogenesis, terminal oxidase expression, and phenazine production and 
utilization. 
3:2: Results 
3.2.1: Identification of carbon sources that support reduction of tetrazolium violet 
 To assess the influence of different carbon sources on P. aeruginosa PA14’s branched 
ETC, I measured respiratory activity using a commercially-available “phenotype 
microarray” (PM). The array is a 96-well plate containing 95 carbon sources and respiration is 
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quantified by incubating cells in a manufacturer-provided growth medium with the redox 
indicator dye “tetrazolium violet,” which undergoes an irreversible color change from faint yellow 
to purple upon reduction. The reduction of tetrazolium dyes is dependent on the ETC (Berridge 
et al., 2005).  
 I compared dye reduction by the PA14 strains WT, PaCco, and PaCio in the presence 
and absence of phenazines to address the question of how different respiratory chain 
components and phenazines might affect electron flow in P. aeruginosa. PaCco (∆cox∆cyo∆cio; 
the cox operon encodes Aa3, the cyo operon encodes Bo3, and the cio operon encodes Cio) is a 
terminal oxidase mutant that only has the Cco terminal oxidases remaining; PaCio 
(∆cox∆cyo∆cco1cco2) only has the Cio terminal oxidase remaining (Figure 3.1A). The 
respective phenazine-null strains of these mutants are referred to as PaCco∆phz and 
PaCio∆phz. I chose to focus on these terminal oxidases because they have been shown to be 
most important for aerobic and microaerobic growth in P. aeruginosa under laboratory 
conditions (Alvarez-Ortega and Harwood, 2007; Arai, 2011). Because terminal oxidase gene 
deletions can result in growth defects (Alvarez-Ortega and Harwood, 2007; Arai et al., 2014; Jo 
et al., 2017; Chapter 2) I wanted to ensure that any dye reduction phenotype observed in the 
terminal oxidase mutants was an effect of altered electron flow rather than abrogated growth. 
Therefore, I performed a separate set of experiments, using the same strains, in which cells 
were resuspended in a MOPS-buffered medium (with no tetrazolium violet or added carbon 
source) and measured cell density at 500 nm to assay for growth on the provided carbon 
source. Carbon sources that did not support growth are listed in Figure 3.1–figure supplement 
1. 
 37 of the 95 tested carbon sources supported PA14 growth, and of those, 22 supported 
dye reduction by PA14 (Figure 3.1B). I did not notice any obvious carbon source preference 
with respect to amino acids, carbohydrates, and carboxylic acids. These results are consistent 
with previous reports that have shown P. aeruginosa to be capable of utilizing a variety of 
carbon sources (Stanier et al., 1966). 
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Figure 3.1. Carbon sources that support growth of PA14. (A) A simplified diagram of 
electron flow through the P. aeruginosa electron transport chain, indicating the terminal 
oxidases remaining in the WT (left), PaCco (middle), and PaCio (right). Terminal oxidases in 
gray indicate those that have been deleted in respective strains. (B) Carbon sources that 
support growth of PA14 strains (total = 37), classified into groups based on levels of tetrazolium 
violet reduction in the presence (left) and absence (right) of phenazines. Gray, no reduction in 
any strains; blue, group 1 (WT > PaCco > PaCio); yellow, group 2 (WT = PaCco > PaCio); 
orange, group 3 (PaCco > WT > PaCio); lavender, group 4 (PaCco > WT = PaCio); red, group 5 
(WT = PaCco = PaCio). Dashed lines interconnecting carbon sources indicate those whose dye 
reduction patterns were affected by phenazines.
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3.2.2: Respiratory chain composition influences tetrazolium dye reduction in P. 
aeruginosa  
 For the carbon sources that facilitated tetrazolium violet reduction, I then asked whether 
this activity was predominantly mediated by the quinol oxidase Cio or the cytochrome c oxidase 
Cco complexes. To assess how availability of the various ETC branches affects carbon source 
utilization with respect to dye reduction and growth, I tested the terminal oxidase mutants 
PaCco and PaCio. I grouped the carbon sources into five categories according to their relative 
levels of dye reduction: (1) WT > PaCco > PaCio, (2) WT = PaCco > PaCio, (3) PaCco > WT > 
PaCio, (4) PaCco > WT = PaCio, and (5) WT = PaCco = PaCio (Figure 3.1B). I have 
encountered some discrepancies between trials of the same strain, and more trials are planned 
to elucidate which trends are reproducible. However, I have been able to preliminarily group the 
carbon sources into the aforementioned categories and make some general observations. 
 Carbon sources that fell into groups 1 and 2 (i.e., WT or WT and PaCco exhibited the 
most dye reduction) were consistent with previous observations that the Cco terminal oxidases 
support WT-like physiology in liquid cultures and biofilms (Arai et al., 2014; Jo et al., 2017). In 
contrast, carbon sources in the remaining groups resulted in altered electron flow, with PaCco 
displaying most dye reduction (groups 3 and 4) or WT, PaCco, and PaCio contributing equally to 
dye reduction (group 5). While the latter does represent an interesting deviation from expected 
dye reduction kinetics (i.e., those seen in groups 1 and 2), I was particularly intrigued by groups 
3 and 4 as we recently showed that the Cco terminal oxidases are required for WT biofilm 
development and phenazine utilization on tryptone (Jo et al., 2017). 
 Carbon sources in group 3 resulted in the most dye reduction by PaCco, followed by WT, 
then PaCio. The carbon sources that fell into this group were acetic acid, D-mannitol, L-proline, 
and L-glutamine (Figure 3.2A). The lower levels of dye reduction in these carbon sources by 
PaCio could be attributed to this strain’s significant growth defect (Figure 3.2–figure 
supplement 1A). However, the dye reduction phenotype of PaCco relative to the WT in group 3 
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carbon sources cannot be attributed to differential growth, as I observed similar growth yields for 
these two strains (Figure 3.2–figure supplement 1A). 
 Group 4 represented carbon sources that again lead to the most dye reduction by 
PaCco, but in which dye reduction by WT is comparable to that by PaCio (Figure 3.2B). Only 
one carbon source was in this group: ɑ-ketoglutaric acid, a TCA cycle intermediate that serves 
as a branchpoint from central metabolism to the synthesis of various amino acids including 
proline and glutamine, two carbon sources identified in group 3 (Figure 1.1B). 
Figure 3.2. Dye reduction kinetics of carbon sources of interest. Dye reduction 
(absorbance at 590 nm) over time of carbon sources in group 3 (A) and group 4 (B). Initial 
designations into groups were based on dye reduction with phenazines, and dye reduction 
curves are shown in the presence (top, closed circles) and absence (bottom, open circles) of 
phenazines. Data represent the average of two biological replicates. (C) Dye reduction over 
time for glucose, a representative glycolytic carbon source, and succinate, a representative TCA 
cycle carbon source, in the presence (top, closed circles) and absence (bottom, open circles) of 
phenazines.
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3.2.3: Phenazines have differential effects on tetrazolium dye reduction depending on 
respiratory chain composition 
 Recently we found that the Cco terminal oxidases are required for phenazine reduction 
in tryptone-grown colonies (Jo et al., 2017). Because phenazines have been shown to receive 
electrons from the mitochondrial ETC (Armstrong and Stewart-Tull, 1971), I studied dye 
reduction patterns of the aforementioned strains in the phenazine-null (∆phz) background as 
well. Indeed, by comparing dye reduction kinetics of WT, PaCco, and PaCio with the equivalent 
strains in a phenazine-null (∆phz) background, I found that the group assignment changed for 
14 out of the 37 carbon sources that support WT growth (Figure 3.1B), indicating that the 
presence of phenazines had significant effects on dye reduction and, by extension, electron flow 
in PA14. For example, when phenazines are present, PaCco reduces tetrazolium violet more 
than WT when grown in L-glutamine or L-proline (Figure 3.2A, top). However, when phenazines 
are absent, ∆phz and PaCco∆phz exhibit similar levels of dye reduction (Figure 3.2A, bottom); 
in other words, carbon sources that were categorized into group 3 with phenazines could now 
be classified into group 2 (Figures 3.1B and 3.2A). A similar switching of groupings was 
observed for acetic acid and ɑ-ketoglutaric acid (Figures 3.1A and 3.2A, B). 
 Of the five carbon sources in groups 3 and 4, three (L-proline, L-glutamine, and ɑ-
ketoglutaric acid) are intermediates or direct branchpoints off of the TCA cycle (Figure 1.1). 
Therefore, I wondered what dye reduction patterns would be observed for the standard 
glycolytic and TCA cycle carbon sources glucose and succinate. When I compared dye 
reduction patterns of PA14 in glucose and succinate, I found that glucose fell into carbon-source 
group 3 while succinate fell into group 2 (Figure 3.2C). When comparing growth profiles of WT 
and PaCco, I found similar levels of growth (Figure 3.2–figure supplement 1C), again 
indicating that any dye reduction phenotypes observed are independent of growth differences. 
 While the PM-based dye reduction and growth assays provided insights into factors that 
alter electron flow through the P. aeruginosa ETC (the presence of certain terminal oxidases 
and phenazines), I chose to focus subsequent experiments on the following carbon sources: ɑ-
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ketoglutaric acid, glutamine, glucose, succinate, and tryptone. All of these carbon sources, with 
the exception of tryptone, are directly or closely linked to central metabolic pathways. Glucose 
and succinate represent P. aeruginosa’s two main pathways for carbon source oxidation, the 
Entner-Doudoroff pathway and the TCA cycle, respectively. Additionally, while many previous 
studies have been carried out using these two carbon sources in liquid culture, less has been 
done exploring how they alter biofilm growth and physiology. ɑ-ketoglutaric acid is another TCA 
cycle intermediate and the precursor for glutamine synthesis. The ɑ-ketoglutaric acid-glutamine 
branchpoint also represents an important hub between carbon and nitrogen metabolism 
(Doucette et al., 2011). The experiments using ɑ-ketoglutaric acid and glutamine have not yet 
been completed and, as such will not be discussed further here. Finally, I included tryptone as 
an additional carbon source because it is commonly used to culture P. aeruginosa in laboratory 
settings and may more closely mimic the nutrient-rich conditions in which P. aeruginosa is 
sometimes found in nature (Frimmersdorf et al., 2010).  
3.2.4: Effects of phenazines and carbon sources on planktonic and biofilm growth in 
PA14 
 To confirm the growth trends for glucose and succinate that I observed in the PM plates 
(Figure 3.2), I grew the same six strains (WT, PaCco, PaCio, ∆phz, PaCco∆phz, PaCio∆phz) 
using the following media: a MOPS-buffered defined medium with either 20 mM glucose or 
succinate as the sole carbon source or a broth made with tryptone, an undefined tryptic protein 
digest that is a popular ingredient in bacterial growth media. Consistent with the data shown in 
Figure 3.2, PaCio had a growth defect relative to WT and PaCco in all media tested (Figure 
3.3A). Cells grew fastest in 1% tryptone, followed by MOPS-succinate, then MOPS-glucose 
(Figure 3.3A). Because glucose is a 6-carbon compound while succinate is a 4-carbon 
compound, I wanted to ensure that these growth trends were not a byproduct of discrepancies 
in molar availabilities of carbon source. When I grew PA14 in MOPS medium with 30 mM 
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succinate, I found that the trends observed in Figure 3A persisted (Figure 3–figure 
supplement 1).  
 WT and PaCco exhibited similar growth patterns in 1% tryptone and MOPS-succinate 
(Figure 3.3A). However, PaCco had an exponential-phase growth defect relative to the WT 
when grown in MOPS-glucose (Figure 3.3A). Also specifically in glucose, the lack of 
phenazines resulted in an exponential phase growth defect for all strains tested (Figure 3.3A), 
suggesting that phenazines promote optimal planktonic growth when glucose is the sole carbon 
source. Phenazines have been implicated in redox balancing during anaerobic survival via 
pyruvate fermentation (Glasser et al., 2014); their contribution to growth on glucose suggests 
that phenazines may also help to offset a redox imbalance that occurs during metabolism of this 
carbon source. 
 While liquid culture represents one mode of bacterial growth, in nature bacteria often 
grow as biofilms, multicellular aggregates of cells encased in a self-produced matrix (Hall-
Stoodley et al., 2004; Toyofuku et al., 2016), which affords protection from external assaults. 
The increased resistance of biofilms to chemicals such as antibiotics presents a formidable 
challenge to eradicating biofilm-based bacterial infections (Høiby et al., 2011; Murray et al., 
2007). To test whether the growth phenotypes I saw in liquid culture would be recapitulated in 
biofilms, I next grew PA14 colony biofilms on agar plates containing tryptone, glucose, or 
succinate and monitored their development. 
 Growth on tryptone yielded the largest and thickest WT biofilms (Figure 3.3B, Figure 
3.4B). The colonies also exhibited the most wrinkling and Congo red binding, two features that 
are indicative of matrix production as a result of redox stress (Dietrich et al., 2013; Friedman 
and Kolter, 2004; Jennings et al., 2015; Okegbe et al., 2014). On glucose, WT colonies were 
smaller and paler than those grown on tryptone, while biofilms on succinate were thin (Figure 
3.4B) and translucent, indicative of poor growth (Figure 3.3B). In contrast, ∆phz biofilms grown 
on succinate were thicker and more robust (Figure 3.3B), indicating that phenazines negatively 
affect growth on succinate. I did not notice any obvious differences between WT and ∆phz 
92
colonies on glucose and tryptone. I observed the same trends for strains containing only the Cio 
terminal oxidases (PaCio), although they generally formed thinner and smaller colonies (Figure 
3.3B). 
 PaCco phenocopied WT biofilms on all three carbon sources (Figure 3.3B; Jo et al., 
2017). PaCco∆phz biofilms were indistinguishable from those formed by ∆phz on tryptone and 
succinate, but they showed delayed wrinkling and less Congo red binding on glucose (Figure 
3.3B). Taken together, these results suggest a role for phenazines in modulating the efficiency 
of terminal oxidases in a carbon source-dependent manner, both in liquid culture (Figures 3.2 
and 3.3A) and in biofilms (Figure 3.3B).  
Figure 3.3. Carbon source affects PA14 growth in liquid culture and biofilms. (A) Growth 
of P. aeruginosa PA14 strains in 1% tryptone (left), MOPS defined medium with 20 mM glucose 
(middle), and MOPS defined medium with 20 mM succinate (right). Data represent the mean 
values of at least six biological replicates. Error bars denote standard deviation. (B) Colony 
biofilms of P. aeruginosa strains on day three of development on varying carbon sources. 
Colony morphologies are representative of at least three biological replicates. 
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3.2.5: Carbon source influences expression of terminal oxidases 
 The growth data suggested that the presence (or absence) of specific terminal oxidases 
affects carbon source utilization. To test if carbon sources themselves influence terminal oxidase 
expression, I created reporters by fusing the promoters of the five terminal oxidases to gfp and 
monitored their expression in tryptone, glucose, and succinate.  
 I found that in liquid culture, both cco operons were most highly expressed on tryptone, 
with cco2-gfp sharply induced upon entry into stationary phase (Figure 3.4A). cco2’s 
expression is consistent with previous studies demonstrating that cco2 is regulated by Anr, a 
global transcription factor that regulates gene expression during the shift from oxic to anoxic 
conditions (Ray and Williams, 1997). While aa3 was equally well-expressed on tryptone and 
glucose, it was barely detectable on succinate. bo3 expression was slightly elevated in glucose 
over tryptone, while I did not detect a significant signal on succinate. Finally, the expression of 
cio was comparable on all three carbon sources. These results illustrate the importance of 
carbon source on the relative expression pattern for terminal oxidases in liquid culture (Figure 
3.4A). 
 Shaking liquid cultures are characterized by a constant influx of O2 and a homogeneous 
environment. This is in stark contrast to biofilms which form nutrient gradients that are likely to 
affect the expression of terminal oxidases. We previously showed that a three-day-old colony 
biofilm contains O2 concentrations ranging from atmospheric levels at the top to undetectable 
levels at the bottom (Jo et al., 2017), making it an intriguing system in which to study terminal 
oxidase expression. I grew the reporter strains for three days on agar plates with tryptone, 
glucose, or succinate as the sole carbon sources, then fixed and thin-sectioned the biofilms to 
visualize terminal oxidase expression along the oxygen gradient (Figure 3.4B). 
 bo3-gfp expression was not observed in biofilms grown on any carbon source (Figure 
3.4B), indicating that Bo3 is not highly expressed in the biofilm under these conditions. That I 
detected bo3-gfp expression in tryptone and glucose when cells were grown planktonically 
(Figure 3.4A) suggests differential regulation of bo3 in the liquid versus biofilm context. Aa3, 
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Figure 3.4. Differential expression of terminal oxidases in tryptone, glucose, and 
succinate. (A) Expression profiles of P. aeruginosa’s five terminal oxidases (aa3, bo3, cio, cco1, 
cco2) during liquid-culture growth. Strains expressing GFP under the control of terminal oxidase 
promoters were grown in tryptone (yellow), MOPS-glucose (blue), and MOPS-succinate (red). 
Top graphs show expression of terminal oxidases (RFU) while bottom graphs show growth 
curves of corresponding strains. Data represent the average of at least three biological 
replicates, and error bars denote standard deviation. (B) Representative images of thin sections 
prepared from WT biofilms grown for 3 days on tryptone, MOPS-glucose, or MOPS-succinate 
agar plates. Each biofilm is expressing GFP under the control of the aa3, bo3, cio, cco1, or cco2 
promoter. Reporter fluorescence (green) is overlain on respective DIC images. Scale bars 
indicate depth (µm) into the biofilm, with “0” representing the biofilm-air interface. Images are 
representative of at least six biological replicates.




while the predominant terminal oxidase enzyme in many bacteria (Arai, 2011) and the one most 
closely-related to the mitochondrial terminal oxidase, is expected to play a minor role under 
normal laboratory conditions in P. aeruginosa (Arai et al., 2014). In tryptone and glucose, I 
observed the highest level of aa3-gfp expression in the top ~ 40 µm of the biofilm (Figure 3.4B). 
As the biofilm-agar interface is at the bottom of the biofilm, the top of the biofilm represents the 
region that would be the most nutrient-starved, and this is the location where I saw aa3 
expressed.  
 We have previously shown that cco1 is expressed throughout biofilms grown on 
tryptone, while cco2 expression is sharply induced at ~ 40 µm (Jo et al., 2017; Figure 3.4B). 
cco2-gfp expression coincides with the biofilm depth at which O2 becomes limiting (Jo et al., 
2017; Figure 3.4B) again consistent with its regulation by Anr. cio-gfp expression on tryptone 
was similar to that of cco1 with two exceptions: cco1-gfp showed a bright, thin band of high 
expression at ~ 45 µm coinciding with a void in cio-gfp expression and cio-gfp showed a 
discrete thin band of expression at ~ 100 µm, coinciding with a void in cco1-gfp expression. aa3-
gfp had an almost inverse expression profile as that of cco2-gfp: it was highly expressed only in 
the top ~ 40 µm of the biofilm. 
 When biofilms were grown on glucose (Figure 3.4B, middle row), cco1-gfp was again 
seen throughout the biofilm; however, expression was more homogeneous and relatively lower 
than on tryptone (Figure 3.4B, top row). cco2-gfp again showed brightest expression in parts of 
the biofilm that were microaerobic, with expression between 45-90 µm into the biofilm. In 
contrast to tryptone, where cco2-gfp was seen to the bottom of the biofilm, cco2-gfp on glucose 
was only expressed at background levels past 90 µm into the colony. The expression profiles of 
cio-gfp and aa3-gfp were intriguingly similar on glucose, with both having the highest expression 
at the top ~ 40 µm of the biofilm, and another (slightly less bright) band of high expression 
between 80-100 µm. 
 When biofilms were grown on succinate (Figure 3.4B, bottom row), colonies were 
thinner (only ~ 80 µm as opposed to the 120-150 µm thickness of colonies grown on tryptone 
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and glucose). cco1-gfp and cio-gfp showed similar expression on succinate: both were 
expressed throughout the biofilm, excepting a small void at ~ 60-70 µm, with a band of highest 
expression seen between ~ 30-50 µm. aa3-gfp expression was similar, but its highest 
expression was in a very thin strip at ~ 35 µm. cco2-gfp expression on succinate again peaked 
at ~ 45 µm, as it did on tryptone and glucose, but was restricted to one thin ~ 10 µm strip. 
3.2.6: Carbon source affects phenazine production in P. aeruginosa 
 Given that both carbon source and phenazines affected tetrazolium violet reduction 
(Figures 3.1 and 3.2), I next asked if carbon source itself affects phenazine production. P. 
aeruginosa produces a diverse set of phenazines that have different chemical properties 
(varying redox potentials, hydrophobicity, and colors) (Price-Whelan et al., 2006; Wang and 
Newman, 2008). The precursor phenazine, phenazine-1-carboxylic acid (PCA), can be modified 
into derivatives, such as phenazine-1-carboxamide (PCN) and pyocyanin (PYO) (Figure 1.7A). 
I grew WT PA14 in liquid cultures and biofilms on tryptone, glucose, and succinate and 
quantified phenazines produced under each condition using high performance liquid 
chromatography (HPLC). 
 In agreement with a previous report (Recinos et al., 2012), PCN was produced in 
biofilms grown on all three carbon sources (Figure 3.5B), but it was barely detectable in liquid 
cultures (Figure 3.5A). Conversely, PYO, which was amply produced in liquid culture, was 
detectable in only trace amounts in biofilms, or not at all in the case of glucose (Figure 3.5B 
and C). This indicates a biofilm-specific but carbon source-independent switch from PYO to 
PCN production between the planktonic and biofilm growth states (Figure 3.5A). I note that 
most of the phenazines produced in biofilms were released into the agar (Figures 3.5B and 
3.5–figure supplement 1) and, as such, I will only consider phenazines detected in the agar 
when discussing phenazines produced in biofilms.  
 PCA is the precursor for PCN and PYO (Figure 1.7A). Intriguingly, while the conversion 
of PCA to PYO (liquid culture) or PCN (biofilm) occurred in a 10:1 ratio on tryptone and 
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succinate, only ~ 20% of PCA was converted when grown on glucose. These dynamics in 
phenazine production indicate that the carbon source influences the kind and amount of 
phenazine(s) produced by PA14 and highlights the plasticity of phenazine production in 
response to environment. 
3.2.7: Phenazine reduction patterns are altered by carbon source 
 Since the redox activity of phenazines is crucial for their functionality (Price-Whelan et 
al., 2007, 2006; Wang and Newman, 2008) I next asked if carbon sources not only affect their 
production (Figure 3.5) but also their electrochemical reduction. To address this question, I 
directly measured phenazine reduction throughout the depth of three-day-old biofilms using 
redox microelectrodes. We have previously shown that WT colonies grown on tryptone show a 
gradient of increasingly-reduced extracellular redox state as depth into the colony increases and 
that this reduction gradient is phenazine-dependent (Figures 2.5A and 3.6A; Jo et al., 2017). 
We have also shown that the Cco terminal oxidases are necessary for phenazine reduction 
through tryptone-grown colonies (Figures 2.5B and 3.6A; Jo et al., 2017).  
 When colonies were grown on glucose, phenazines were reduced in the topmost, 
aerobic zone of the biofilm (Figure 3.6B), displaying different reduction patterns than those 
Figure 3.5. Phenazine production is altered in response to carbon source. (A) 
Quantification of phenazines produced by planktonic WT PA14 cells in late stationary phase of 
growth. (B) Quantification of phenazines secreted into the agar beneath three-day-old WT 
biofilms. (C) Close-up of pyocyanin concentrations shown in panel (B). For all panels, individual 
data points represent biological replicates, and bars indicate the mean. Error bars denote 
standard deviation. The phenazines quantified were phenazine-1-carboxylic acid (PCA), 
phenazine-1-carboxamide (PCN), and pyocyanin (PYO). 
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observed on tryptone (Figure 3.6A). Furthermore, the Cco oxidases no longer appeared to be 
required for phenazine reduction on glucose. On succinate, phenazine reduction was not 
detectable, in spite of the fact that colonies produced similar amounts of phenazine on succinate 
as they did on tryptone (Figure 3.5B). Together, these results support the hypothesis that 
electron flux through the respiratory chain is altered significantly in response to different carbon 
sources. 
 Because PA14 synthesizes multiple different phenazine compounds, all with differing 
chemical structures, redox potentials, and likely physiological function, I created a “clean” 
background in which I would be able to measure the reduction of individual phenazines. To this 
end, I made a mutant unable to produce or modify any of PA14’s phenazines, 
∆phzH∆phzM∆phzS ∆phzA1-G1∆phzA2-G2 (referred to as “∆HMS∆phz”; Figure 1.7A). I then 
grew this mutant on agar plates containing one of the pure phenazine compounds (PCA, PCN, 
PMS, or PYO) and measured their reduction on glucose and tryptone. I did not include 
succinate in this analysis because I did not detect any phenazine reduction in biofilms grown on 
succinate (Figure 3.6C). Because the endogenous PCA derivative 5-methyl-PCA (5-Me-PCA) is 
Figure 3.6. Phenazine reduction is influenced by carbon source. Change in redox potential 
(mV) with depth in three-day-old PA14 biofilms grown on tryptone (A), MOPS-glucose (B), or 
MOPS-succinate (C). Data shown are representative of at least six biological replicates. 
Dashed lines indicate approximate colony thickness.
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highly reactive and unstable (Hansford et al., 1972), I used its synthetic analog, phenazine 
methosulfate (PMS), as a proxy to study 5-Me-PCA reduction. 
 ∆HMS∆phz biofilms grown on tryptone did not significantly reduce PCA or PCN (Figure 
3.7A, circles). Both PMS and PYO, on the other hand, were reduced substantially, with differing 
patterns of reduction. The majority of PYO reduction occurred within the top 50 µm of the 
biofilm, while PMS showed more gradual reduction until ~ 100 µm into the colony. The PMS 
reduction curve most resembled that seen in WT colonies grown on tryptone (Figure 3.6A). 
When reduction of exogenously-added phenazines was measured in glucose-grown colonies, I 
again saw drastically different redox profiles than those observed on tryptone. Here, neither 
Figure 3.7. Cco terminal oxidases contribute differently to phenazine reduction on tryptone 
and glucose. Change in redox potential (mV) with depth in three-day-old PA14 biofilms grown on 
tryptone (A) or MOPS-glucose (B) supplemented with 200 µM of PCA (yellow), PCN (green), PMS 
(red), or PYO (blue) by ∆HMS∆phz (circles) or ∆HMS∆phz∆cco1cco2 (squares). Data shown are 
representative of at least six biological replicates.
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PMS nor PYO were reduced significantly, while PCA and PCN were; in essence, the reverse of 
what I observed on tryptone (Figure 3.7B).  
 Because on tryptone phenazine reduction is dependent on the Cco terminal oxidases 
(Jo et al., 2017), I wondered whether these enzymes were required for phenazine reduction in 
general or whether they are involved in the reduction of distinct phenazines. To address this 
question, I created a ∆HMS∆phz∆cco1cco2 deletion mutant and investigated its ability to reduce 
exogenously-added phenazines. On tryptone, I found that deleting the Cco’s in the ∆HMS∆phz 
background compromised the reduction of all four phenazines tested (Figure 3.7A, squares). 
The most striking phenotype, however, was seen with PMS, one of the two phenazines that are 
most potent with respect to affecting colony morphogenesis on tryptone (Sakhtah et al., 2016). 
While the parent strain was able to reduce PMS substantially, the ∆cco1cco2 mutant showed no 
PMS reduction.  
 On glucose, deleting the Cco terminal oxidases did not change the redox profiles seen 
for ∆HMS∆phz grown on PMS or PYO (Figure 3.7B), not entirely unexpectedly since these two 
phenazines were barely, if at all, reduced in the parent strain. However, I was surprised to see 
that the ∆HMS∆phz∆cco1cco2 mutant showed reduction defects for both PCA and PCN, 
because redox profiles of endogenously-produced phenazines indicated that the Cco terminal 
oxidases were not required for phenazine reduction on glucose (Figure 3.6). These results 
indicate that singly-provided, exogenously-added phenazines may not have the same 
physiological roles as their endogenously-produced counterparts, which are synthesized in 
concert with other phenazine derivatives. 
3.3: Discussion 
 Pseudomonas aeruginosa is an important clinical pathogen, notoriously forming chronic 
infections in nosocomial settings. These infections are hard to eradicate due to characteristics 
associated with the biofilm lifestyle, in which cells arrange themselves into a multicellular 
consortium encased in an extracellular matrix. In the cystic fibrosis lung, P. aeruginosa is well-
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known for causing chronic, biofilm-based infections that ultimately lead to the mortality of 
patients. In this environment, mutations associated with changes in nutrient uptake and 
metabolism have been found to be associated with growth in the CF lung environment (Hoboth 
et al., 2009; Son et al., 2007). Furthermore, ETC genes, including those encoding 
dehydrogenases and the high-O2-affinity terminal oxidases Ccos, are upregulated in conditions 
that mimic those found in the CF lung (Eichner et al., 2014). Therefore, a deeper understanding 
of the interplay of nutrient availability and respiratory activity may yield new strategies for the 
treatment of P. aeruginosa infections. In this chapter, I describe how carbon sources affect P. 
aeruginosa growth and characterized how a subset of these carbon sources (tryptone, glucose, 
and succinate) affect biofilm development, expression of terminal oxidase genes, and 
phenazine production and utilization.  
3.3.1: Electron flux through the respiratory chain is modulated in response to terminal 
oxidase and phenazine availability 
 I began by screening for carbon sources that support growth and electron flow through 
the aerobic respiratory chain of P. aeruginosa. Strikingly, phenazines or altering the complement 
of terminal oxidases affected electron flow through the respiratory chain, as indicated by PA14’s 
ability to reduce the redox indicator dye tetrazolium violet (Figures 3.1B and 3.2). 
 Based on dye reduction kinetics, I classified carbon sources into five groups (Figure 
3.1B). For all carbon sources that supported growth, tetrazolium violet dye reduction by PaCco 
was comparable or greater than WT (Figure 3.1B). This is in agreement with previous work 
from our group indicating that the Cco terminal oxidases are mostly responsible for the 
reduction of another tetrazolium dye, triphenyl-tetrazolium chloride (Jo et al., 2017). Groups 3 
and 4 contained carbon sources in which PaCco (where only the Cco terminal oxidases remain) 
was able to reduce tetrazolium violet even more efficiently than the WT and PaCio, despite the 
fact that growth levels were comparable between PaCco and WT (Figures 3.2A and B; 3.2–
figure supplement 1A and B). On these carbon sources, the other terminal oxidases (Aa3, Bo3, 
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and Cio) may contribute to growth and divert electrons away from the Cco’s. In PaCco, 
electrons are directly routed to the Cco’s, leading to enhanced dye reduction and possibly more 
efficient electron flow through the respiratory chain, resulting in elevated dye reduction.  
 I was particularly intrigued by carbon sources in groups 3 and 4 as ɑ-ketoglutaric acid 
and glutamine represent a node between carbon and nitrogen metabolism where the TCA cycle 
branches off into the synthesis of glutamate and then glutamine (Figure 1.1). Furthermore, 
glutamine is directly linked to phenazine biosynthesis with one glutamine being required for the 
production of PCA and another one for its derivatization to PCN (Culbertson and Toney, 2013; 
Pierson and Thomashow, 1992), Figure 1.7). These carbon sources will be the focus of future 
studies and I expect them to give us new insights with respect to the regulation of phenazine 
production and reduction (Figures 3.5, 3.6, and 3.7). The current study was focused on 
establishing benchmarks for the various assays utilizing some of the most commonly-used 
carbon sources for growth of P. aeruginosa, i.e. tryptone, a complex, undefined medium 
composed of peptides resulting from the digest of casein; glucose, a fermentable sugar and 
precursor of the glycolytic pathway; and succinate, a TCA cycle intermediate (Figure 1.1).  
 On tryptone and succinate, Cco terminal oxidases were necessary and sufficient for WT-
like planktonic growth (Figure 3.3). On glucose, however, the Cco terminal oxidases were not 
sufficient for WT-like growth (Figure 3.3A), suggesting that other terminal oxidases are more 
required on glucose. Consistent with this, cco1 and cco2 expression are lower while bo3 
expression was more than 2-fold higher in glucose relative to tryptone (Figure 3.4A). Because 
Bo3 is upregulated under iron limitation (Arai, 2011; Arai et al., 2014), growth on glucose may 
yield a higher demand for iron, possibly due to changes in the respiratory chain since 
cytochrome biosynthesis may lead to a high demand for this metal.  
3.3.2: Gradients formed within the biofilm inform expression of respiratory complexes 
 Biofilms and liquid cultures are physiologically quite distinct. An important characteristic 
of biofilms is the formation of gradients (Werner et al., 2004). As biofilms develop, they increase 
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in thickness (Figure 2.3C; Jo et al., 2017), leading to a carbon source gradient originating at the 
bottom of the colony and an O2 gradient originating at the top. In this study I observed biofilm-
specific characteristics with respect to the expression and utilization of terminal oxidases. The 
bo3 terminal oxidase is expressed in liquid culture but not in biofilms, irrespective of the carbon 
source. In glucose, Cco’s are not sufficient for WT levels of liquid culture growth (Figure 3.3A), 
but are for WT-like biofilm development (Figure 3.3B). In succinate, the lack of phenazines 
confers more robust growth in biofilms (Figure 3.3B) that is not seen in liquid (Figure 3.3A). 
 I found that the biofilm-specific gradients inform expression of different terminal oxidases 
(Figure 3.4B). The switch from free-living to biofilm growth is also accompanied by altered 
phenazine production, which is further impacted by growth medium (Figure 3.5). Differential 
phenazine production then contributes to different phenazine utilization throughout biofilm 
depths, as observed through redox microprofiling (Figure 3.6). These results demonstrate the 
differences that exist between the liquid culture and biofilm modes of growth. This has important 
implications in the quest for discovery of new antibiotics that are able to fight biofilm-based 
infections in clinical settings, as the majority of that research is done in liquid culture (Penesyan 
et al., 2015). However, my results presented here and in Chapter 2 highlight the need for more 
biofilm-based research during the process of new drug discovery.  
3.3.3: Phenazine utilization is not determined solely by phenazine availability 
 While overall phenazine production levels were similar in PA14 biofilms grown on 
tryptone and succinate (Figure 3.5), I did not detect any phenazine reduction in succinate-
grown biofilms (Figure 3.6), suggesting that phenazine reduction is dependent upon more than 
just availability and/or amount of phenazines produced. ∆phz colonies grown on succinate 
formed more robust biofilms than their phenazine-producing counterparts (Figure 3.3B), 
indicating that phenazines may have a negative effect on biofilm growth on succinate. As 
succinate-grown biofilms do not reduce phenazines, the redox-active role of phenazines is likely 
rendered irrelevant on this carbon source and their accumulation may become harmful. This is 
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supported by the fact that phenazines have been shown to become toxic at high concentrations 
(Meirelles and Newman, 2018; Sakhtah et al., 2016). 
 We have previously shown reduction of phenazines on tryptone to be mediated by the 
Cco terminal oxidases (Jo et al., 2017). Here, I expanded upon these findings by measuring 
reduction of individual phenazines (Figure 3.7). On tryptone, I saw that phenazine methosulfate 
(PMS, a synthetic analog of the endogenous but highly reactive 5-methyl-PCA [5-Me-PCA]) and 
pyocyanin (PYO) contributed the majority of redox-active behavior in biofilms (Figure 3.7A, 
circles), indicating that these phenazines are predominantly used on this carbon source. The 
∆cco1cco2 mutant showed reduction defects when grown on PMS and PYO (Figure 3.7A, 
squares), consistent with the Cco-dependent phenazine reduction profiles observed in Figure 
3.6 and reported previously (Jo et al., 2017). As PMS/5-Me-PCA is important for WT colony 
biofilm morphogenesis and redox balancing (Sakhtah et al., 2016) and PYO has been shown to 
play a role in virulence in a mouse model (Lau et al., 2004), their successful utilization could 
have important implications for P. aeruginosa growth and virulence. 
 In contrast to tryptone, here I found that phenazine reduction is Cco-independent on 
glucose-grown biofilms that endogenously produce phenazines (Figure 3.6). These biofilms 
almost exclusively produce (Figure 3.5) and most efficiently reduce (Figure 3.7) phenazine-1-
carboxamide (PCN) and phenazine-1-carboxylic acid (PCA). Intriguingly, when single 
phenazines were provided exogenously, Cco’s were required for the reduction of both PCN and 
PCA on glucose (Figure 3.7B). This discrepancy between endogenous and exogenous 
phenazine reduction suggests that phenazines, when produced in mixtures, may have 
synergistic or antagonistic effects that remain to be elucidated. 
3.3.4: Conclusion 
 Together, these results inform our understanding of how P. aeruginosa metabolism is 
influenced by carbon source and mode of growth. Our biofilm results are especially illuminating, 
as biofilm growth is associated with the formation and persistence of chronic infections in 
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various host environments. This includes the heterogeneous environment found in the lungs of 
CF patients, in which varying oxygen concentrations, nutrient availabilities, and antibiotic 
concentrations are found along airways (Winstanley et al., 2016). P. aeruginosa’s adaptable 
metabolism contributes to its ability to colonize nearly all of these microenvironments and, by 
extension, its virulence. Phenazines are also involved in mediating virulence, as they have been 
detected at high concentrations in CF sputum samples (Wilson et al., 1988) and influence 
immune response in human airway epithelial cells by increasing oxidant production (Price-
Whelan et al., 2006). This in turn can affect gene expression patterns in the host (Look et al., 
2005) while also having negative repercussions on host tissue. Therefore, the identification of 
the mechanisms that underlie P. aeruginosa persistence in heterogeneous environments, 
including mediators of phenazine production and/or utilization, would have the potential to vastly 
improve how chronic P. aeruginosa infections are treated.  
3:4: Materials and methods 
3.4.1: Strains and growth conditions 
 Pseudomonas aeruginosa strain UCBPP-PA14 (Mathee, 2018; Rahme et al., 1995) 
overnight precultures were routinely grown for 12-16 hours in lysogeny broth (LB; 1% tryptone, 
1% NaCl, 0.5% yeast extract) (Bertani, 2004) at 37˚C with shaking at 250 rpm. Overnight 
precultures serving as biological replicates were inoculated from separate clonal source 
colonies grown on streaked LB + 1.5% agar plates. Liquid subcultures were made from diluting 
overnight precultures 1:100 (1:50 for PaCio and PaCio∆phz) in LB and grown at 37˚C with 
shaking at 250 rpm until mid-exponential phase (OD at 500 nm ~ 0.5). Liquid subcultures were 
used for experiments unless otherwise noted. Strains used in this study are listed in Table 3.1. 
 The growth media used in this study were 1% tryptone and MOPS minimal medium (50 
mM 4-morpholinepropanesulfonic acid (pH 7.2), 43 mM NaCl, 93 mM NH4Cl, 2.2 mM KH2PO4, 1 
mM MgSO4•7H2O, 1 µg/ml FeSO4•7H2O). MOPS minimal medium contained either 20 mM D-
glucose (MOPS-glucose) or 20 mM sodium succinate hexahydrate (MOPS-succinate) as a 
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carbon source unless otherwise noted. Agar-containing versions of each growth medium 
contained 1% agar (Teknova A7777). 
3.4.2: Construction of P. aeruginosa deletion mutant strains 
 Markerless deletions mutants were created by amplifying ~ 1 kb of flanking DNA 
sequence from each side of the gene(s) to be deleted using the primers listed in Table 3.2. 
These flanking sequences were inserted into pMQ30 via gap repair cloning in Saccharomyces 
cerevisiae strain InvSc1 (Shanks et al., 2006). The resulting plasmids, listed in Table 3.3, were 
then transformed into Escherichia coli strain UQ950, verified by restriction digests and/or 
sequencing, and moved into PA14 using biparental conjugation. Single recombinants in PA14 
were selected using LB agar plates containing 100 µg/ml gentamicin. Markerless deletions 
(double recombinants) were selected on LB without NaCl containing 10% sucrose and 
confirmed by PCR. Combinatorial mutants were constructed by using single mutants as hosts 
for biparental conjugation as described in Table 3.1. 
3.4.3: Construction of reporter strains  
 Reporter constructs for P. aeruginosa’s five terminal oxidases (Aa3, Bo3, Cio, Cco1, and 
Cco2) were constructed using the primers listed in Table 3.2 to amplify respective promoter 
regions (500 bp upstream of the respective terminal oxidase operon), adding an SpeI and an 
XhoI digest site to the 5’ and 3’ ends of the promoter, respectively. Purified PCR products were 
digested and ligated into the pLD2722 vector at the multiple cloning site (MCS), upstream of the 
gfp sequence. The resulting plasmids (listed in Table 3.3) were transformed into E. coli strain 
UQ950, verified by sequencing, moved into PA14 using biparental conjugation with E. coli strain 
S17-1. Recombinants were selected for as described previously (Jo et al., 2017). 
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3.4.4: Growth assays and determination of carbon sources that support PA14 growth 
 One ml of liquid subculture was washed two times in sterile 1x phosphate-buffered 
saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4), resuspended in 1 
ml MOPS minimal medium without a carbon source, and diluted 1:100 in MOPS minimal 
medium without a carbon source. One hundred microliters of this cell suspension were 
dispensed into each well of a phenotype microarray carbon microplate PM1 (Biolog 12111) and 
incubated at 37˚C with continuous shaking on the medium setting in a Synergy 4 plate reader 
(BioTek). Growth was measured by taking OD readings at 500 nm every 30 min for 20-24 hr. 
Each strain was assayed twice in Biolog plate PM1. 
 Carbon sources that support growth of PA14 strains producing phenazines were then 
determined by monitoring growth over 20 hours for two biological replicates of each phenazine-
producing PA14 strain, and a cutoff of 0.15 was applied to cell density (OD at 500 nm) values. 
Anything falling below this cutoff was designated as background. Carbon sources with OD500nm 
readings that exceeded the cutoff of 0.15 were manually inspected to verify growth. I found that 
37 carbon sources supported growth (Figure 3.1B) while 58 did not (Figure 3.1–figure 
supplement 1). 
3.4.5: Biolog phenotype microarrays (i.e., dye reduction assays) and determination of 
carbon sources that support reduction of tetrazolium violet 
 For dye reduction assays, PBS-washed cells were resuspended in 1x IF-0 (IF-0a GN/GP 
Base Inoculating Fluid, Biolog 72268) to a percent transmittance of 42. The 42 %T cell 
suspension was diluted 1:5 in 1x IF-0 + 1x Redox Dye A (tetrazolium violet; Biolog 74221). One 
hundred microliters of this cell + dye suspension were dispensed into each well of a PM1 
microplate and incubated at 37˚C with continuous shaking on the medium setting in a Synergy 4 
plate reader. Growth and dye reduction were measured by taking absorbance readings at 500 
nm and 590 nm, respectively, every 30 min for 20-24 hr. After the run was completed, an 
endpoint spectral scan of the plate was taken, reading absorbance of each well at wavelengths 
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between (and including) 300 to 800 nm in 10 nm steps. As tetrazolium dye reduction is 
irreversible, the endpoint scan at 590 nm should represent the maximal dye reduction value. 
 To determine which carbon sources yield tetrazolium dye reduction, only carbon sources 
that supported PA14 growth (Figure 1B) were considered. Endpoint, maximal dye reduction 
values for each of these 37 carbon sources for each strain were determined by subtracting the 
absorbance value at 800 nm (which I considered as background) from the absorbance value at 
590 nm. These values were then subjected to a cutoff of 0.25, and anything lower than this 
value was considered background dye reduction. Values meeting the cutoff were then compared 
for each carbon source across strains, with phenazine-producing strains compared to each 
other and phenazine-null strains being compared to each other. Finally, each carbon source was 
then classified into one of the following six groups based on dye reduction levels: group 1, WT 
or ∆phz > PaCco or PaCco∆phz > PaCio or PaCio∆phz; group 2, WT or ∆phz = PaCco or 
PaCco∆phz > PaCio or PaCio∆phz; group 3, PaCco or PaCco∆phz > WT or ∆phz > PaCio or 
PaCio∆phz; group 4, PaCco or PaCco∆phz > WT or ∆phz = PaCio or PaCio∆phz; group 5, WT 
or ∆phz = PaCco or PaCco∆phz = PaCio or PaCio∆phz; or no reduction. 
3.4.6: Liquid culture growth and terminal oxidase reporter expression assays 
 For growth assays, one ml of liquid subculture cells was washed two times in sterile 1x 
PBS and resuspended in one ml sterile 1x PBS. These cells were then diluted 1:100 in 
respective growth medium (1% tryptone, MOPS-glucose, or MOPS-succinate) in either a clear, 
flat-bottom polystyrene 96-well plate (VWR 82050-716; for growth assays) or a clear, flat-bottom 
polystyrene black 96-well plate (VWR 82050-756; for reporter expression assays) and incubated 
at 37˚C with continuous shaking on the medium setting in a Synergy 4 plate reader. Growth was 
monitored by taking OD readings at 500 nm every 30 minutes for 20-24 hr.  
 For reporter expression assays, expression of GFP was also assessed by taking 
fluorescence readings at excitation and emission wavelengths of 480 nm and 510 nm, 
respectively, for the duration of the experiment. RFU values for a strain lacking a promoter 
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upstream of the gfp gene (MCS-gfp) were subtracted from the fluorescence values of each 
reporter. Fluorescence and absorbance readings were taken simultaneously. 
3.4.7: Colony biofilm morphology assays 
 Ten microliters of liquid subcultures were spotted onto 60 ml of colony morphology 
medium in a 10 cm x 10 cm x 1.5 cm square Petri dish (LDP D210-16). Colony morphology 
medium was 1% tryptone agar, MOPS-glucose agar, or MOPS-succinate agar supplemented 
with 40 µg/ml Congo red dye (VWR AAAB24310-14) and 20 µg/ml Coomassie blue dye (VWR 
EM-3300). Colony biofilms were incubated for up to five days in the dark at 25˚C with >90% 
humidity (Percival CU-22L) and imaged daily using a VHX-1000 digital microscope (Keyence). 
Images shown are representative of at least four biological replicates.  
3.4.8: Thin sectioning assays 
 Two layers of 1% tryptone with 1% agar were poured to depths of 4.5 mm (bottom) and 
1.5 mm (top) and left to solidify overnight. Overnight precultures were diluted 1:100 in LB and 
grown for ~ 2 h, until early-mid exponential phase. Five microliters of subculture were then 
spotted onto the top agar layer and colonies were incubated in the dark at 25˚C with > 90% 
humidity (Percival CU-22L) and grown for three days. After three days, colonies were covered 
by a 1.5-mm-thick 1% agar layer. Colonies sandwiched between two 1.5-mm agar layers were 
lifted from the bottom layer, washed for 10 min in 1x PBS (pH 7.4) at room temperature in the 
dark, and fixed in 4% paraformaldehyde in PBS overnight at room temperature in the dark. 
Fixed colonies were washed twice in PBS and dehydrated through a series of ethanol washes 
(25%, 50%, 70%, 95%, 3 × 100% ethanol) for 60 min each. Colonies were cleared via three 60-
min incubations in Histoclear-II (National Diagnostics HS-202) and infiltrated with wax via two 
separate washes of 100% Paraplast Xtra paraffin wax (Thermo Fisher Scientific 50-276-89) for 
2 hr each at 55˚C, then colonies were allowed to polymerize overnight at 4˚C. Tissue processing 
was performed using an STP120 Tissue Processor (Thermo Fisher Scientific 813150). Trimmed 
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blocks were sectioned in 10-µm-thick sections perpendicular to the plane of the colony using an 
automatic microtome (Thermo Fisher Scientific 905200ER), floated onto water at 45˚C, and 
collected onto slides. Slides were air-dried overnight, heat-fixed on a hotplate for 1 hr at 45˚C, 
and rehydrated in the reverse order of processing. Rehydrated colonies were immediately 
mounted in TRIS-Buffered DAPI:Fluorogel (Thermo Fisher Scientific 50-246-93) and overlaid 
with a coverslip. Differential interference contrast (DIC) and fluorescent confocal images were 
captured using an LSM800 confocal microscope (Zeiss, Germany). Each strain was prepared in 
this manner in at least biological triplicates. 
3.4.9: Phenazine detection and quantification 
 (i) For phenazine extraction from liquid cultures, overnight cultures of WT PA14 were 
inoculated in 2 ml of respective growth medium (1% tryptone, MOPS-glucose, or MOPS-
succinate) in 13 x 100 mm culture tubes (VWR 10545-936) in at least biological triplicate and 
incubated at 37˚C with shaking at 250 rpm for 14-16 hr. One milliliter of each overnight culture 
was dispensed into a microfuge tube and centrifuged for two minutes at 14,000 rpm to pellet 
cells. Three hundred microliters of the supernatant were applied to a 0.22 µm Spin-X column 
(VWR 29442-754), centrifuged for two minutes at 14,000 rpm, and 200 µl of the resulting cell-
free flow-through were loaded into an HPLC vial for analysis.  
 (ii) For phenazine extraction from biofilms, 1 ml of liquid subcultures was washed twice 
in 1x PBS and resuspended in 1 ml of 1x PBS. A 25 mm filter disk with a pore size of 0.2 µm 
(GE Healthcare 110606) was placed into the center of one 35 x 10 mm round Petri dish (VWR 
25373-041) filled with 4 ml of 1% tryptone agar, MOPS-glucose agar, or MOPS-succinate agar 
and 10 µl of the washed cells were spotted onto the filter disk. Colony biofilms were grown for 3 
days in the dark at 25˚C with >90% humidity, after which point each colony and filter were lifted 
off their plate. The colony biofilm and filter were placed into one 5-ml aliquot of 100% methanol 
while the agar upon which the biofilm had developed was placed into another 5-ml aliquot of 
100% methanol, and phenazines were extracted from the biofilms or agar overnight at room 
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temperature in the dark. Three hundred microliters of the phenazine extraction were filtered 
through a 0.22 µm Spin-X column as described above and 200 µl of the cell-free flow-through 
were loaded into an HPLC vial for analysis. 
 (iii) Phenazines were identified using high-performance liquid chromatography (Agilent 
1100 HPLC System) as described previously (Dietrich et al., 2006; Sakhtah et al., 2016) and 
comparing sample peaks to peaks of pure phenazine standards run as controls. The area under 
each peak (mAU*s) was used to determine the concentrations of each phenazine. For 
phenazines extracted from liquid culture, the area under each peak was first normalized to cell 
density at the time of phenazine extraction and concentration was determined using the 
extinction coefficient for each phenazine. Dilution standards of purified PYO, PCA, and PCN 
were prepared at known concentrations and extinction coefficients (ε) were generated for each 
based on seven biological replicates. εPYO = 0.0253 µM/mAU*s, εPCA = 0.0104 µM/mAU*s, εPCN 
= 0.0099 µM/mAU*s. 
3.4.10: Redox microprofiling 
 (i) Extracellular redox states of day 3 (~ 72 hr) phenazine-producing biofilms (Figure 3.6) 
were measured using a 25 µm-tip redox microelectrode and external reference (Unisense RD25 
and REF-RM). Colony biofilms were grown as for the colony biofilm morphology assays, except 
that Congo red and Coomassie blue dyes were omitted. Calibration and redox measurements 
were performed using the SensorTrace Profiling software (Unisense) as described previously 
(Jo et al., 2017).  
 (ii) For measuring extracellular redox states of biofilms grown on exogenously-added 
phenazines, the respective growth medium (tryptone agar, MOPS-glucose agar, or MOPS-
succinate agar) was autoclaved and allowed to cool to ~ 55˚C in a water bath. Purified 
phenazine compounds were added to final concentrations of 200 µM for all phenazines tested. 
The phenazines tested were PCA (Apexmol), PCN (Apexmol), PMS (Thermo Fisher Scientific 
AC130160010), and PYO (Cayman Chemicals); PCA and PCN stock solutions were 25 mM in 
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DMSO while PMS and PYO stock solutions were 200 mM in DMSO. Extracellular redox states 
of biofilms were measured on DMSO-only plates to ensure that the solvent did not alter 
extracellular redox state. Extracellular redox states of day 3 (~ 72 hr) ∆HMS∆phz biofilms grown 
on exogenously-added phenazines were measured as above.  
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Table 1: Strains used in this study 
strain number description source
Pseudomonas aeruginosa strains
UCBPP-PA14 Clinical isolate UCBPP-PA14. Rahme et al., 1995
PA14 ∆phz LD24 PA14 with deletions in phzA1-G1 and phzA2-
G2 operons.
Dietrich et al., 
2006
PA14 ∆cco1cco2 LD1933 PA14 with both cco operons (cbb3-1, cbb3-2; 
PA14_44340-PA14_44400) deleted 
simultaneously.
Jo et al., 2017
PA14 ∆cio LD2076 PA14 with a deletion in the cio operon 
(PA14_13030-13040)
this study
PA14 PaCco LD2587 PA14 with deletions in PA14_01290-01320 
(cox/aa3 operon), PA14_47150-47210 (cyo/
bo3 operon), and PA14_13030-13040 (cio 
operon).
Jo et al., 2017
PA14 PaCco∆phz LD2588 PA14 with only the Cco terminal oxidases 
remaining in the phenazine-null background; 
deletions in the phzA1-G1, phzA2-G2, aa3, 
bo3, and cio operons.
this study
PA14 PaCio LD1989 PA14 with only the Cio terminal oxidase 
remaining; deletions in the aa3, bo3, cco1, 
and cco2 operons.
this study
PA14 PaCio∆phz LD1990 PA14 with only the Cio terminal oxidase 
remaining in the phenazine-null background; 
deletions in the phzA1-G1, phzA2-G2, aa3, 
bo3, cco1, and cco2 operons.
this study
PA14 ∆phzH ∆phzM 
∆phzS ∆phzA1-G1 
∆phzA2-G2
LD3122 PA14 with deletions in the phenazine 
biosynthetic genes phzH (PA14_00640), phzM 
(PA14_09490), phzS (PA14_09400), phzA1-
G1, and phzA2-G2.
this study
PA14 ∆phzH ∆phzM 
∆phzS ∆phzA1-G1 
∆phzA2-G2 ∆cco1cco2
LD3140 PA14 with deletions in the phenazine 
biosynthetic genes phzH, phzM, phzS, phzA1-
G1, phzA2-G2, and the terminal oxidase 
operons of cco1 and cco2. Made by mating 
LD1933 to LD3122.
this study
PA14 Paa3-gfp LD2962 PA14 with promoter of aa3 operon driving gfp 
expression.
this study
PA14 Pbo3-gfp LD2966 PA14 with promoter of bo3 operon driving gfp 
expression.
this study
PA14Pcio-gfp LD2969 PA14 with promoter of cio operon driving gfp 
expression.
this study
PA14 Pcco-1-gfp LD2784 PA14 with promoter of cco1 operon driving gfp 
expression.
Jo et al., 2017
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Table 3.2: Primers used in this study 
Table 3.1 (continued): Strains used in this study
strain number description source
PA14 Pcco-2-gfp LD2786 PA14 with promoter of cco2 operon driving gfp 
expression.
Jo et al., 2017
Escherichia coli strains
UQ950 LD44 E. coli DH5 λpir strain for cloning. F-∆(argF-
lac)169φ80 dlacZ58(∆M15) glnV44(AS) rfbD1 
gyrA96(NaIR) recA1 endA1 spoT thi-1 hsdR17 
deoR λpir+
D. Lies, Caltech
BW29427 LD661 Donor strain for conjugation. thrB1004 pro thi 





β2155 LD69 Helper strain. thrB1004 pro thi strA hsdsS 
lacZ∆M15 (F’lacZ∆M15 lacIq traD36 proA+ 
proB+) ∆dapA::erm (Ermr)pir::RP4 [::kan 
(Kmr) from SM10]
Dehio and Meyer, 
1997.
S17-1 LD2901 StrR , TpR , F− RP4-2-Tc::Mu aphA::Tn7 recA 
λpir lysogen
Teng et al., 1998
Saccharomyces cerevisiae strains


















Table 3.2 (continued): Primers used in this study
primer 
number sequence






















Table 3.3: Plasmids used in this study 
plasmid description source
pMQ30 7.5 kb mobilizable vector; oriT, sacB, GmR. Shanks et al., 2006
pLD2722 GmR, TetR flanked by Flp recombinase target (FRT) sites to 
resolve out resistance casettes.
Jo et al., 2017
pFLP2 Flp recombinase-producing plasmid Hoang et al., 1998.
pLD1929 ∆cco1 cco2 PCR fragment introduced into pMQ30 by gap 
repair cloning in yeast strain InvSc1.
Jo et al., 2017
pLD1966 ∆aa3 PCR fragment introduced into pMQ30 by gap repair 
cloning in yeast strain InvSc1.
this study
pLD1967 ∆bo3 PCR fragment introduced into pMQ30 by gap repair 
cloning in yeast strain InvSc1.
this study
pLD2044 ∆cio PCR fragment introduced into pMQ30 by gap repair 
cloning in yeast strain InvSc1.
this study
pLD2958 PCR-amplified aa3 promoter ligated into pLD2722 using SpeI 
and XhoI.
this study
pLD2959 PCR-amplified bo3 promoter ligated into pLD2722 using SpeI 
and XhoI.
this study
pLD2960 PCR-amplified cio promoter ligated into pLD2722 using SpeI 
and XhoI.
this study
pLD2777 PCR-amplified cco1 promoter ligated into pLD2722 using 
SpeI and XhoI.
Jo et al., 2017
pLD2778 PCR-amplified cco2 promoter ligated into pLD2722 using 
SpeI and XhoI.
Jo et al., 2017
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3.7: Figure supplements 
 
carbon source mode of action carbon source mode of action
1,2-propanediol C-Source, alcohol glycyl-L-glutamic acid C-Source, amino acid
2-deoxyadenosine C-Source, carbohydrate glyoxylic acid C-Source, carboxylic acid
acetoacetic acid C-Source, carboxylic acid L-alanyl-glycine C-Source, amino acid
adenosine C-Source, carbohydrate L-arabinose C-Source, carbohydrate
adonitol C-Source, carbohydrate L-fucose C-Source, carbohydrate
D-aspartic acid C-Source, amino acid L-galactonic acid-γ-
lactone
C-Source, carboxylic acid
D-cellobiose C-Source, carbohydrate L-lyxose C-Source, carbohydrate
D-fructose-6-phosphate C-Source, carbohydrate L-serine C-Source, amino acid
D-galactonic acid-γ-lactone C-Source, carboxylic acid L-threonine C-Source, amino acid
D-galactose C-Source, carbohydrate lactulose C-Source, carbohydrate
D-galacturonic acid C-Source, carboxylic acid m-hydroxyphenyl-acetic 
acid
C-Source, carboxylic acid
D-glucosaminic acid C-Source, carboxylic acid m-inositol C-Source, carbohydrate
D-glucose-1-phosphate C-Source, carbohydrate m-tartaric acid C-Source, carboxylic acid
D-glucose-6-phosphate C-Source, carbohydrate maltose C-Source, carbohydrate
D-glucuronic acid C-Source, carboxylic acid maltotriose C-Source, carbohydrate
D-mannose C-Source, carbohydrate monomethylsuccinate C-Source, carboxylic acid
D-melibiose C-Source, carbohydrate mucic acid C-Source, carboxylic acid
D-psicose C-Source, carbohydrate N-acetyl-β-D-
mannosamine
C-Source, carbohydrate
D-ribose C-Source, carbohydrate phenylethylamine C-Source, amine
D-saccharinic acid C-Source, carboxylic acid sucrose C-Source, carbohydrate
D-serine C-Source, amino acid thymidine C-Source, carbohydrate
D-threonine C-Source, amino acid tricarballylic acid C-Source, carboxylic acid
D-trehalose C-Source, carbohydrate uridine C-Source, carbohydrate
D-xylose C-Source, carbohydrate α-D-lactose C-Source, carbohydrate
dulcitol C-Source, carbohydrate α-hydroxy-butyric acid C-Source, carboxylic acid
formic acid C-Source, carboxylic acid α-hydroxy-glutaric acid-γ-
lactone
C-Source, carboxylic acid
glucuronamide C-Source, amide α-ketobutyric acid C-Source, carboxylic acid
glycolic acid C-Source, carboxylic acid α-methyl-D-galactoside C-Source, carbohydrate
glycyl-L-aspartic acid C-Source, amino acid β-methyl-D-glucoside C-Source, carbohydrate
Figure 3.1–figure supplement 1. Carbon sources that do not support growth of PA14. The 58 
carbon sources (and their modes of action as designated by Biolog, Inc.) in the phenotype microarray 
plate that did not support growth of PA14 strains.
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Figure 3.2–figure supplement 1. Growth profiles of carbon sources of interest. Growth 
curves (absorbance at 500 nm) over time of carbon sources in group 3 (A), group 4 (B), and 
glucose and succinate (C) in the presence (top, closed circles) and absence (bottom, open 
circles) of phenazines. Data represent the average of two biological replicates.  
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Figure 3.3–figure supplement 1. PA14 growth in MOPS + 30 mM succinate. Growth 
curves of PA14 strains in MOPS defined medium with 30 mM succinate. Data represent 
the mean values of at least three biological replicates, and error bars denote standard 
deviation. 
Figure 3.5–figure supplement 1. Phenazine production in three-day-old biofilms. 
Quantification of phenazines retained in three-day old WT biofilms. Individual data 
points represent biological replicates, and bars indicate the mean. Error bars denote 




Other pathways of energy generation in Pseudomonas aeruginosa  
and the contribution of redox state to biofilm formation in Bacillus subtilis 
In the preceding chapters, I have discussed projects for which I was the primary contributor. The 
main metabolic pathways considered in those chapters involved the oxidation of a carbon 
source via aerobic respiration. This chapter represents a collection of papers to which I 
contributed as a co-author through various collaborations. I have distilled each paper into its 
main points, including experiments that I performed.  
Here, I will discuss some alternative pathways of energy generation carried out by P. 
aeruginosa, starting with two alternative fates of pyruvate. During aerobic respiration, pyruvate 
is oxidized to acetyl-CoA at the end of the Entner-Doudoroff pathway. At this point, it will enter 
the TCA cycle and its oxidation (ultimately to CO2) will be coupled to energy generation via the 
ETC. However, under different environmental conditions and nutrient availabilities, pyruvate can 
be reduced to lactate or carboxylated to oxaloacetate. I will discuss each of these fates, in the 
context of my collaborations, in turn. I will then discuss research elucidating the role of a 
metabolic enzyme originally believed to mediate the carboxylation of pyruvate to oxaloacetate. 
Finally, I will conclude with a project that demonstrates a role for redox state in driving biofilm 
development in another bacterium, Bacillus subtilis. 
The figures presented in this chapter were modified from their respective articles with the 
exception of Figures 4.11 (modified from Okegbe et al., 2014) and 4.12 (my unpublished data). 
Materials and methods relevant to the points discussed in this chapter are adapted from their 
respective articles, with minor revisions. 
4:1: The Pseudomonas aeruginosa complement of lactate dehydrogenases contributes 
to growth in CF lung-like environments 
This section is adapted from: 
Lin, YC, Cornell, WC, Jo, J, Price-Whelan, A, Dietrich, LEP (2018). The Pseudomonas 
aeruginosa complement of lactate dehydrogenases enables use of D- and L-lactate and 
metabolic cross-feeding. mBio 9, e00961-18. 
I performed the growth assays in the various synthetic CF media (Figure 4.4) and the data 
analysis and interpretation for those experiments.  
 In addition to being able to produce energy via oxygen or nitrate respiration, P. 
aeruginosa is also capable of fermenting arginine or pyruvate when it encounters anoxic 
conditions (Figure 1.6). Arginine fermentation provides enough ATP to allow for growth while 
pyruvate fermentation is less efficient, allowing for anaerobic survival but not growth (Shoesmith 
and Sherris 1960; Vander Wauven et al. 1984; Williams, Zlosnik, and Ryall 2007). The P. 
aeruginosa genome encodes four enzymes annotated to be involved in the conversion between 
lactate and pyruvate. LdhA reduces pyruvate to the D-enantiomer of lactate (D-lactate) while 
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LldE mediates the reverse reaction (conversion of D-lactate to pyruvate). P. aeruginosa also 
encodes LldD, an enzyme that converts L-lactate to pyruvate, as well as an additional, less-
characterized enzyme LldA, which is 44% identical to LldD. lldD and lldE are co-transcribed in 
the same operon along with another gene encoding a lactate permease (lldP) while lldA is found 
elsewhere in the genome, not in an operon (Figure 4.1). That P. aeruginosa has two enzymes 
for L-lactate metabolism is interesting in light of the facts that (1) this bacterium does not 
produce L-lactate and (2) L-lactate is mostly a byproduct of plant and mammalian metabolism 
(Petersen 2005; Maurino and Engqvist 2015). We therefore hypothesized that LldA functions 
redundantly with LldD as an L-lactate dehydrogenase, and that together these enzymes would 
contribute to P. aeruginosa survival in a host. 
 In order to characterize the conditions under which the different lactate metabolism 
genes are expressed, we created reporter constructs that fused the promoters of lldPDE and 
lldA to gfp. We then grew these reporters planktonically in a defined MOPS-buffered medium 
with D-glucose, L-lactate, or D-lactate as the sole carbon source (Figure 4.2). We saw a quick 
and strong expression of lldPDE-gfp in both D- and L-lactate starting from early stages of 
growth, as expected, and a low level of expression in D-glucose starting later in growth. The 
latter was most likely lldPDE-gfp expression in response to production of D-lactate at later 
Figure 4.1. The P. aeruginosa genome encodes several enzymes that interconvert 
pyruvate and lactate. (Left) Reactions catalyzed by P. aeruginosa’s lactate 
dehydrogenases; (right) chromosomal loci encoding each of the corresponding 
enzymes. LdhA catalyzes the reduction of pyruvate during anaerobic survival. LldE 
catalyzes the oxidation of D-lactate during aerobic growth. Unlike E. coli, which 
contains only one gene encoding an L-lactate dehydrogenase, P. aeruginosa contains 
two orthologues for this enzyme. LldD catalyzes the oxidation of L-lactate during 
aerobic growth. This study describes a role for LldA in catalyzing the oxidation of L-
lactate during aerobic growth.
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stages of growth (Figure 4.2). lldA-gfp expression, on the other hand, was more gradual and 
only seen in response to L-lactate, consistent with the hypothesis that LldA specifically oxidizes 
L-lactate to pyruvate. 
 To then assess the physiological contributions of lldD, lldE, and lldA to P. aeruginosa 
growth, we generated deletion mutants of lldDE and lldA and characterized the development of 
the resulting colony biofilms on different carbon sources. Mutants grown with D-glucose as the 
sole carbon source showed biofilm development indistinguishable from that of the WT (Figure 
4.3). Indeed, ∆lldA showed WT-like growth in all carbon sources tested, including L- and D-
lactate, indicating that LldA alone is not necessary for metabolism of either lactate enantiomer. 
When ∆lldDE was grown on D-lactate, colony biofilms exhibited a severe growth defect with 
almost no growth, consistent with previous reports that LldE is likely solely responsible for D-
lactate metabolism (Gao et al. 2012). When ∆lldDE was grown on L-lactate, the resulting 
colonies were able to grow robustly, but displayed more wrinkled biofilms that bound more 
Congo red dye relative to the WT (Figure 4.3), features we have previously shown to be 
indicative of redox stress in biofilms (Dietrich et al. 2008, 2013). This phenotype indicated that 
LldD participates in L-lactate utilization, but that it is likely working in conjunction with another 
enzyme whose presence allows ∆lldDE to grow on L-lactate. Strikingly, while ∆lldA showed WT-
like biofilm development on L-lactate, the ∆lldDE∆lldA double mutant produced biofilms that 
Figure 4.2. Expression of loci associated with pyruvate and lactate metabolism 
during aerobic, liquid-culture growth. Strains engineered to express GFP under the 
control of promoters upstream of lldP (which is cotranscribed with lldD and lldE) or lldA 
were grown in MOPS medium, with the indicated compounds provided as sole carbon 
sources. Background fluorescence from a strain with a promoterless reporter (MCS-gfp) 
was subtracted before normalization to the OD at 500 nm. Error bars, which are often 
obscured by the point markers, represent the standard deviations from biological 
triplicates. AU, arbitrary units.
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were unable to grow on this carbon source (Figure 4.3). These results suggest that LldA 
functions redundantly with LldD in L-lactate metabolism.  
 As previously mentioned, it is noteworthy that P. aeruginosa has two enzymes for the 
conversion of L-lactate to pyruvate when it itself does not produce L-lactate as a metabolic 
byproduct. Furthermore, the redundant role we described for LldA in biofilm formation on L-
lactate was in contrast to previous reports in another pseudomonad, P. stutzeri, which showed 
that the lldDE operon alone is required for growth on L-lactate (Gao et al. 2012). These 
observations led us to hypothesize that the presence of a redundant gene for L-lactate 
utilization in P. aeruginosa contributes to its success as a human pathogen.  
 To further explore the possibility that lldA contributes to P. aeruginosa growth in a 
pathogenic context, we grew our mutants in a variety of synthetic CF media designed to mimic 
sputum from CF patients (Palmer, Aye, and Whiteley 2007; Fung et al. 2010; Turner et al. 2015). 
Nutrient conditions found in CF sputum are markedly different from those found in sputum from 
healthy individuals. Healthy sputum is a mixture of water, salts, mucins, and surfactants; in CF 
patients, the levels of these ingredients are altered, and additional molecules not found in 
healthy sputum are detected. Specifically, CF sputum contains higher amounts of free amino 
Figure 4.3. Physiological roles of enzymes that interconvert pyruvate and lactate 
during biofilm growth. Growth and morphological development of the indicated strains 
under an oxic atmosphere on MOPS medium containing the dyes Congo red and 
Coomassie blue and amended with D-glucose, L-lactate, or D-lactate. Images were 
taken after 4 days of incubation. WT, wild type.
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acids, DNA, iron, and lactate. Lactate has been measured in millimolar concentrations ranging 
from 3-14.1 mM and the presence of it in CF sputum correlates to lung inflammation (Conway 
and Cohen 2015). We tested the growth of ∆lldDE∆lldA in three kinds of synthetic CF media: (1) 
synthetic CF medium (SCFM, a defined mixture of ions, amino acids, iron, and carbon sources; 
(Palmer, Aye, and Whiteley 2007)), (2) ASMDM (modified artificial sputum medium, similar to 
SCFM but also containing bovine serum albumin, mucin, and herring sperm DNA; (Fung et al. 
2010)), and (3) SCFM2, which is similar to ASMDM but also contains the large molecules N-
acetyl-D-glucosamine and dipalmitoylphosphatidylcholine (Turner et al. 2015).  
 Compared to WT P. aeruginosa, the ∆lldDE∆lldA mutant had about 10% less growth in 
SCFM, with the growth defect starting after cells were in stationary phase (Figure 4.4A). The 
mutant also had a stationary growth defect compared to the WT in ASMDM (Figure 4.4B) and 
SCFM2 (Figure 4.4C), but in the former, ∆lldDE∆lldA showed slower growth starting in 
exponential phase. Together, these data indicate that the lactate dehydrogenases contribute to 
growth in media that are similar in makeup to the sputum found in CF patients. That the 
∆lldDE∆lldA mutant displayed growth defects relative to the WT in all three synthetic media 
tested also suggests that these enzymes may contribute to the virulence of P. aeruginosa in the 
CF lung. 
Figure 4.4. PA14 utilizes the L-lactate in various synthetic cystic fibrosis sputum media 
for growth. Growth of the indicated strains in SCFM (A), ASMDM (B), and SCFM2 (C). Error 
bars represent the standard deviations from at least four biological replicates and are omitted in 
cases where they would be obscured by point markers. Dashed lines indicate onset of 
stationary phase. In panel (B), ∆lldDE ∆lldA reaches stationary phase at a later time point than 
the other two strains; its onset of stationary phase is delineated by the red dashed line while the 
onset of stationary phase for the other two strains is indicated by the black dashed line.
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 Lactate is a major component of the CF sputum (Palmer, Aye, and Whiteley 2007), and 
while P. aeruginosa can convert pyruvate into D-lactate, the L-enantiomer is produced by 
eukaryotes rather than bacteria (Starkey and Rahme 2009; Lorenz et al. 2016; Winsor et al. 
2016). Therefore, the presence of a gene for L-lactate utilization is likely tied to P. aeruginosa’s 
prevalence as a plant and human pathogen. Furthermore, the presence of lldA, a redundant 
gene for L-lactate utilization, may allow this bacterium to more efficiently metabolize this carbon 
source when colonizing a eukaryotic host. In support of this hypothesis are our results in Figure 
4.4, which demonstrate that LldD and LldA cooperatively contribute to optimal growth in media 
that mimic the nutrient conditions of CF sputum. While the majority of pseudomonad species 
contain either the LldD or LldA enzymes for L-lactate utilization, P. aeruginosa contains both (Lin 
et al. 2018); together, these two enzymes may endow this bacterium to more successfully 
colonize and persist in CF lung environments. 
4:2: Pyruvate carboxylation affects Pseudomonas aeruginosa biofilm morphogenesis 
This section is adapted from: 
Choi, PH, Jo, J, Lin, YC, Lin, MH, Chou, CY, Dietrich, LE, Tong, L (2016). A distinct holoenzyme 
organization for two-subunit pyruvate carboxylase. Nat Commun 7, 12713. 
The work presented in this section resulted from a collaboration with the Tong lab at Columbia 
University. I generated all of the Pseudomonas aeruginosa mutant and complementation strains 
discussed in this section and conducted initial liquid culture and colony biofilm growth assays. I 
also contributed to the data analysis and interpretation of the work pertaining to P. aeruginosa 
and the role of pyruvate carboxylase in biofilm morphogenesis and redox balancing. 
 Pyruvate, in addition to being oxidized to acetyl-CoA and reduced to lactate, can be 
carboxylated to oxaloacetate, an intermediate of the TCA cycle. Pyruvate carboxylase (PC) is 
the enzyme that catalyzes the carboxylation of pyruvate to oxaloacetate, thereby functioning in 
anaplerosis of the TCA cycle. When P. aeruginosa grows on organic acids (such as succinate) 
or amino acids (which are plentiful in a complex carbon source like tryptone), it is able to 
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synthesize oxaloacetate easily from these compounds. However, when it is grown on a sugar 
(i.e., glucose), PC activity is necessary for oxaloacetate replenishment. 
 Through a collaboration with the Tong lab at Columbia University, we were able to gain 
more insight into the structure and function of PC (PA14_71720-71740), a member of the biotin-
dependent carboxylase family, which also includes acetyl-CoA carboxylase (ACC) and 
propionyl-CoA carboxylase (PCC) (Tong 2013). Reactions mediated by biotin-dependent 
carboxylases function in two steps: first, the enzyme carboxylates its biotin cofactor and then 
this carboxyl group is transferred from the biotin to the substrate (Tong 2013; Tran et al. 2015). 
These enzymes contain three core domains: the biotin carboxylase (BC) domain, the 
carboxyltransferase (CT) domain, and the biotin carboxyl carrier protein (BCCP) domain. The 
biotin cofactor interacts with the carboxylase enzyme at the BCCP domain and is carboxylated 
by the BC domain. The CT domain mediates the transfer of the carboxyl group to the enzyme’s 
substrate.  
 In pyruvate carboxylases of eukaryotes and most bacteria, these domains are found 
within one polypeptide chain and are therefore called “single-chain” PCs. However, in a subset 
of Gram-negative bacteria, including Methylobacillus flagellatus and P. aeruginosa, the domains 
are encoded by two genes, the ɑ and β subunits (Figure 4.5A), and are accordingly classified 
as two-subunit enzymes. In these enzymes, the ɑ subunit contains the BC domain while the β 
subunit contains the CT and BCCP domains. 
 The structures of single-chain PCs had been previously reported and showed that the 
holoenzyme consists of four PC monomers forming a two-layered homotetramer (St Maurice et 
al. 2007; Xiang and Tong 2008); Figure 4.5B). Each layer contains two PC monomers and 
previous structural insights have indicated that PC will only be catalytically active in the 
tetrameric form; the tetramerization of PC is mediated by the PC tetramerization (PT) domain 
(Tong 2013). This is because the BCCP-biotin is carboxylated by the BC domain of one 
monomer and then transfers the CO2 to a pyruvate molecule in the CT domain of another 
monomer in the same layer, hence making both monomers necessary for pyruvate 
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carboxylation. However, the conformation of these two monomers is only stable when the 
enzyme forms a tetramer, as two monomers in the same layer have minimal interactions with 
one another. 
 
 Based on these details, the structure of the two-subunit PCs were expected to show an 
ɑ4β4 stoichiometry, which would correspond to the homotetrameric organization of single-chain 
PCs previously shown to be important for catalytic activity. Surprisingly, the structure of M. 
flagellatus PC (MfPC), the first reported for a holoenzyme of a two-subunit PC, revealed an ɑ2β4 
stoichiometry and an overall divergent structure from the single-chain PCs (Figure 4.6).  
 The region corresponding to the PT domain of MfPC showed a less than 10% sequence 
identity to the PT domain of single-chain PCs. The ɑ and β subunits of MfPC interact through a 
helix at the C terminal end of an ɑ subunit making contact with a region in the CT-BCCP linker 
Figure 4.5. Organization of single-chain and two-subunit pyruvate carboxylases. 
(A) Domain organization of Staphylococcus aureus pyruvate carboxylase (SaPC), a 
representative single-chain PC, and Methylobacillus flagellatus PC, a representative 
two-subunit PC. (B) Schematic drawing of the structure of the single-chain SaPC 
holoenzyme (Xiang and Tong, 2008). The domains in the four monomers are labeled 
and colored according to (A). 
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of a β subunit (Figure 4.6); this interaction corresponds to that mediated through the PT domain 
of single-chain PCs. Furthermore, the structure of the two-subunit MfPC revealed novel 
interactions between a CT domain (in a β subunit) and the aforementioned helix (in an ɑ 
subunit). This interaction led to the formation of a new, “BT-like” domain (Figure 4.6, “BT-L” in 
orange) that resembles the BT domains (which mediate the interaction between BC and CT 
domains) found in ACCs and PCCs. This BT-like domain is very likely the driving force behind 
the ɑ2β4 stoichiometry seen in the two-subunit PCs, which, based on sequence homologies, is 
expected to be conserved among all bacterial two-subunit PCs.  
 ACCs also contain BC, CT, and BCCP domains; however, this helix domain is not found 
in the BC subunit. The presence of this domain has been the source of some confusion, leading 
to P. aeruginosa’s ACC and PC to originally be misannotated (Stover et al. 2000). Through the 
in vivo studies described next and another collaboration with the Tong Lab (to be discussed in 
section 4.3 below), we were able to clarify the functions of these two enzymes in P. aeruginosa. 
 Because the identity of P. aeruginosa’s ACC and PC were somewhat nebulous, and 
because P. aeruginosa PC (PaPC) represents another two-subunit PC, we then conducted 
Figure 4.6. Structure of MfPC holoenzyme. (A) 
Structure of the wild-type MfPC holoenzyme, 
having the shape of a butterfly in this view. The 
domains are colored according to Figure 4.5A, 
except that the BC domain of the second subunit 
is colored in pink. BT-L, BT-like domain. (B) 
Structure of the wild-type MfPC holoenzyme 
viewed down the BC domain dimer, along the 
arrow of A.
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functional studies to investigate the physiological role of PaPC. PaPC has high sequence 
identity with MfPC, and in vitro biochemical assays predict it to also have an ɑ2β4 stoichiometry. 
In order to study the contribution of this enzyme to P. aeruginosa growth, we generated a 
mutant lacking this enzyme (∆PC) as well as point mutants for some key residues identified 
through the MfPC structure. The point mutants generated were: K451stop (K451*) in the ɑ 
subunit, which would disrupt holoenzyme formation, K572A in the β subunit, which would 
eliminate biotinylation, and A55T in the β subunit, which would interfere with biotin binding to the 
CT domain and predicted to reduce PC activity by ~50-fold. We also generated a 
complementation strain that complemented WT PC back into the site of deletion. 
 In agreement with known contributions of PaPC to P. aeruginosa growth on specific 
carbon sources, ∆PC and all point mutants grew comparably to the WT when grown on 
succinate as a sole carbon source. However, when glucose or pyruvate was the sole carbon 
source, ∆PC showed a significant growth defect in liquid culture relative to the WT (Figure 
4.7A), indicative of a stalled TCA cycle resulting from a depletion of oxaloacetate. In glucose, 
growth of K451* and K572A recapitulated that of ∆PC, while A55T showed a less severe growth 
defect than the full deletion. In pyruvate, K451* and K572A again phenocopied ∆PC, while A55T 
displayed WT-like growth. These results confirmed that the A55T point mutation was not as 
deleterious to enzyme activity as the other two point mutations as expected. 
 We then extended these physiological studies to biofilms by looking at pellicle and 
colony formation. Pellicles are biofilms that form from static liquid cultures at the liquid-air 
interface. When pellicles or colonies were grown on succinate, the ∆PC mutant, as expected, 
looked like the WT. However, when biofilms were grown on either glucose or pyruvate as the 
sole carbon source, the ∆PC mutant conferred a strong growth defect, reflective of what was 
observed in liquid culture (Figure 4.7B, C).  
 After assessing  the contribution of PC to biofilm growth on a single carbon source, we 
next tested 1% tryptone, a complex, rich medium. When WT biofilms are grown on tryptone, 
they remain relatively smooth until day three of development, when they begin to wrinkle 
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(Figure 4.8A). The onset of wrinkling has previously been shown to correspond to an increase 
in intracellular redox stress, which is alleviated by increased surface exposure to O2 (Dietrich et 
al. 2013). Compared to the WT, ∆PC mutant biofilms displayed morphologies indicative of 
increased redox stress: they wrinkled earlier and formed thinner biofilms with higher wrinkle 
structures (Figure 4.8A). Of the point mutants generated, only the K572A mutant phenocopied 
the ∆PC mutant.  
Figure 4.7. The two-subunit PaPC is required for growth on selected carbon sources. (A) 
Shaken liquid-culture growth of wild-type P. aeruginosa PA14, ∆PC, the PC-complemented 
strain and various site-specific mutants in a defined medium containing 20 mM succinate, 
pyruvate, or glucose as the sole carbon source. Each growth curve represents the average of 
three biological replicates. Error bars denote standard deviation. (B) Pellicles formed by P. 
aeruginosa PA14, ∆PC, and the PC-complemented strain on a defined medium containing 
succinate, pyruvate, or glucose as the sole carbon source. (C) Colony morphology of P. 
aeruginosa PA14, ∆PC, and the PC-complemented strain on a defined medium (supplemented 
with 1% agar, Congo red, and Coomassie blue) containing succinate, pyruvate, or glucose as 
the sole carbon source. Images depict day three of colony development. Scale bar is 1 cm.
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 As matrix production is necessary for the formation of biofilms structures, we 
hypothesized that the ∆PC mutant would have increased matrix production relative to the WT. 
To this end, we measured matrix production by quantifying Pel, a major component of PA14 
matrix. Pel is a cationic polysaccharide that binds to the anionic dye Congo red, so the 
proportion of bound Congo red dye is directly proportional to matrix production. We found that 
∆PC biofilms formed on tryptone bound significantly higher levels of Congo red than the WT 
(Figure 4.8B). Consistent with our tryptone biofilm morphology results, we saw that only the 
Figure 4.8. PaPC dysfunction leads to increased matrix production and altered colony 
morphology. (A) Colony morphology of wild-type P. aeruginosa PA14, ∆PC, the PC-
complemented strain, and the K572A mutant on 1% tryptone, 1% agar (supplemented with 
Congo red and Coomassie blue). Scale bar is 1 cm. (B) Quantification of Congo red binding, a 
proxy for matrix production, for P. aeruginosa PA14, ∆PC, the PC-complemented strain, and 
various site-specific mutants grown on 1% tryptone, 1% agar with no added dyes. Colonies 
were grown for 3 days before they were collected for the Congo red binding assay. (C) Shaken 
liquid-culture growth of P. aeruginosa PA14, ∆PC, the PC-complemented strain, and various 
site-specific mutants in 1% tryptone. Each growth curve represents the average of three 
biological replicates. Error bars denote standard deviation.
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K572A point mutant showed increased matrix production relative to the WT, while A55T and 
K451* produced WT levels of matrix.  
 Surprisingly, we found that the ∆PC-mediated growth phenotypes on tryptone were 
biofilm-specific: when we grew all strains planktonically, we saw that ∆PC and all of the point 
mutants grew like the WT (Figure 4.8C). This indicates that the function of PC on a complex 
medium is more linked to growth in a biofilm context than it is in liquid culture, another indication 
that growth in the liquid and biofilm contexts are quite divergent and illustrating how P. 
aeruginosa may switch its metabolism in response to its mode of growth. The biofilm-specific 
phenotype of the PC deletion mutant on a complex medium corresponds to increased redox 
stress as indicated by colony morphology and Congo red binding assays. Additionally, ∆PC 
showed abrogated growth on glucose and no growth on pyruvate, two carbon sources that are 
found in CF sputum (Palmer, Aye, and Whiteley 2007; Bensel et al. 2011). Together, these 
results indicate that PC’s expected anaplerotic role does indeed sustain TCA cycle function and 
participates in redox balancing in biofilms; both of these functions may have important 
contributions to P. aeruginosa as a clinically-relevant pathogen. 
4.3: Structure and function of a single-chain, multi-domain long-chain acyl-CoA 
carboxylase 
This section is adapted from: 
Tran, TH, Hsiao, YS, Jo, J, Chou, CY, Dietrich, LE, Walz, T, Tong, L (2015). Structure and 
function of a single-chain, multi-domain long-chain acyl-CoA carboxylase. Nature 518, 120-124. 
The work presented in this section resulted from another collaboration with the Tong Lab at 
Columbia University. I generated the Pseudomonas aeruginosa ∆LCC mutant strain and 
contributed to data analysis and interpretation of the experiments performed in P. aeruginosa. 
 In collaboration with the Tong lab, we studied the function of P. aeruginosa’s acetyl-CoA-
carboxylase, or ACC. While eukaryotic ACCs are single-chain, multi-domain enzymes, those 
found in bacteria have been shown to be multi-subunit enzymes. ACCs catalyze the 
carboxylation of acetyl-CoA to malonyl-CoA, which is then used as a precursor of fatty acid 
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biosynthesis (Kutchma, Hoang, and Schweizer 1999). In Tran et al., 2015, the structure of ACC 
from Mycobacterium avium subspecies paratuberculosis was solved and shown to be a single-
chain, multi-domain enzyme (Figure 4.9A). A homolog of this enzyme is found in P. aeruginosa 
but had been previously mis-annotated to be a pyruvate carboxylase (Stover et al. 2000) and 
later shown to be an acetyl-CoA carboxylase (Lai et al. 2006). Biochemical assays performed 
within the scope of our study confirmed that this enzyme did not possess PC activity but instead 
showed activity toward a variety of acyl-CoAs, including acetyl-CoA and propionyl-CoA, but 
showed a preference for long-chain substrates, leading this group of enzymes to be named 
long-chain acyl-CoA carboxylases (or LCCs) (Tran et al. 2015).  
 The structure of ACC from M. avium subspecies paratuberculosis (MapLCC) showed its 
holoenzyme to be a homohexamer (Figure 4.9B). Each monomer contained BC, BCCP, and CT 
domains as expected and the monomers within the holoenzyme have significant interactions 
with each other (these interactions include van der Waals and ionic interactions and hydrogen 
bonding). In contrast to other ACCs, the BC-CT (BT) interaction domain is not found in MapLCC 
and the BCCP domain of LCC is found in the middle of the peptide rather than at the end of the 
polypeptide chain (Figure 4.9A). As a result, there are two linkers from the BCCP domain to the 
rest of the protein, making this region very flexible during catalysis, allowing for optimal contact 
between the biotin and the BC and CT domains, resulting in good catalytic activity (Tong 2013). 
Figure 4.9. Structure of LCC from M. avium 
subspecies paratuberculosis. (A) Domain 
organization of MapLCC, with the domains 
labeled. (B) Overall structure of the 720 kDa 
hexameric holoenzyme of MapLCC. The six 
monomers are labeled. The domains in the three 
monomers in the top layer (numbered 1, 2, 3) are 
colored as in A. The BC, BCCP, N, and C CT 
domains in the three monomers in the bottom layer 
(numbered 4, 5, and 6) are colored pink, pale blue, 
and pale cyan, and pale yellow, respectively. The 
disordered region of the BCCP-CT linker is 
indicated with a dashed line.The BC active sites 
are indicated with asterisks. The CT active sites 
are on the side of the CT domain core and 
indicated with black arrows.
138
 To further study the physiological role of this enzyme, we generated a deletion mutant for 
its ortholog in P. aeruginosa (PA14_46320; the resulting deletion strain will be referred to as 
∆LCC) and evaluated its growth under ~ 2,000 conditions using Biolog phenotype microarrays. 
Some of the conditions tested included growth on various carbon and nitrogen sources and 
exposure to different antibiotics. Growth was measured as a function of the chemical reduction 
of a tetrazolium dye that undergoes a color change upon a change in redox state. Overall, 
∆LCC in P. aeruginosa was similar to the reference WT PA14 strain in most conditions tested. 
Only a few conditions elicited different growth profiles between WT and ∆LCC. These were 
growth in the carbon sources fumarate and gly-pro (a dipeptide) and in the dipeptide nitrogen 
sources asp-phe, glu-val, met-asp, and met-val (Figure 4.10). Only the results on fumarate and 
met-val were considered significant. On met-val, the ∆LCC mutant had a growth defect relative 
to the WT while on fumarate, the mutant grew significantly better than the WT. 
 The metabolism of methionine and valine both lead to the production of propionyl-CoA 
(Tran et al. 2015). It is possible that the activity of LCC toward propionyl-CoA, which was 
demonstrated in this work, contributes to further degradation of propionyl-CoA, a hypothesis 
Figure 4.10. In vivo function of P. aeruginosa LCC. Phenotypic differences between 
wild type and LCC knockout (∆PA14_46320) P. aeruginosa PA14 strains, revealed by a 
colorimetric assay that monitors the reduction of a tetrazolium dye. Assays were 
performed twice in each medium for the wild-type (red and orange) and mutant (blue 
and cyan) strains. For each panel, the horizontal axis is time (24 h) and the vertical axis 
is OmniLog signal, indicating levels of dye reduction (Shea et al., 2012).
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supported by the fact that P. aeruginosa does not encode a dedicated PCC (Tran et al. 2015). 
Propionyl-CoA can also be converted to succinyl-CoA, an important TCA cycle intermediate 
whose oxidation is linked directly to the reduction of the quinone pool (Williams, Zlosnik, and 
Ryall 2007). Therefore, met-val metabolism may ultimately lead to anaplerosis of succinate in 
the TCA cycle and the growth defect of ∆LCC seen on met-val may be indicative of succinate 
depletion, leading to a stalled TCA cycle. Interestingly, the oxidation of succinate leads to the 
production of fumarate, the only other nutrient source in which the ∆LCC showed a significant 
phenotype. In the case of fumarate, the mutant grows better than WT, which would be 
consistent with the provision of fumarate allowing the mutant to bypass its succinate deficiency 
and thus restoring growth to levels surpassing those of  WT.  
Figure 4.11. Architecturally complex biofilms are formed by diverse microbial species. (A) 
Candida albicans, a eukaryotic fungus (D. Morales and D. Hogan). (B) Saccharomyces cerevisiae SK1 
(C. Sison, B. Miller, L. Dietrich).  (C) Escherichia coli K-12 derivative AR3110 (S. Herbst and R. 
Hengge). (D) Bacillus subtilis NCIB3610 (J. Jo and L. Dietrich). (E) Pseudomonas oryzihabitans, 
isolated from a bench in Riverside Park, NY (S. Jordan and L. Dietrich). (F) Pseudomonas aeruginosa 
PA14 (J. Jo and L. Dietrich). 
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4:4: Redox state contributes to biofilm physiology in Bacillus subtilis 
This section is adapted from: 
Arnaouteli, S, Ferreira AS, Schorb, M, Morris, RJ, Bromley, KM, Jo, J, Cortez, KL, Sukhodub, T, 
Prescott, AR, Dietrich LEP, MacPhee, CE, Stanley-Wall, NR (2017). Binfunctionality of a biofilm 
matrix protein controlled by redox state. PNAS 114, E6184-6191. 
The work presented in this section resulted from a collaboration with the Stanley-Wall Lab at the 
University of Dundee. I generated the oxygen and redox microprofiling data (Figure 4.15) and 
contributed to the data analysis and interpretation of those results. 
 My thesis work has been focused on studying the mechanisms that underlie biofilm 
formation in P. aeruginosa. However, the ability to form biofilms is a quality shared by many 
divergent bacteria and even single-celled eukaryotes such as Saccharomyces cerevisiae 
(Figure 4.11; Okegbe et al., 2014).  All these biofilms share key characteristics: they are 
multicellular assemblages encased within a self-produced matrix that face challenges arising 
from the formation of nutrient gradients. Here, I will discuss the work I did in collaboration with 
the Stanley-Wall Lab at the University of Dundee to further elucidate how redox state drives 
biofilm formation in Bacillus subtilis. 
 B. subtilis is a motile, spore-forming, Gram-positive bacterium commonly found in 
diverse habitats. It, like P. aeruginosa, is a facultative anaerobe with fermentative and 
denitrification capabilities and possesses a branched respiratory chain whose terminal oxidases 
can oxidize both the quinone pool and cytochrome c (García Montes de Oca et al. 2012). B. 
subtilis is capable of forming highly-structured, rugose biofilms and wrinkle formation appears to 
be at least partially driven by O2 availability (Kolodkin-Gal et al., 2013). The matrix of these 
biofilms is composed of an exopolysaccharide whose components are the products of the epsA-
O operon, protein fibers encoded by the tapA-sipW-tasA operon, and bslA, which encodes a 
small secreted protein (Arnaouteli et al. 2017). A distinct feature of B. subtilis biofilms is their 
hydrophobicity, which renders the biofilm impermeable to water, gases, and solvents (Figure 
4.12; Epstein et al. 2011). As this hydrophobic nature also prevents entry of some biocides into 
the biofilm, it is thought that this feature affords B. subtilis biofilms an added layer of protection 
against external assault (Arnaouteli et al. 2017). Previous work has attributed the formation of 
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this so-called hydrophobic “raincoat” to the matrix component BslA (Biofilm Surface Layer 
Protein A).  
 BslA is a ~19 kDa amphipathic protein with structural features reminiscent of the 
immunoglobulin (Ig) superfamily (Arnaouteli et al. 2017). A key feature of BslA is the presence of 
a series of hydrophobic amino acids that form a “cap” (Hobley et al. 2013). When BslA is in an 
aqueous environment, its structure is configured in the “cap in” formation wherein the 
hydrophobic cap is tucked into the protein. When BslA encounters a hydrophobic interface, such 
as the biofilm-air interface, it will switch to the “cap out” conformation, exposing its hydrophobic 
residues to form the biofilm raincoat.  
 Previous work has shown that the ∆bslA deletion mutant forms featureless biofilms that 
do not have hydrophobic coats but instead a “wetting,” hydrophilic surface (Kobayashi and 
Iwano 2012). Hydrophobicity was determined by a simple assay in which a droplet of water was 
dispensed onto the surface of the biofilm. In WT biofilms, which possess the hydrophobic coat, 
the water droplet is retained in a sphere, but in ∆bslA biofilms, the water droplet spreads out 
across the surface of the biofilm. An outstanding question remains in the field as to how B. 
subtilis biofilms access nutrients if they are surrounded by a protective shield of sorts formed by 
BslA (Hobley et al. 2013; Arnaouteli et al. 2017). An additional feature of BslA, also found 
among BslA variants in other Bacillus species, is the presence of two conserved cysteine 
residues in the C-terminus, forming a “CxC” motif. Because of the importance of cysteine 
Figure 4.12. Colony biofilms of B. subtilis form a hydrophobic coat at the biofilm-air interface. 
Colored droplets of water placed onto the surface of two-day-old colony biofilms of B. subtilis strain 
NCIB3610 grown on MSgg agar.
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residues in stabilizing protein structure, we set out to determine the contribution of the CxC motif 
to biofilm development.   
 Preliminary biochemical results indicated that recombinant BslA forms monomers, 
dimers, and tetramers in vitro. To see if oligomerization is also observed in vivo, we purified BslA 
from wild-type (3610) B. subtilis biofilms in the presence of Cu(II)-(o-phenanthroline)3, which 
cross-links disulfide bonds. Western blotting results showed that the monomeric, dimeric, and 
tetrameric forms of BslA are indeed found in WT biofilms (Figure 4.13A). When either of the two 
cysteine residues of the C-terminus was mutated to an alanine (“CxA” or “AxC”), dimerization, 
but not tetramerization, of BslA was retained. When both cysteine residues were abolished 
(“AxA”), only monomeric BslA was detected. As expected, the ∆bslA deletion mutant showed no 
BslA in any form. When DTT, a reducing agent that would break disulfide bonds, was added 
during protein purification, only monomeric BslA was observed in all strains (Figure 4.13B). 
Together, these results indicate that dimerization and tetramerization of BslA are dependent on 
disulfide bonds formed between the CxC motifs of BslA.  
Figure 4.13. BslA is a bifunctional protein. Western blot analysis of BslA in a native (A) and 
reduced (B) state using proteins extracted from biofilms. (C) Architecture and hydrophobicity of 
various BslA mutant biofilms. For panels (A), (B), and (C), strains used were WT (NCIB3610), 
bslA– (NRS2097), CxC (NRS2299), AxC (NR5177, CxA (NRS5178), AxA (NRS5179), ∆Cterm 
(NRS2957). (D) Architecture and hydrophobicity of the ∆bdbA∆bdbCD biofilm. For all panels, 
under each biofilm is an image of a water droplet on the upper surface of the biofilm, illustrating 
surface hydrophobicity.
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 We next investigated the physiological contribution of disulfide bonds in B. subtilis biofilm 
development. While the AxA mutant was unable to oligomerize BslA, it was able to form 
architecturally complex biofilms similar to those formed by the WT (Figure 4.13C). However, the 
surface of the AxA biofilms were hydrophilic (Figure 4.13C), suggesting that monomeric BslA 
contributes to the formation of complex biofilm structures but not surface hydrophobicity. The 
AxC and CxA mutants, in which tetrameric BslA was not detected, formed complex biofilms 
whose surfaces were hydrophobic (Figure 4.13C), indicating that tetramerization is not required 
for surface hydrophobicity. These results indicated that at least dimerization is required for the 
production of the hydrophobic coat. 
 Because dimerization of BslA is likely mediated by the formation of disulfide bonds, we 
then explored the mechanisms of disulfide bond formation in B. subtilis. Disulfide bond 
formation, which can be spontaneous in the presence of O2 (Bardwell 2002), is catalyzed by 
thiol-disulfide oxidoreductases. In B. subtilis, disulfide bond formation is carried out by two such 
enzymes, BdbA and BdbD. If these enzymes mediate disulfide bond formation, deleting them 
should result in structured biofilms with a hydrophilic surface. To test this, we generated a 
deletion mutant lacking the genes encoding both of these enzymes, ∆bdbA∆bdbCD (bdbD is 
encoded in an operon with bdbC). ∆bdbA∆bdbCD produced biofilms whose surfaces were more 
hydrophilic than that of WT but not to the same degree as the ∆bslA mutant (Figure 4.13D). 
This result suggests that there may either be (1) a redundant, yet-undiscovered mechanism of 
active disulfide bond formation in B. subtilis or (2) spontaneous, in conjunction with TDOR-
mediated, disulfide bond formation occurring that contributes to BslA dimerization. This in turn 
would lead to the presence of the hydrophobic coat on the biofilm surface. 
 To test if the conditions within the biofilm are amenable to spontaneous disulfide bond 
formation at the surface of the biofilm, we measured O2 concentrations throughout the depth of 
WT B. subtilis biofilms. We observed a steep O2 gradient within the biofilm, with no detectable 
O2 after ~ 50µm into the biofilm (Figure 4.14). The presence of O2 at the top of the biofilm is in 
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agreement with the hypothesis that spontaneous disulfide bond formation could be contributing 
to BslA dimerization. 
 In P. aeruginosa biofilms, O2 depletion correlates with a more reduced extracellular state 
in the deeper portions of the biofilm relative to the top (Jo et al. 2017). To confirm that the same 
is true in B. subtilis biofilms, we then measured extracellular redox state using a redox 
microelectrode and found that the upper portions of the biofilm were more oxidized relative to 
the bottom (Figure 4.14). Together with the O2 data, which show that the bottom of the biofilm is 
anoxic, the redox profiling results indicate that there is a lack of electron acceptors in this region, 
leading to a more reduced environment.  
 As shown previously, a reduced environment abolishes BslA dimerization and 
tetramerization (Figure 4.13B), so it is likely that BslA exists in its monomeric form in the lower 
biofilm. This would mean that the bottom of the biofilm would be hydrophilic rather than 
hydrophobic. We tested this by flooding the agar on which a mature WT biofilm had developed 
with pigmented water. We saw that, rather than being pushed back by a hydrophobic layer, the 
dye moved outward-in under the biofilm (Figure 4.15). Furthermore, when a mature biofilm was 
turned upside-down, a hydrophilic surface was revealed. Therefore, we concluded that BslA 
only forms a hydrophobic coat at the biofilm-air interface while the bottom remains hydrophilic, 
Figure 4.14. Quantification of chemical gradients 
formed in a B. subtilis biofilm. Measurement of the 
oxygen concentration (µM) and redox potential (mV) 
as a function of the depth of a three-day-old WT 
biofilm, with 0 mV being set at the biofilm surface.
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thus explaining how B. subtilis biofilms access nutrients in the presence of a hydrophobic BslA 
layer. 
 While it is thought that hydrophobic coat formation protects B. subtilis biofilms from 
environmental stressors such as antimicrobial agents, this had not been directly tested. 
Because we were able to genetically separate the mechanisms of biofilm architectural 
complexity (sufficiently mediated by presence of monomeric BslA) and hydrophobic coat 
formation (via disulfide bonding and dimeric BslA), we were able to elucidate which feature is 
necessary for protection against external assault. To do this, we used three strains: WT, which 
forms structured biofilms with a hydrophobic coat, ∆bslA, which forms featureless, hydrophilic 
biofilms and the AxA mutant, which forms structured, hydrophilic biofilms. Previous studies have 
shown that the BslA coat prevents certain biocides from entering B. subtilis biofilms (Epstein et 
al. 2011). One of the common active ingredients in these biocides is the antiseptic chlorhexidine 
gluconate (CHG), which we used to test whether hydrophobicity or structural complexity (or 
both) was required to protect the biofilm.  
 We exposed biofilms to this reagent by placing a 5 µl droplet of 1% CHG onto a mature 
biofilm. We confirmed that the surface of WT biofilms was hydrophobic to 1% CHG and that the 
surface of both ∆bslA and AxA were hydrophilic (Figure 4.16A). We then measured cell survival 
after a five-minute exposure to 1% CHG relative to that after a five-minute saline exposure. WT 
biofilms saw a ~ 75% survival rate after exposure to CHG (Figure 4.16B). In contrast, we saw 
that ∆bslA biofilms had a nearly 0% survival rate after exposure to CHG, the equivalent of a ~ 
38-fold decrease in surviving cells relative to the WT. The AxA mutant, which morphologically 
Figure 4.15. The biofilm surface at the biofilm-agar interface is hydrophilic. Time 
course of water uptake by a mature biofilm visualized by using pigmented water: before 
treatment (0 min), 2 min after exposure; and 15 min after exposure. At 15 min, 5-µL 
colored water droplets demonstrate retention of upper biofilm hydrophobicity.
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resembles the WT, also had a drastic decrease in survival (~ 15%), indicating that architectural 
complexity, while affording limited protection, is not sufficient for WT levels of survival against 
CHG. Taken together, these data suggest that the hydrophobic coat formed by dimeric BslA is 
mainly responsible for protecting cells growing in biofilms. 
 The results from this study expand our knowledge of how O2 contributes to biofilm 
formation. As I and others from our lab have shown, O2 plays a critical role in driving 
morphological and gene expression changes in P. aeruginosa biofilms (Dietrich et al. 2013; 
Okegbe, Price-Whelan, and Dietrich 2014; Jo et al. 2017). Similarly, the presence of O2 at the 
top of a B. subtilis biofilm allows for dimerization of BslA, thus allowing for the formation of a 
protective hydrophobic coat at the surface of the biofilm.  
 Hydrophobic coat formation may also play a larger role than protecting just resident B. 
subtilis biofilm cells. In nature, B. subtilis often forms populated communities in the upper layers 
of the soil. Here, it forms mutualistic relationships with plant rhizospheres, preemptively 
colonizing plant roots thereby protecting plants from pathogenic bacterial colonization while 
taking advantage of the nutrients released by the plant roots (Arnaouteli et al. 2017). For 
example, B. subtilis colonization and biofilm formation in the roots of Arabidopsis thaliana have 
been shown to protect the plant from infection by a competing, pathogenic bacterium, P. 
syringae (Bais, Fall, and Vivanco 2004). It is possible that the hydrophobic coats of B. subtilis 
biofilms could extend their protective capabilities to offer limited protection to their host from 
potentially harmful compounds it may encounter. 
Figure 4.16. Cell survival after 
exposure to chlorhexidine gluconate. 
(A) An image of a 1% (vol/vol) 
chlorhexidine gluconate droplet on the 
upper surface of the biofilm for strain WT 
(NRS5132), bslA– mutant (NRS5131), 
and the bslA– mutant complemented 
with BslAC178A C180A (AxA; NRS5136). (B) 
The strains described above were 
exposed to 1% (vol/vol) chlorhexidine 











4.5: Concluding remarks 
 Together, the research presented in this chapter convey the eclectic mechanisms used 
by bacteria to maintain redox homeostasis and an efficient metabolism regardless of external 
environment. The work described in sections 4.1-4.3 add further evidence of P. aeruginosa’s 
astounding metabolic versatility, which renders it a formidable pathogen in clinical settings. The 
more we understand about this bacterium’s fundamental pathways of energy generation and 
survival, the better equipped we will be at eradicating infections caused by it. The research 
presented in section 4.4 demonstrates how bacteria can use a principle as foundational as 
redox state to coordinate complex, multicellular behaviors and illustrates how common this 
principle is in driving biofilm formation across genera. 
4.6: Materials and methods 
4.6.1: Methods pertaining to section 4.1  
Bacterial strains and growth conditions 
 Unless otherwise indicated, P. aeruginosa strain UCBPP-PA14 and mutants thereof were 
routinely grown in lysogeny broth (LB; 1% tryptone, 1% NaCl, 0.5% yeast extract) (Bertani, 
2004) at 37˚C with shaking at 250 rpm. Overnight cultures were grown for 16 ± 1 h. For genetic 
manipulation, strains were typically grown on LB solidified with 1.5% agar. Strains used in this 
study are listed in Table 4.1. In general, liquid precultures served as inocula for experiments. 
Overnight precultures for biological replicates were started from separate clonal colonies on 
streak plates.  
Construction of mutant P. aeruginosa strains 
 For making markerless deletion mutants in P. aeruginosa PA14 (Table 1), 1-kb flanking 
sequences from each side of the target gene were amplified using the primers listed in Table 
4.2 and inserted into the allelic-replacement vector pMQ30 through gap repair cloning in 
Saccharomyces cerevisiae InvSc1 (Shanks et al., 2006). Each plasmid listed in Table 1 was 
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transformed into Escherichia coli strain UQ950, verified by sequencing, and moved into PA14 
using biparental conjugation. PA14 single recombinants were selected on LB agar plates 
containing 100 µg/ml gentamicin. Double recombinants (markerless deletions) were selected on 
sucrose plates (1% tryptone, 0.5% yeast extract, 10% sucrose, and 1.5% agar). Genotypes of 
deletion mutants were verified by PCR. Combinatorial mutants were constructed by using single 
mutants as parent strains. 
Construction of GFP reporter strains 
 Transcriptional reporter constructs for the genes gacS, lldP, and lldA were made by 
fusing their promoter sequences with gfp using primers listed in Table 2. Respective primers 
were used to amplify promoter regions (as indicated in Table 1) and to add an SpeI digest site to 
the 5’ end of the promoter and an XhoI digest site to its 3’ end. For the reporter, an EcoRI site 
was used instead of XhoI. Purified PCR products were digested and ligated into the multiple 
cloning site (MCS) upstream of the gfp sequence of pLD2722, which is a derivative of pYL122 
(Lequette and Greenberg, 2005) and contains a ribosome-binding site between the MCS and 
gfp. Plasmids were transformed into E. coli strain UQ950, verified by sequencing, and moved 
into PA14 using biparental conjugation. Conjugative transfer of pLD2722 was conducted with 
the E. coli strain S17-1 (Lequette and Greenberg, 2005). PA14 single recombinants were 
selected on M9 minimal medium agar plates (47.8 mM Na2HPO4, 22 mM KH2PO4, 8.6 mM 
NaCl, 18.6 mM NH4Cl, 1 mM MgSO4, 0.1 mM CaCl2, 20 mM sodium citrate dihydrate, 1.5% 
agar) containing 70 µg/ml gentamicin. The plasmid backbone of pLD2722 was resolved from 
PA14 using Flp-Flp recombination target (FRT) recombination by introduction of the pFLP2 
plasmid (Hoang et al., 1998) and selected on M9 minimal medium agar plates containing 300 
µg/ml carbenicillin and further on sucrose plates (1% tryptone, 0.5% yeast extract, 10% sucrose, 
1.5% agar). The presence of gfp in the final clones was confirmed by PCR. 
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Liquid-culture growth assays 
 Overnight (16-h) precultures were diluted 1:100 in a clear-bottom, 
polystyrene black 96-well plate (VWR 82050-756), with each well containing 200 µl of medium. 
Cultures were then incubated at 37˚C with continuous shaking at medium speed in a BioTek 
Synergy 4 plate reader. Reporter strains were grown in MOPS medium (50 mM MOPS, 43 mM 
NaCl, 93 mM NH4Cl, 2.2 mM KH2PO4, 1 mM MgSO4, 1g/ml FeSO4 at pH 7.0) amended with one 
of the following carbon sources: 20 mM D-glucose, 40 mM L-lactate, or 40 mM D-lactate 
(Sigma-Aldrich). Expression of GFP was assessed by taking fluorescence readings at excitation 
and emission wavelengths of 480 nm and 510 nm, respectively, every 30 min for up to 24 h. 
Growth was assessed by taking readings of optical density at 500 nm simultaneously with the 
fluorescence readings.  
Colony growth assays 
 Overnight (16-h) precultures were diluted 1:10 in phosphate-buffered saline (PBS). Five 
microliters of diluted cultures was spotted onto MOPS medium amended with one of the 
following carbon sources: 20 mM D-glucose, 40 mM L-lactate, or 40 mM D-lactate (Sigma-
Aldrich). The culture medium was then solidified with 1% agar (Teknova). Colonies were 
incubated at 25˚C for up to 4 days and imaged with an Epson Expression 11000XL scanner.  
Preparation of synthetic SCFM and derivatives 
 Cystic fibrosis sputum medium (SCFM) was prepared as described previously (Palmer 
et al., 2007). SCFM contains the following ingredients: 2.28 mM NH4Cl, 14.94 mM KCl, 51.85 
mM NaCl, 10 mM MOPS, 1.3 mM NaH2PO4, 1.25 mM Na2HPO4, 0.348 mM KNO3, 0.271 mM 
K2SO4, 1.754 mM CaCl2, 0.606 mM MgCl2, 0.0036 mM FeSO4, 3mM D-glucose, 9.3 mM sodium 
L-lactate, 0.827 mM L-aspartate, 1.072 mM L-threonine, 1.446 mM L-serine, 1.549 mM L-
glutamate•HCl, 1.661 mM L-proline, 1.203 mM glycine, 1.78 mM L-alanine, 0.16 mM L-
cysteine•HCl, 1.117 mM L-valine, 0.633 mM L-methionine, 1.12 mM L-isoleucine, 1.609 mM L-
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leucine, 0.802 mM L-tyrosine, 0.53 mM L-phenylalanine, 0.676 mM L-ornithine•HCl, 2.128 mM 
L-lysine•HCl, 0.519 mM L-histidine•HCl, 0.013 mM L-tryptophan, and 0.306 mM L-arginine•HCl. 
Depending on the solubility of the various salts, concentrations of their stock solutions ranged 
from 0.2 M to 1 M. Stock concentrations for D-glucose and sodium L-lactate were 1 M and 0.1 
M for amino acids. No stock solution was prepared for L-tyrosine or L-tryptophan due to poor 
solubility. The pH of SCFM was adjusted to 6.5 with KOH and sterilized by filtration (Thermo 
Scientific Nalgene Rapid-Flow). ASMDM was prepared as previously described (Fung et al., 
2010) by supplementing SCFM with 10 mg/ml bovine serum albumin, 10 mg/ml mucin from 
porcine stomach, and 1.4 mg/ml herring sperm DNA. SCFM2 was prepared by supplementing 
SCFM with 5 mg/ml mucin from porcine stomach, 100 µg/ml 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC), 300 µM N-acetyl-D-glucosamine, 600 µg/ml herring sperm DNA as 
previously described (Turner et al., 2015). 
4.6.2: Methods pertaining to section 4.2  
Protein expression and purification 
 The ⍺ and β subunits for PC from several bacterial species, including M. flagellatus, P. 
aeruginosa, P. fluorescens and Thiobacillus denitrificans were amplified from genomic DNA 
(American Type Culture Collection) and sub-cloned into the pCDFduet vector (Novagen). The ⍺ 
subunit was sub-cloned into MCS1 with an N-terminal hexa-histidine tag, and the β subunit was 
sub-cloned into MCS2 with no tag. The internal B-domain deletion was made using overlapping 
PCR. Surface entropy reduction mutations were chosen based on the UCLA SerP server 
(Goldschmidt et al., 2007). The individual ⍺ and β subunits for MfPC were sub-cloned into 
pET28a with an N-terminal hexa-histidine tag. All expression constructs were co-transformed 
into BL21 Star (DE3) cells along with a plasmid encoding the E. coli biotin ligase (BirA) gene. 
The cells were cultured in Luria–Bertani (LB) medium with 50 mg/ml streptomycin and 35 mg/ml 
chloramphenicol, and were induced for 14 h with 1mM isopropyl-β-D-thiogalactoside at 20˚C. 
Before induction, 20 mg/L biotin and 10mM MnCl2 were added to the growth medium. The 
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protein was purified through nickel-agarose affinity chromatography (Qiagen) followed by gel 
filtration chromatography (Sephacryl S-300, GE Healthcare). The purified protein was 
concentrated to 15 mg/ml in a buffer containing 20 mM Tris (pH 8.0), 150 mM NaCl, 5% (v/v) 
glycerol and 5 mM dithiothreitol, flash-frozen in liquid nitrogen and stored at -80˚C. The protein 
was confirmed to be fully biotinylated by a streptavidin gel-shift assay. The N-terminal hexa-
histidine tag was not removed for crystallization. 
Protein crystallization 
 Crystals were grown by the sitting-drop vapour diffusion method at 20˚C. For MfPC with 
B-domain deletion, the protein was incubated with 2.5 mM pyruvate for 30 min at 4 C before 
crystallization set-up. The reservoir solution contained 19% (w/v) PEG3350, 2% tacsimate (pH 
6.0) (Hampton) and 3% (v/v) ethanol. The crystals appeared within 1 week and grew to full size 
after an additional week. The crystals were cryo-protected in the reservoir solution 
supplemented with 10% (v/v) ethylene glycol and 5% (w/v) sucrose and were flash-frozen in 
liquid nitrogen for data collection at 100 K. For wild-type MfPC, the protein at 15 mg/ml was 
incubated with 2.5 mM ATP and 2.5 mM pyruvate for 30 min at 4˚C before crystallization set-up. 
The reservoir solution contained 1.3 M ammonium sulfate and 0.1 M sodium citrate (pH 6.0). 
The crystals appeared after 1 day and grew to full size within a week. They were cryo-protected 
in the reservoir solution supplemented with 15% (v/v) ethylene glycol and flash-frozen in liquid 
nitrogen for data collection at 100 K 
Data collection and structure determination 
 X-ray diffraction data were collected at the Advanced Photon Source beamline NE-CAT 
24-ID-E using an ADSC Q315r detector and at the X25 beamline at the National Synchrotron 
Light Source at Brookhaven National Laboratory using a Pilatus 6M detector. The diffraction 
images were processed using HKL2000 (Otwinowski and Minor, 1997). Crystals of the mutant 
MfPC belong to space group R32 with unit cell parameters of a = b = 285.8 Å and c = 274.9 Å. 
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With an ⍺2β4 oligomer in the asymmetric unit, the Vm is 2.9 Å3 Da–1 and the solvent content is 
58%. The structure was solved by the molecular replacement method with the programme 
Phaser (McCoy et al., 2007), using the BC, CT and BCCP domains of the S. aureus PC 
structure (Xiang and Tong, 2008) as the search models. Manual rebuilding was carried out with 
Coot (Emsley and Cowtan, 2004) and refinement with the programme Refmac (Murshudov et 
al., 1997).  
 Crystals of wild-type MfPC belong to space group P3121 with unit cell parameters of a = 
b = 160.8 Å and c = 227.7 Å. A molecular replacement solution for this structure was found with 
the programme Phaser using the individual BC and CT domains of the refined mutant MfPC 
structure as the search models. There is one ⍺ subunit and two β subunits in the asymmetric 
unit, and the full ⍺2β4 complex can be generated by a crystallographic two-fold axis. On the 
basis of this molecular replacement solution, the solvent content of the crystal is 73% and the 
Matthews coefficient is 4.6Å3 Da–1. After one round of refinement, electron density was 
observed indicating the positions of the B domain of BC and the BT-like domain. There was also 
density indicating a BCCP domain in the active site of the distal CT domain, which itself adopts 
a conformation that is consistent with an interaction with BCCP. In addition, the MfPC molecules 
in the crystal do not have direct contacts without this BCCP domain, further supporting its 
placement in the model. After inclusion of these additional domains, we observed a decrease in 
the R values and clear density for these domains on refinement. 
Construction of PC mutant and complementation strains 
 PC mutant and complementation strains were made for the two-gene operon encoding 
PC (PA14_71720-PA14_71740) in P. aeruginosa PA14 as follows. Relevant genomic sequences 
were amplified, with point mutations introduced where noted in Table 4.3, and recombined into 
the allelic replacement vector pMQ30 through gap repair cloning in the Saccharomyces 
cerevisiae strain InvSc1. The deletion construct contained two fused ~ 1-kb sequences 
representing regions upstream and downstream of the PA14_71720-PA14_71740 operon. Point 
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mutant and complementation constructs contained the full operon sequence, with mutations 
where appropriate, plus these two flanking regions. Each plasmid was transformed into E. coli 
strain DH5⍺, verified by sequencing, and put into P. aeruginosa using biparental conjugation. 
PA14 single recombinants were selected on LB plates containing 100 µg/ml gentamicin. Double 
recombinants (with the final genotype of interest) were selected on agar plates containing 10% 
(w/v) sucrose, and their genotypes were confirmed by PCR. For point mutant strains, genotypes 
were confirmed by sequencing. 
P. aeruginosa PA14 growth conditions 
 For genetic manipulation and pre-culturing, PA14 was routinely grown in LB (unless 
otherwise noted) at 37˚C with shaking at 250 rpm. For growth curve analyses, overnight pre-
cultures of PA14 strains were diluted 100-fold in either 1% tryptone or a defined medium (50 
mM MOPS (4-morpholinepropanesulfonic acid), 43 mM NaCl, 93.5 mM NH4Cl, 2.2 mM KH2PO4, 
1 mM MgSO4 and 1 µg/ml FeSO4) amended with 20 mM sodium succinate, sodium pyruvate, or 
glucose as the carbon source and grown to the following approximate OD500nm values: 0.6 for 
succinate; 0.1 for pyruvate; and 0.1 for glucose. These cultures were diluted to OD500nm ~ 0.01 
and dispensed into 96-well plates, then incubated at 37˚C with continuous shaking on the 
medium setting in a Biotek Synergy 4 plate reader.  
P. aeruginosa PA14 colony morphology assay 
 For the standard assay, PA14 was grown overnight in LB and diluted to OD500nm = 0.5. A 
volume of 10 µl of these normalized cell suspensions were spotted on colony morphology assay 
medium (1% tryptone, 1% agar, 40 µg/m Congo red and 20 µg/ml Coomassie blue; 60 ml in 
each 9 cm x 9 cm square plate) and incubated in a humidified chamber at 25˚C for up to 5 days. 
When defined media were used for the colony morphology assay, PA14 pre-cultures were 
grown overnight in MOPS liquid medium with 20mM succinate. Pre-cultures were centrifuged for 
1 min at 12, 396 x g and resuspended in defined medium without a carbon source to OD500nm = 
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0.25. A volume of 10 µl of washed and resuspended cells was spotted onto solidified defined 
medium (25 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 7.6 mM 
(NH4)2SO4, 0.8 mM MgSO4•7H2O, 10 mM K2HPO4, 20 mM of carbon source (succinate, 
pyruvate or glucose), 40 µg/ml Congo red, 20 µg/ml Coomassie blue and 1% agar; 60 ml in 
each 9 cm x 9 cm square plate) and incubated in a humidified chamber at 25˚C for up to 5 days. 
Images were taken with a CanoScan 5600F scanner (Canon). 
P. aeruginosa PA14 Congo red binding assay 
 PA14 colonies were grown for 3 days (76 h) according to the standard colony 
morphology assay, with the modification that dyes were omitted from the 1% tryptone, 1% agar 
medium. Each colony was scraped from the agar using a 1-ml pipette tip and resuspended in 
1.5 ml phosphate-buffered saline (136 mM NaCl, 2.68 mM KCl, 10.1 mM Na2HPO4, 1.76 mM 
KH2PO4 at pH 7.4) supplemented with 60 µg of Congo red. Each colony suspension was briefly 
vortexed and shaken at 250 rpm at 37˚C for 1 h to allow the matrix to bind the Congo red dye. 
The colony biomass was then pelleted by centrifugation at 16,873 x g for 2 min. A volume of 200 
µl of supernatant was dispensed into 96-well plates and the absorbance at 490 nm, 
representing unbound Congo red, was measured using a Biotek Synergy 4 plate reader. Bound 
Congo red was calculated by subtracting the absorbance of the unbound Congo red from that of 
the control solution containing 60 µg Congo red per 1.5 ml PBS.  
P. aeruginosa PA14 pellicle assay 
 Overnight LB pre-cultures of PA14 strains were diluted 100-fold in MOPS liquid medium 
amended with 20 mM sodium succinate as the carbon source and grown to OD500nm ~ 0.7. A 
sample (4.6 ml) of each subculture was centrifuged at 10,000 x g for 1 min, and the pellet was 
resuspended in 23 ml of the defined medium amended with 20 mM sodium succinate, D-
glucose, or sodium pyruvate in a scintillation vial, with a starting OD500nm at 0.14 for pellicle 
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growth. Scintillation vials were incubated without shaking or disturbance at 37˚C for up to 4 days 
and photographed under side illumination using an iPhone 5S.  
Data availability 
 Atomic coordinates and structure factors for the two reported structures of M. flagellatus 
PC have been deposited in the Protein Data Bank under the primary accession code 5KS8. The 
authors declare that all other relevant data supporting the findings of this study are available on 
request. 
4.6.3: Methods pertaining to section 4.3  
Protein expression and purification 
 Full-length LCCs from several different bacterial organisms, including R. palustris, M. 
avium subspecies paratuberculosis and P. aeruginosa, were amplified from genomic DNA by 
PCR and cloned into pET28a, pET26b and/or pET24d vectors (Novagen). The plasmids were 
transformed into BL21Star (DE3) cells (Invitrogen). Protein expression was induced with the 
addition of 1 mM isopropyl β-D-thiogalactoside, and the cells were grown at 16˚C for 16–20 h. 
To facilitate biotinylation, the recombinant enzyme was co-expressed with the E. coli biotin 
ligase BirA, and 15 mg/l biotin was added to the medium. An avidin shift assay of the purified 
enzymes showed that R. palustris LCC was completely biotinylated. However, purified MapLCC 
did not show any biotinylation, possibly indicating some degree of selectivity of the BirA enzyme. 
Expression of P. aeruginosa LCC did not produce any soluble protein and was not pursued 
further.  
 Cells were lysed by sonication in a buffer containing 20 mM Tris-HCl pH8.0, 250 mM 
NaCl, 5% (v/v) glycerol, 10 mM 2-mercaptoethanol, and 1 mM phenylmethylsulphonyl fluoride. 
Soluble enzyme was purified by Ni2+-nitrilotriacetate (Qiagen), anion-exchange and gel-filtration 
(Sephacryl S-300; GE Healthcare) chromatography. The S-300 running buffer for MapLCC 
contained 25 mM HEPES pH 7.4, 250 mM NaCl and 2.5 mM dithiothreitol. The purified protein 
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was concentrated to 6 mg/ml, and the solution was supplemented with 5% (v/v) glycerol before 
being flash-frozen in liquid nitrogen and stored at -80˚C. The selenomethionyl MapLCC protein 
was produced in B834 (DE3) cells (Novagen) that were grown in defined LeMaster medium 
supplemented with selenomethionine (Hendrickson et al., 1990). The protein was purified with 
the same protocol as that for the native enzyme. 
Protein crystallization 
 MapLCC was crystallized at 4˚C using the microbatch method under paraffin oil. The 
protein solution was mixed with a precipitant solution containing 0.1 M Bis-Tris propane pH 7.5–
8.5 and 1.5–2.0 M ammonium sulphate. Crystals took 4–6 weeks to grow to full size, and larger 
crystals were obtained by microseeding. They were cryoprotected with reservoir solution 
supplemented with 12–15% (v/v) glycerol and flash-frozen in liquid nitrogen for data collection at 
100 K. The C-terminal His tag on the protein was not removed before crystallization.  
Data collection and structure determination 
 X-ray diffraction data for the native (wavelength 1.075 Å) and selenomethionyl (0.979 Å) 
crystals were collected with a Q315 charge-coupled device (Area Detector Systems 
Corporation) at the X29A beamline of the National Synchrotron Light Source. The diffraction 
images were processed with the HKL package (Otwinowski and Minor, 1997). The crystals 
belong to space group P213, with cell dimensions of a = b = c = 220.9 Å. There are two 
MapLCC monomers in the crystallographic asymmetric unit.  
 The structure of MapLCC was solved by a combination of molecular replacement and 
selenomethionyl SAD phasing. The orientation and position of the BC, CT and BCCP domains 
were located with the program Phaser (McCoy et al., 2007). The Se sites were located with the 
program SHELX (Sheldrick, 2008), and SOLVE/RESOLVE was used for phasing the reflections 
and automated model building (Terwilliger, 2003). The atomic model was built with the program 
Coot (Emsley and Cowtan, 2004). The structure refinement was performed with the program 
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CNS (Brunger et al., 1998). The crystallographic information is summarized in Table 4.4. We 
also obtained a second crystal form of MapLCC, with an entire hexamer in the asymmetric unit, 
and were able to collect an X-ray diffraction data set to 4.3 Å resolution (space group P212121, a 
= 102Å, b = 292 Å, c = 314Å). The structure of this crystal form was readily solved by the 
molecular replacement method, and it revealed essentially the same holoenzyme architecture 
(data not shown). 
Enzymatic assays 
 The kinetic assays monitored the hydrolysis of ATP by R. palustris LCC in the presence 
of various acyl-CoA substrates, using coupling enzymes to convert the ADP product to NADH 
oxidation (Blanchard et al., 1999). The reaction mixture contained 100 mM HEPES pH7.5, 40 
mM KHCO3, 1.5 mM ATP, 0.4 mM NADH, 200 mM KCl, 10 mM MgCl2, 0.5 mM 
phosphoenolpyruvate, 3.5/3.7U of lactate dehydrogenase/pyruvate kinase (Sigma), 0.25 µM 
enzyme (except for MCC, which was at 1.2 µM) and various concentrations of acyl-CoA. The 
absorbance at 340 nm was monitored for 1.5 min. The initial velocities were fitted to the 
Michaelis–Menten equation using the program Origin (OriginLab). 
Construction of an LCC deletion mutant in P. aeruginosa 
 A markerless deletion was generated for the gene PA14_46320 in P. aeruginosa PA14, 
using previously described methods (Recinos et al., 2012). In brief, ~ 1-kilobase flanking 
regions for PA14_46320 were amplified with primers listed in Table 4.5 and recombined into the 
allelic-replacement vector pMQ30 through gap repair cloning in the yeast strain InvSc1 (Shanks 
et al., 2006). This plasmid was transformed into E. coli BW29427 and moved into PA14 using 
biparental conjugation. Luria–Bertani (LB) agar containing 100 µg/ml gentamicin was used to 
select for P. aeruginosa single recombinants. Markerless deletions in PA14_46320 (double 
recombinants) were then selected with the use of LB agar plates devoid of NaCl and containing 
10% (w/v) sucrose as a counterselection, and their genotypes were confirmed by PCR.  
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Phenotype microarrays 
 Phenotype microarray screening was performed by Biolog, Inc., as described (Shea et 
al., 2012). 
4.6.4: Methods pertaining to section 4.4 
General growth conditions and strain construction 
The B. subtilis and E. coli strains used and constructed in this study are detailed in Table 4.6. E. 
coli strain MC1061 was used for the construction and maintenance of plasmids. B. subtilis 168 
derivatives were obtained by transformation of competent cells with plasmids using standard 
protocols (Harwood and Cutting, 1990). SPP1 phage transductions were used to introduce DNA 
into B. subtilis strain NCIB3610 (Verhamme et al., 2007). Both E. coli and B. subtilis strains 
were routinely grown in Lysogeny Broth (LB) medium (10 g of NaCl, 5 g of yeast extract, and 10 
g of tryptone per liter) at 37 °C for 16 h. For complex colony formation, B. subtilis strains were 
grown on MSgg medium (5 mM potassium phosphate and 100 mM MOPS at pH 7.0 
supplemented with 2 mM MgCl2, 700 µM CaCl2, 50 µM MnCl2, 50 µM FeCl3, 1 µM ZnCl2, 2 µM 
thiamine, 0.5% glycerol, and 0.5% glutamate) (Branda et al., 2001) solidified with 1.5% Select 
Agar (Invitrogen) at 30°C for 48 h (Branda et al., 2001) and imaged as described (Verhamme et 
al., 2007). Ectopic gene expression was induced by medium supplementation with 25 µM 
isopropyl β-D-1-thiogalactopyranoside (IPTG) as indicated. When appropriate, antibiotics were 
used at the following concentrations: ampicillin 100 µg/ml, chloramphenicol 5 µg/ml , 
erythromycin 1 µg/ml with lincomycin 25 µg/ml, kanamycin 25 µg/ml, and spectinomycin 100 µg/
ml. ΔbdbA, ΔbdbCD, and ΔbdbACD mutant strains were constructed as described in Table 4.6 
by using standard methodologies.  
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Plasmid construction and site-directed mutagenesis 
 All strains, plasmids, and primers used in this study are presented in Tables 4.6, 4.7, 
and 4.8 and were constructed by using standard methods. The plasmids for BslA42–181 
overproduction were obtained by site directed mutagenesis using the plasmid pNW1128 as 
template, which is a pGEX-6P-1 derivative used previously to overexpress BslA42–181 (Hobley et 
al., 2013). Primers for the codon substitutions are included in Table 8, and mutagenesis was 
achieved following the Stratagene QuikChange kit recommendations. 
Protein purification 
 BslA41–181 protein and its derivatives were overexpressed and purified as described 
(Hobley et al., 2013). Briefly, the pGEX1–6P derivative plasmids were introduced into E. coli 
BL21 (DE3). After growth and overexpression, the protein was purified in HEPES buffer. To 
achieve this purification, the E. coli cells were lysed in an Emulsiflex cell disruptor, and the 
solubilized protein extracts, cleared of cell debris, were incubated with Glutathione Sepharose 
4B (GE Healthcare), allowing the fused protein to bind to the GST binding beads. After 
incubation, the beads containing the BslA-fusion were recovered by using a gravity flow column 
(Bio-Rad) and suspended into new buffer containing DTT and TEV–His-tagged protease. TEV 
removed the GST tag from BslA protein, which remained soluble in the purification buffer. The 
protease and unbound GST were then separated from BslA by incubating the mixture with 
Ninitrilotriacetic acid (Ni-NTA) agarose (Qiagen) and glutathione beads, followed by a new 
passage in a gravity flow column. The flow-through recovered contained the purified protein, 
which was then concentrated by using VivaSpin concentrator. Protein quality was confirmed by 
size exclusion chromatography analysis. 
Size exclusion chromatography (SEC 
 To evaluate the presence or absence of dimers in the purified proteins, 500 ng of purified 
protein was analyzed by SEC using a Superdex 75 10/300GL column with a low rate of 0.5 ml/
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min in the original purification buffer. Protein samples were also analyzed by using 14% SDS/
PAGE, with and without the addition of a reducing agent (β-mercaptoethanol) as the loading dye 
and stained with Instant Blue before photography. 
Oxidative cross-linking of cysteines in colony biofilms 
 B. subtilis 48-h grown complex colonies were collected from the agar plate by using a 
sterile loop and suspended in 250 µl of LB. The biomass was disrupted by passage through a 
23 x 1 needle 10 times. The cell suspension obtained was incubated for 15 min at 37°C with 1.8 
mM Cu(II)-(o-phenanthroline)3 (hereafter CuPhe) or 10 mM DTT, followed by centrifugation and 
wash of the pellet with 250 µl of PBS. After centrifugation, the pellet was suspended in 250 µl of 
PBS, followed by a 15 min incubation with 8 mM N-ethylmaleimide/10 mM EDTA to stop the 
reaction (Lee et al., 1995; Lee et al, 1994). Samples were then centrifuged, and the pellet was 
washed with 250 µl of PBS. The cell pellet was suspended in 250 µl of BugBuster Master Mix 
(Novagen), followed by gentle sonication to promote the release of the proteins from the biofilm 
matrix. The samples were then incubated at room temperature with agitation for 20 min, and the 
insoluble cell debris was removed by centrifugation at 17,000 x g for 10 min at 4°C. The proteins 
samples were then analyzed by Western blot.  
Western blot analysis 
 The 1.5 µg of total protein extract (see above) was separated on a 14% SDS/PAGE 
before transfer onto PVDF membrane (Millipore) by electroblotting at 25 V for 2 h. The 
membrane was incubated for 16 h in 3% (wt/vol) powdered milk in TBS [20 mM Tris·HCl (pH 
8.0) and 0.15 M NaCl] at 4°C with shaking. This step was followed by 2-h incubation with 
purified anti-BslA antibody at a dilution of 1:500 (vol/vol) in TBS in 3% powdered milk wash 
buffer (TBS + 0.05% Tween 20). The membrane was washed by using wash buffer (TBS + 
0.05% Tween 20) and incubated for 45 min with the secondary antibody conjugated to 
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horseradish peroxidize [goat anti-rabbit (Pierce)] at a dilution of 1:5,000. The membrane was 
washed, developed, and exposed to X-ray film. 
Oxygen profiling of biofilms 
 Overnight cultures of B. subtilis strain 3610 were inoculated from a streaked plate and 
subsequently grown in LB at 37°C with shaking at 250 rpm for 12–16 h. Precultures were diluted 
10-fold in LB and grown at 37°C with shaking at 250 rpm until OD600nm ~ 1.0. Five microliters 
of the culture were spotted onto an MSgg agar plate and grown at 30 °C for 2 d before analysis. 
A 25-µm-tip Clark-type oxygen microsensor (Unisense OX-25) was used to measure the oxygen 
concentrations. The oxygen microsensor was calibrated according to manufacturer’s 
instructions, and measurements were taken throughout the depth of the biofilm (step size = 5 
µm, measurement period = 3 s, wait time between measurements = 3 s). Four different colonies 
were probed, and representative data are shown.  
Redox profiling of biofilms 
 Biofilms were grown as described above, and a 25-µm-tip redox microelectrode with an 
external reference (Unisense RD-25 and REF-RM) was used to measure the extracellular redox 
potential. After calibrating the redox microelectrode according to the manufacturer’s instructions, 
redox measurements were taken throughout the depth of the biofilm (step size = 5 µm, 
measurement period = 3 s, wait time between measurements = 5 s). The redox potential was 
set to zero at the surface of the colony, and relative values are plotted. Three different colonies 
were probed, and representative data are shown. 
Cell survival upon chlorhexidine gluconate exposure 
 To test biofilm resistance to chlorhexidine gluconate, colony biofilms were grown for 48 h 
at 30°C. Droplets of 5 µl of 1% (vol/vol) chlorhexidine gluconate were placed on the biofilm 
surface (near the periphery) for 5 min at room temperature. The solution was removed, and a 
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punch biopsy of 5 mm in diameter was recovered (this area encompassed the entire exposed 
region). This sample was transferred immediately into 500 µl of saline solution, thus diluting any 
remaining chlorhexidine gluconate, disrupted by passage through a 23 × 1 needle 10 times and 
washed once with saline solution. The sample was subsequently subjected to mild sonication 
(20% amplitude, 1 s on, 1 s off, for 5 s total) to liberate bacterial cells from the matrix. Serial 
dilutions of the cell suspension were made, and 100 µl were plated onto LB agar supplemented 
with 100 µg/ml spectinomycin; saline solution was used as a control for the process. The 
percentage survival was evaluated by colony forming unit counting, and results are presented 
as the percentage of colony forming units obtained after exposure to 1% (vol/vol) chlorhexidine 
gluconate, divided by the number of colony forming units recovered on the control spots. 
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4.8: Tables 
Table 4.1: Strains and plasmids used in section 4.1 
strain/plasmid number description source or 
reference
Pseudomonas aeruginosa strains
UCBPP-PA14 Clinical isolate UCBPP-PA14. Rahme et al., 1995
PA14 ∆lldDE LD2735 PA14 with deletion in lldDE Lin et al., 2018
PA14 ∆lldA LD2844 PA14 with deletion in lldA Lin et al., 2018
PA14 ∆lldDE ∆lldA LD2759 PA14 with deletion in lldDE and lldA Lin et al., 2018
Table 4.1 (continued): Strains and plasmids used in section 4.1




LD2904 PA14 ∆ldDE ∆lldA with complementation of 
lldDE
Lin et al., 2018
PA14 attB::MCS-gfp LD2820 PA14 with MCS-gfp inserted at the attB site 
using pLD2722
Lin et al., 2018
PA14 attB::lldPp-gfp LD2798 PA14 with lldPp-gfp inserted at the attB site 
using pLD2797
Lin et al., 2018
PA14 attB::lldAp-gfp LD2868 PA14 with lldAp-gfp inserted at the attB site 
using pLD2867
Lin et al., 2018
Escherichia coli strains
UQ950 LD44 E. coli DH5 λpir strain for cloning. F-∆(argF-
lac)169φ80 dlacZ58(∆M15) glnV44(AS) rfbD1 
gyrA96(NaIR) recA1 endA1 spoT thi-1 hsdR17 
deoR λpir+
D. Lies, Caltech
BW29427 LD661 Donor strain for conjugation. thrB1004 pro thi 




S17-1 LD2901 StrR , TpR , F− RP4-2-Tc::Mu aphA::Tn7 recA 
λpir lysogen
Teng et al., 1998
Saccharomyces cerevisiae strains




pMQ30 LD621 Yeast-based allelic-exchange vector; sacB+ , CEN/ARSH, URA3+ , 
GmR
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Table 4.2: Primers used in section 4.1 
Table 4.1 (continued): Strains and plasmids used in section 4.1




ΔlldDE flanking fragments introduced into 
pMQ30 by gap repair cloning in yeast strain 
InvSc1
Lin et al., 2018
pLD2758 (pMQ30-
∆lldA)
ΔlldA flanking fragments introduced into 
pMQ30 by gap repair cloning in yeast strain 
InvSc1
Lin et al., 2018
pLD2903 (pMQ30-
lldDE-comp)
lldDE complementation flanking fragments 
introduced into pMQ30 by gap repair cloning in 
yeast strain InvSc1
Lin et al., 2018




pUC18-mini-Tn7 AmpR ColE1 replicon mini-Tn7 base vector Choi et al., 2005
pLD844 (pSEK101) rhlA promoter of pYL122 was removed (XhoI 
and EcoRI) and replaced with a multiple 
cloning site (MCS) from pUC18-mini-Tn7
Lin et al., 2018b
pLD2722 (pSEK103) aacC1 (gentamicin resistance cassette) from 
pMQ30 was inserted at the BspDI site of 
pLD844
Lin et al., 2018b
pLD2797 (pSEK103-
lldPp)
324 bp of lldP promoter sequence inserted at 
the MCS (SpeI and XhoI) of pLD2722
Lin et al., 2018
pLD2867 (pSEK103-
lldAp)
356 bp of lldA promoter sequence inserted at 
the MCS (SpeI and XhoI) of pLD2722
Lin et al., 2018
pFLP2 Site-specific excision vector with cI857-
controlled FLP recombinase; sacB+, AmpR
Hoang et al., 1998
primer number name sequence description
1087 attB::gfp-inCheck1 AGGGCCAATCGATAGAGTTT To verify the genotype 
of gfp reporter strains
1088 attB::gfp-inCheck2 TCTTCGTGATCTGAAGCCATT To verify the genotype 
of gfp reporter strains
1089 attB::gfp-outCheck1 TAGAAGAACAGGCGGACGAT To verify the genotype 
of gfp reporter strains
1090 attB::gfp-outCheck2 AGCATCATCGGTACCCAGTC To verify the genotype 




To make pLD2734 
(pMQ30-ΔlldDE) by gap 
repair cloning in yeast 
strain InvSc1
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Table 4.2 (continued): Primers used in section 4.1
primer number name sequence description
2089 ∆lldDE-yeast2 caccaggtagaccacccc 
GTAGTCGGTGGAAGCGGAAAT
To make pLD2734 
(pMQ30-ΔlldDE) by gap 
repair cloning in yeast 
strain InvSc1
2090 ∆lldDE-yeast3 atttccgcttccaccgactac 
GGGGTGGTCTACCTGGTG
To make pLD2734 
(pMQ30-ΔlldDE) by gap 




To make pLD2734 
(pMQ30-ΔlldDE) by gap 
repair cloning in yeast 
strain InvSc1
2092 ∆lldDE-check1 ACCCTGTTCCTCAAGGTCTG To verify the genotype 
of ∆lldDE strains
2093 ∆lldDE-check2 GTCGTGACGTAGGGCGAATA To verify the genotype 
of ∆lldDE strains
2094 ∆lldDE-check3 GCATGCTGGTGCACTGAC To verify the genotype 
of ∆lldDE strains





To make pLD2758 
(pMQ30-ΔlldA) by gap 
repair cloning in yeast 
strain InvSc1
2101 ∆lldA-yeast2 tatcgcgggtagcttcccgg 
GTCTTCGATATCGGTGATGACG
To make pLD2758 
(pMQ30-ΔlldA) by gap 
repair cloning in yeast 
strain InvSc1
2102 ∆lldA-yeast3 cgtcatcaccgatatcgaagac 
CCGGGAAGCTACCCGCGATA
To make pLD2758 
(pMQ30-ΔlldA) by gap 




To make pLD2758 
(pMQ30-ΔlldA) by gap 
repair cloning in yeast 
strain InvSc1
2104 ∆lldA-check1 GACGCGGTATCCCTGATCT To verify the genotype 
of ∆lldA strains
2105 ∆lldA-check2 ACCTGCTGGAAAGCTTCGAC To verify the genotype 
of ∆lldA strains
2106 ∆lldA-check3 GACTGAAACGGCGGAATTT To verify the genotype 
of ∆lldA strains
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Table 4.2 (continued): Primers used in section 4.1
primer number name sequence description

























To make pLD2903 
(pMQ30-lldDE-comp) by 
gap repair cloning in 
yeast strain InvSc1
2214 lldDE-comp-yeast2 ACGGTCTCGAGAAAGGGAAT To make pLD2903 
(pMQ30-lldDE-comp) by 
gap repair cloning in 
yeast strain InvSc2
2215 lldDE-comp-yeast3 CGCCAGAAAAGCCTGAAA To make pLD2903 
(pMQ30-lldDE-comp) by 
gap repair cloning in 
yeast strain InvSc3
2216 lldDE-comp-yeast4 CGGCCTTTTCCAGCAGAC To make pLD2903 
(pMQ30-lldDE-comp) by 
gap repair cloning in 
yeast strain InvSc4
2217 lldDE-comp-yeast5 GGCCACGGGTGGTCTATC To make pLD2903 
(pMQ30-lldDE-comp) by 




To make pLD2903 
(pMQ30-lldDE-comp) by 
gap repair cloning in 
yeast strain InvSc6
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Table 4.3: Primers used in section 4.2 





To make the in-frame 




gtctactccgaggccgatcAGGCGATGAAGATGGAAACC To make the in-frame 




ggtttccatcttcatcgcctGATCGGCCTCGGAGTAGAC To make the in-frame 






To make the in-frame 








































To make the K451stop point 






To make the K451stop point 






To make the K451stop point 






To make the K451stop point 
mutation in PA14_71740 (α 
subunit)
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Table 4.3 (continued): Primers used in section 4.2





To make the A55T point 






To make the A55T point 






To make the A55T point 






To make the A55T point 






To make the K572A point 






To make the K572A point 






To make the K572A point 






To make the K572A point 
mutation in PA14_71720 (β 
subunit)
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  a, b, c (Å) 220.9, 220.9, 220.9
  ⍺, β, ɣ ( ˚ ) 90, 90, 90
Resolution (Å) 50-3.0 (3.1-3.0)*
Rmerge 9.6 (44.6)
I/σI 10.3 (1.9)















Bond lengths (Å) 0.007
Bond angles ( ˚ ) 1.4
Two crystals were used for data collection
* the highest-resolution shell is shown in parenthesis
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Table 4.5. Primers used in section 4.3 
Table 4.6. Strains used in section 4.4 























To make the in-frame markerless 
deletion of PA14_46320
strain relevant genotype/description* source/construction†
Bacillus subtilis strains
NCIB3610 phototroph BGSC
NRS2097 NCIB3610 bslA::cml Verhamme et al., 2009
NRS2299 NCIB3610 bslA:: cml amyE::Phy-spank-bslA-lacI (spc) Verhamme et al., 2009
NRS5177 NCIB3610 bslA:: cml amyE::Phy-spank-bslAC178A-lacI 
(spc)
SPP1 NRS5165 → NRS2097
NRS5178 NCIB3610 bslA:: cml amyE::Phy-spank-bslAC180A-lacI 
(spc)
SPP1 NRS5166 → NRS2097
NRS5179 NCIB3610 bslA:: cml amyE::Phy-spank-bslA 
C178AC180A-lacI (spc)
SPP1 NRS5167 → NRS2097
NRS2957 NCIB3610 bslA:: cml amyE::Phy-spank-bslA Δ172–181-
lacI (spc)
SPP1 NRS2953 → NRS2097
NRS5553 NCIB3610 bdbCD::spc bdbA::erm SPP1 NRS5139→ NRS5552
NRS5132 NCIB3610 bslA::cml amyE-Pspac-hy-gfpmut2 (spc) 
sacA::PbslA-bslA (kan)
SSP1 NRS1113→ NRS2978
NRS5136 NCIB3610 bslA::cml amyE-Pspac-hy-gfpmut2 (spc) 
sacA::PbslA-bslA C178A C180A (kan)
SSP1 NRS5149→ NRS5131
Escherichia coli strains
MC1061 E. coli F’lacIQ lacZM15 Tn10 (tet) E. coli Genetic Stock Center
BL21 (DE3) F– ompT hsdSB(rB–, mB–) gal dcm (DE3) Studier and Moffatt, 1986
*Drug resistance cassettes are indicated as follows: cml, chloramphenicol resistance; kan, kanamycin 
resistance; mls, lincomycin and erythromycin resistance; and spc, spectinomycin resistance. BSGC 
represents the Bacillus genetic stock center.
†The direction of strain construction is indicated with DNA or phage (SPP1) (→) recipient strain.
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Table 4.7. Plasmids used in section 4.4 
plasmid description * source†
pDR111 B. subtilis amyE integration vector for IPTG-induced 
expression
Britton et al., 2002
pGEX-6P-1 Vector for production of GST-fused proteins GE Healthcare
pQE70 Cloning vector for His-tag fusions Qiagen
pET15b-TEV Vector for production of His tag-fused proteins Lab sources
pSac-Kan B. subtilis sacA integration vector Middleton et al., 2004
pNW1500 pDR111-bslAC178A this study
pNW1501 pDR111-bslAC180A this study
pNW1502 pDR111-bslAC178A C180A this study
pNW1128 pGEX-6P-1-TEV-bslA42–181 Hobley et al., 2013
pNW1503 pGEX-6P-1-TEV-bslA42–181 C178A this study
pNW1504 pGEX-6P-1-TEV-bslA42–181 C180A this study
pNW1505 pGEX-6P-1-TEV-bslA42–181 C178A C180A this study
pNW1510 pGEX-6P-1-TEV-bslA42–171 (Δ172–181) this study
pNW518 pSac-Kan-PbslA-bslA this study (coding region 
amplified with primers 
NSW646 and NSW645 cloned 
into pSac-Kan)
pNW1231 pSac-Kan-PbslA-bslAC178A C180A this study(C178A and C180A 
mutations introduced into 
pNW518 with primers 
NSW1124 and NSW1125)
pNW1079 pDR111- bslAss- yweA-bslA171–181 this study (coding region from 
pNW1075 cloned into pDR111 
using HinDIII and SphI)
pNW611 pQE70-bslA signal sequence (hereafter bslAss) Ostrowski et al., 2011
pNW1075 pQE70-bslAss-yweA-bslA171–181 This work (synthetic gene 
amplified with primers 
NSW2026 and NSW645 and 
cloned into pNW611)
pNW512 pDR111-bslA Ostrowski et al., 2011
pNW621 pDR111-bslAΔ172–181- This work (coding region 
amplified with primers 
NSW626 and NSW838)
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Table 4.8. Primers used in section 4.4 
primer name sequence description
NSW12 CGATTCAAAACCTCTTTACTG amyE locus for assessing 
double crossovers
NSW13 GCTTAAGCCCGAGTC amyE locus for assessing 
double crossovers
NSW1900 TCCTCCGACTCAGCCTgcaGGTTGCAACTAAGCAT Site-directed mutagenesis 
(SDM) on pNW512 to convert 
C178 to Ala (AxC)
NSW1901 ATGCTTAGTTGCAACCtgcAGGCTGAGTCGGAGGA SDM on pNW512 to convert 
C178 to Ala (AxC)
NSW1902 GACTCAGCCTTGCGGTgcaAACTAAGCATGCAAGC SDM on pNW512 to convert 
C180 to Ala (CxA)
NSW1903 GCTTGCATGCTTAGTTtgcACCGCAAGGCTGAGTC SDM on pNW512 to convert 
C180 to Ala (CxA)
NSW1904 TCCGACTCAGCCTgcaGGTgcaAACTAAGCATGCA SDM on pNW512/pNW1079 to 




5:1: Thesis summary and implications
This thesis presents data that enhance our understanding of Pseudomonas aeruginosa’s 
impressive metabolic flexibility. Specifically, this work has explored the modularity of P. 
aeruginosa’s aerobic respiratory chain and the distinct physiological roles of its terminal 
oxidases, particularly as they pertain to growth in multicellular communities called biofilms. The 
research discussed in this thesis has also considered the effects that phenazines, redox-active 
secondary metabolites, have on electron flow through the P. aeruginosa respiratory chain and 
explored other pathways of energy generation/conservation in P. aeruginosa. Because biofilm 
formation and respiratory flexibility contribute to P. aeruginosa’s potential to colonize and persist 
in hosts, a more detailed understanding of these features will support efforts to treat infections 
caused by this bacterium. 
5:2: An orphan cbb3-type cytochrome oxidase subunit supports Pseudomonas 
aeruginosa biofilm growth and virulence
The research presented in Chapter 2 focused on one type of P. aeruginosa’s five 
terminal oxidases, the Cco’s, which can contain subunits encoded by redundant genes located 
at distinct sites on the chromosome (Arai et al. 2014; Hirai et al. 2016; Jo et al. 2017). I 
identified a biofilm-specific role for the so-called “orphan” Cco terminal oxidase subunit CcoN4. 
Through genetic analyses, I demonstrated that CcoN4 functions redundantly with the canonical 
CcoN catalytic subunits CcoN1 and CcoN2 to support WT biofilm development. I showed that 
CcoN1 and CcoN2 function predominantly in liquid culture and during early stages of biofilm 
development, conditions where O2 is abundant. In contrast, CcoN4 does not contribute to 
growth in liquid culture but rather supports later stages of biofilm development, when the 
thickness of the community leads to the formation of an anoxic zone at depth. I also 
demonstrated that CcoN4-containing complexes are important for mediating reduction of 
phenazines, whose presence is necessary for the formation and maintenance of an anoxic 
177
zone. These results broadened the scope of terminal oxidase function to include phenazine 
utilization in addition to the reduction of O2.  
Because biofilm formation and survival in O2-limited environments are important for P. 
aeruginosa’s success as a pathogen, I then asked whether CcoN4-containing heterocomplexes 
are involved in virulence using a nematode infection model. The results showed that CcoN4-
containing complexes do indeed contribute to P. aeruginosa pathogenicity and uncovered a 
potential target for novel drugs.  
5:3: Carbon source influences electron flow through the aerobic respiratory chain of 
Pseudomonas aeruginosa
Experiments described in Chapter 3 characterized P. aeruginosa growth on different 
carbon sources and examined how the presence of a subset of terminal oxidases and the 
production of phenazines affect electron flow through the respiratory chain. I found P. 
aeruginosa respiration and metabolism in liquid cultures to be highly adaptable to different 
carbon sources. In contrast, I found that carbon sources contribute differentially to biofilm 
development, underscoring the physiological differences between planktonic and biofilm growth.  
I identified carbon sources that support reduction of a redox dye that is typically used to 
report respiratory activity and discovered that the presence of phenazines also had a profound 
effect on dye reduction during growth on specific carbon sources. I then focused my 
experiments on three carbon sources of particular interest (glucose, succinate, and tryptone) 
and found that biofilm morphology, matrix production, terminal oxidase expression, phenazine 
production, and phenazine utilization were all affected by carbon source identity. My results 
show that the earliest steps in catabolism (i.e., initial oxidations or transformations of the 
electron donor) influence the latest steps (i.e., reduction of the terminal electron acceptor) an 
that these primary metabolic pathways do not function in the purely modular way that they are 
often presented in textbooks. Although we can elucidate the mechanistic details of a pathway by 
studying it in isolation, attempts to control bacterial growth require that we take a global view of 
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metabolism and the relationships between pathways that may, at first, appear to function 
independently. 
5:4: Other pathways of energy generation in Pseudomonas aeruginosa and the 
contribution of redox state to biofilm formation in Bacillus subtilis
The experiments described in Chapter 4 were conducted for the collaborations in which I 
participated as part of my thesis work. Some of this research explored other pathways of energy 
generation in P. aeruginosa and illustrates other facets of P. aeruginosa metabolic flexibility. 
First, I considered the fate of pyruvate, an important intermediate of central metabolism that can 
be modified in a variety of ways. While Chapters 2 and 3 describe pathways that lead to 
pyruvate oxidation through aerobic respiration, Chapter 4 investigated the contribution of 
pyruvate fermentation and carboxylation to P. aeruginosa growth under specific conditions. 
Through my collaborations with the Tong Lab, I was able to contribute in vivo functional data 
that elucidated the physiological roles of pyruvate and acetyl-CoA carboxylases.  
My work with the Stanley-Wall Lab generated data that serve as another example of how 
redox state drives community behavior. I contributed evidence that the conditions found within 
Bacillus subtilis biofilms are amenable to spontaneous disulfide bond formation between BslA 
monomers, which leads to the formation of a hydrophobic coat at the surface of the biofilm. 
These data show how chemical gradients influence the construction of B. subtilis biofilms, much 
as they do in those of P. aeruginosa, emphasizing the universality of redox-dependent 
mechanisms that influence biofilm structure.  
5:5: Concluding remarks
In conclusion, my thesis contributes to the growing body of evidence that Pseudomonas 
aeruginosa is a metabolic powerhouse, able to adjust its physiology in response to electron 
acceptor availability, carbon source, respiratory chain content, and mode of growth. The results 
presented in my thesis remind us that planktonic and biofilm growth are distinct, with specific 
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respiratory enzymes contributing differentially to optimal fitness in either condition. This 
highlights the need for more biofilm-based research when searching for anti-microbial 
compounds that might combat P. aeruginosa (and other bacterial) growth and biofilm-based 
infection in clinical settings. My thesis also serves a more fundamental purpose, to illustrate how 
bacteria are able to withstand major deviations in growth conditions and still grow efficiently. 
These “lesser” organisms are capable of fastidiously tuning their metabolism and have evolved 
to exploit diverse resources for survival and growth. 
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An Aerobic Exercise: Defining the Roles of Pseudomonas aeruginosa Terminal Oxidases 
This chapter is adapted from a commentary article I co-authored in 2014 in the Journal of 
Bacteriology, which was written as a companion piece to a study published in the same issue 
that characterized Pseudomonas aeruginosa’s five terminal oxidases. This chapter is referred to 
in section 1.3.4. 
The opportunistic pathogen Pseudomonas aeruginosa encodes a large and diverse 
complement of aerobic terminal oxidases, which is thought to contribute to its ability to thrive in 
settings with low oxygen availability. In this issue, Arai et al. present a thorough characterization 
of these five complexes, enabling a more detailed understanding of aerobic respiration in this 
organism. 
Although the Earth’s atmosphere contains approximately 21% oxygen, bacteria in 
environments that are ostensibly aerobic still encounter zones where the concentration is much 
lower, due to the effects of oxygen solubility, low diffusibility, and consumption by neighboring 
cells. Many bacteria cope with this in part through the use of branched respiratory chains that 
can be modulated in response to changing conditions (Poole and Cook 2000) . Aerobic terminal 
oxidases, which catalyze electron transfer from the respiratory apparatus to oxygen, vary in their 
affinities and efficiencies (Morris and Schmidt 2013). Five such enzymes have been identified in 
the opportunistic pathogen Pseudomonas aeruginosa (Fig. 1), and these are thought to 
contribute to its ability to thrive under hypoxia (Poole and Cook 2000; Matsushita et al. 1980; 
Comolli and Donohue 2004; Alvarez-Ortega and Harwood 2007; Kawakami et al. 2010; 
Williams, Zlosnik, and Ryall 2007; Arai 2011). A diverse collection of aerobic terminal oxidases 
may be especially critical for an organism that has a proficiency for persisting in biofilms, which 
are characterized by the formation of steep oxygen gradients (Xu et al. 1998; Dietrich et al. 
2013; Wessel et al. 2014). In addition to contributing to P. aeruginosa’s growth under 
microaerobic conditions, some of these complexes have been implicated in its ability to cope 
with various stresses (Kawakami et al. 2010; Cunningham and Williams 1995). In this issue of 
the Journal of Bacteriology, Arai et al. conduct a comprehensive study of these complexes, 
probing their biochemical properties and contributions to aerobic growth (Arai et al. 2014). They 
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describe a systematic investigation of the attributes of each enzyme, which clarified many 
aspects of P. aeruginosa’s aerobic biology and revealed a new potential role for a particular 
high-affinity oxidase. 
The P. aeruginosa aerobic terminal oxidases include enzymes that can use ubiquinol or 
cytochromes as electron donors, ones that have low or high affinities for O2, and a cyanide-
insensitive oxidase (CIO) that functions in the presence of this endogenously produced 
virulence factor (Cunningham and Williams 1995). Aside from CIO, the four other aerobic 
terminal oxidases encoded by the P. aeruginosa genome are the bo3 oxidase (Cyo), the aa3 
oxidase (Aa3), cbb3 oxidase-1 (Cbb3-1), and cbb3 oxidase-2 (Cbb3-2). Earlier studies predicted 
that Cyo and Aa3 (which is most similar to the mitochondrial terminal oxidase) would have low 
affinities for oxygen and that CIO and the Cbb3 enzymes would have high oxygen affinities 
(Comolli and Donohue 2004; Alvarez-Ortega and Harwood 2007; Kawakami et al. 2010; Bosma 
The P. aeruginosa membrane-bound electron transport chain can employ five different 
oxygen reductases. Ubiquinone (Ub) is reduced by a dehydrogenase (not shown) and acts as 
the electron donor for the cytochrome bc1 complex, Cyo, or CIO. The cytochrome bc1 complex 
reduces a c-type cytochrome, which then acts as the electron donor for Aa3, Cbb3-1 (or Cco1), 
or Cbb3-2 (or Cco2). Heme-copper oxidases are represented by pink shapes. Oxidases that 
support growth better under microaerobic conditions are shaded yellow, while those that support 
growth better under typical conditions are shaded blue. These roles are influenced by intrinsic 
chemical properties and expression levels of the individual complexes. Approximate affinities for 
oxygen (Km Values obtained amperometrically) are shown. 
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et al. 1987; Winstedt and von Wachenfeldt 2000). In batch cultures grown under typical 
conditions (i.e., in nutrient-rich media and atmospheric oxygen, with vigorous shaking), the low-
affinity enzymes Cyo and/or Aa3 would thus be expected to play major roles during exponential 
growth, when oxygen is relatively abundant. The high-affinity enzymes Cbb3-1 and Cbb3-2 
would be expected to function primarily in stationary phase, when oxygen is relatively scarce, 
and/or during growth in microaerobic conditions. Hypothetically, CIO would be particularly 
important in stationary phase, as it is the only terminal oxidase that functions in the presence of 
cyanide, which P. aeruginosa produces at high cell density (Williams, Zlosnik, and Ryall 2007; 
Cunningham and Williams 1995; Cunningham, Pitt, and Williams 1997). 
Using gene expression and mutant analyses, previous studies have revised and clarified 
this working model of P. aeruginosa aerobic respiration. They have shown that the Aa3 oxidase, 
which plays a major role in aerobic respiration in other bacteria ((Bosma et al. 1987; Winstedt 
and von Wachenfeldt 2000), is expressed primarily under nutrient-limited conditions and is 
otherwise a minor player under typical conditions (Kawakami et al. 2010). Rather, the Cbb3-1, 
Cbb3-2, and CIO oxidases play major roles, and their importance is exaggerated when oxygen 
becomes limiting and during growth in biofilms (Comolli and Donohue 2004; Alvarez-Ortega and 
Harwood 2007; Kawakami et al. 2010; Hamada et al. 2014). The two Cbb3 oxidases are very 
similar at the amino acid level (with a similarity of 87% for the catalytic subunit in strain PAO1), 
but they are differentially regulated: the Cbb3-1 complex is expressed constitutively, while the 
Cbb3- 2 complex is induced by oxygen limitation (Comolli and Donohue 2004; Alvarez-Ortega 
and Harwood 2007). Critically, these studies also showed that oxidase gene expression can be 
compensatory, such that loss of one or more oxidases leads to induction of others (Kawakami et 
al. 2010). 
To study the physiological roles of the P. aeruginosa aerobic terminal oxidases in 
isolation, Arai et al. took the important step of generating combinatorial mutants, each 
containing only one of these complexes, in strain PAO1. Growth experiments confirmed the 
unique primary physiological roles of the Cbb3 complexes in this bacterium (Comolli and 
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Donohue 2004; Alvarez-Ortega and Harwood 2007; Kawakami et al. 2010). Under typical 
conditions, the strain containing the Cbb3-1 oxidase grew like the wild type, while the strain 
containing the Cbb3-2 oxidase showed a defect earlier in the growth experiment before 
“catching up” to the final wild-type density. This growth profile is consistent with the prior 
observation that Cbb3-2 is induced specifically by oxygen limitation (Comolli and Donohue 
2004); basal levels of expression could support initial growth before increased oxygen 
consumption by the denser culture brings the oxygen level down and thereby enhances 
expression. The growth phenotypes of the other individual single-oxidase strains also reflected 
what was known about regulation of the P. aeruginosa terminal oxidases (Comolli and Donohue 
2004; Kawakami et al. 2010).  
Prior work looking at expression of genes encoding putative c-type cytochromes had 
provided clues as to which of these proteins might carry electrons from the cytochrome bc1 
complex to the Cbb3-type oxidases (Kawakami et al. 2010). Arai et al. used a genetic approach 
to determine that cytochrome c4, encoded by ORF PA5490 in strain PAO1, is the predominant 
mediator functioning at this step in the electron transport pathway under typical and 
microaerobic conditions. This finding fills in an important gap that was remaining in our model of 
the P. aeruginosa aerobic respiratory chain.  
To assess their positions in the electron transport chain and oxygen affinities, Arai et al. 
conducted in vitro studies with membranes prepared from strains producing each of the 
individual oxidases. Oxygen consumption assays confirmed the electron donor (ubiquinone or 
cytochrome c) predictions for each complex (Comolli and Donohue 2004), as well as the 
cyanide sensitivity of all of the oxidases but CIO. A battery of affinity assays also confirmed 
predictions for the relative affinities of the oxidases, with one exception: CIO, a cytochrome bd-
type enzyme, was found to differ from the canonical Escherichia coli cytochrome bd (D’mello, 
Hill, and Poole 1996) in that it showed a low affinity for oxygen. The physiological consequences 
of the low oxygen affinity of CIO were examined by expressing the P. aeruginosa cioAB genes in 
an E. coli mutant lacking native terminal oxidases. The growth of this strain was compared to a 
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version of the same mutant expressing the E. coli cytochrome bd under the same promoter. 
Growth rates and yields for the two strains were similar under typical conditions, but the CIO-
expressing strain showed a slower growth rate under microaerobic conditions, further 
supporting the conclusion that CIO functions optimally when oxygen availability is relatively 
high. 
By generating P. aeruginosa mutants that each expressed only one terminal oxidase, 
Arai et al. were able to address outstanding questions regarding oxygen respiration and provide 
a more complete picture of the aerobic electron transport chain in this pathogen. A particularly 
intriguing feature of the P. aeruginosa system is that a high-affinity oxidase, Cbb3-1, functions as 
the major oxygen reductase in well-aerated cultures (Fig. 1). The authors point out that this is a 
unique trait, as most other bacteria regulate high-affinity oxidases such that they are expressed 
specifically under low-oxygen conditions, with low-affinity enzymes similar to Aa3 and/or Cyo 
acting as the major oxidase(s) under high-oxygen conditions (Bosma et al. 1987; Winstedt and 
von Wachenfeldt 2000; Ugidos et al. 2008). Even the closely related Pseudomonas putida, 
which also possess two Cbb3-type enzymes, employs Cyo as its major oxidase under typical 
conditions (Ugidos et al. 2008). Though the measured proton translocation efficiency (protons 
translocated across the membrane per oxygen atom consumed) values of the Cbb3-type 
oxidases were lower than that of the Aa3 oxidase, they were higher than the efficiency value of 
CIO and comparable to that of the Cyo oxidase.  
The critical role of Cbb3-1 during exponential growth with relatively high oxygen 
availability raises the question of whether this enzyme contributes capabilities beyond oxygen 
reduction in typical P. aeruginosa cultures. The Cbb3 oxidases differ from other heme-copper 
oxidases in their subunit and binuclear active site composition exhibiting structural similarities to 
nitric oxide reductases (NORs) (Buschmann et al. 2010; Pitcher and Watmough 2004). Cbb3 
oxidase purified from P. stutzeri has been shown to have NOR activity (Forte et al. 2001), and P. 
aeruginosa’s Cbb3 oxidases have been implicated in anaerobic denitrification and NO-mediated 
effects on biofilm formation (Hamada et al. 2014). In diverse organisms, effects of the Cbb3 
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oxidases on the expression of other metabolic genes and on biomineralization have suggested 
that they may be involved in sensing and responding to changes in redox homeostasis (Comolli 
and Donohue 2004; Oh and Kaplan 2000; Li et al. 2014) Finally, results from the current study 
and others suggest that modulation of the P. aeruginosa respiratory chain is strongly influenced 
by environmental stresses, and the different oxidases provide activity under distinct, specialized 
conditions (Kawakami et al. 2010; Williams, Zlosnik, and Ryall 2007; Cunningham, Pitt, and 
Williams 1997). Aa3 is expressed during nutrient starvation, Cyo is expressed under iron 
starvation and in the presence of a NO-generating reagent, and CIO is induced by copper 
starvation and cyanide (Kawakami et al. 2010). As Arai et al. note, utilization of Cbb3-1 during 
exponential growth may provide protection from reactive oxygen species or another unknown 
source of stress. Further investigation into the ecophysiology of P. aeruginosa biofilm formation 
and infection may uncover the significance of Cbb3 activity for this bacterium, which utilizes 
oxygen preferentially and yet dominates in environments where it is in short supply. 
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